UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

_________________________________________

WASHINGTON, D.C. 20549

FORM 20-F/A

(Amendment No. 1)

(Mark One)

[   ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

[ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2016

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________

OR

[   ] SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report _____________

Commission file number 000-55103

_________________________________________

TOWER ONE WIRELESS CORP.
(Exact name of registrant as specified in its charter)

N/A
(Translation of registrant’s name into English)

British Columbia, Canada
(Jurisdiction of incorporation or organization)

600-535 Howe Street, Vancouver, BC V6C 2Z4 Canada
(Address of principal executive offices)

Tel: 604-559-8051
(Name, Telephone, E-Mail and/or Facsimile Number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:
NONE

Securities registered or to be registered pursuant to Section 12(g) of the Act:

Title of each class: Name of each exchange on which registered:

 





CLASS A COMMON SHARES,
NO PAR VALUE
Canadian Securities Exchange

_________________________________________

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
NONE

Indicate the number of outstanding shares of each of the Company’s classes of capital or common stock as of the close of the period covered by the annual report:
6,735,885 Class A Common Shares, no par value as of December 31, 2016.

Indicate by check mark if the registrant is a well-known seasoned Company, as defined in Rule 405 of the Securities Act.

YES [   ]    NO [ X ]

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

YES [   ]    NO [ X ]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES [ X ]    NO [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site: www.toweronewireless.com, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

YES [   ]    NO [ X ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 in the Exchange Act. (Check one):

Large Accelerated Filer  [   ] Accelerated Filer  [   ] Non-Accelerated Filer  [ X ]

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

[   ]    U.S. GAAP
[ X ]    International Financial Reporting Standards as issued by the International Accounting Standards Board
[   ]    Other

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:

[   ] Item 17   [ X ] Item 18

If this is an annual report indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act:

YES [   ]    NO [ X ]





Explanatory Note

This Amendment No. 1 on Form 20-F/A (this “Amendment No. 1”) to our annual report on Form 20-F for the year ended December 31, 2016, filed with the Securities and Exchange Commission on May 9, 2017 (the “2016 Form 20-F”), is filed to amend and restate the entire 2016 Form 20-F.

Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, we have included the entire text of the 2016 Form 20-F in this Amendment No. 1 and new certifications by our chief executive officer and chief financial officer are being filed as exhibits to this Amendment No. 1.





Table of Contents

PART I  
Item 1. Identity of Directors, Senior Management and Advisors 1
Item 2. Offer Statistics and Expected Timetable 1
Item 3. Key Information 1
Item 4. Information on the Company 10
Item 4A. Unresolved Staff Comments 14
Item 5. Operating and Financial Review 14
Item 6. Directors, Senior Management and Employees 20
Item 7. Major Shareholders and Related Party Transactions 26
Item 8. Financial Information 27
Item 9. The Offer and Listing 28
Item 10. Additional Information 29
Item 11. Quantitative and Qualitative Disclosures about Market Risk 37
Item 12. Description of Securities Other Than Equity Securities 37
PART II 38
Item 13. Defaults, Dividend Arrearages and Delinquencies 38
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds 38
Item 15. Controls and Procedures 38
Item 16A. Audit Committee Financial Experts 38
Item 16B. Code of Ethics 38
Item 16C. Principal Accountant Fees and Services 39
Item 16D. Exemptions from the Listing Standards for Audit Committees 39
Item 16E. Purchases of Equity Securities by the Company and Affiliated Purchasers 39
Item 16F. Change in Registrant’s Certifying Accountant 39
Item 16G. Corporate Governance 41
Item 16H. Mine Safety Disclosure 41
PART III  
Item 17. Financial Statements 42
Item 18. Financial Statements 42
Item 19. Exhibits 42
SIGNATURES 43

 





Part I

References in this Annual Report on Form 20-F to “we,” “our” and the “Company” refer to Tower One Wireless Corp. and its predecessor, as applicable, individually and collectively with its subsidiaries as the context requires.

Brief Introduction

Tower One Wireless Corp. is a British Columbia, Canada corporation, incorporated on September 12, 2005. It is a reporting Company in British Columbia and Ontario, and its shares are listed for trading on the Canadian Securities Exchange (“CSE”).

Item 1. Identity of Directors, Senior Management and Advisers

Not applicable.

Item 2. Offer Statistics and Expected Timetable

Not applicable

Item 3. Key Information

A. Selected financial data

The following selected information should be read in conjunction with the Company’s financial statements, and notes, filed with this Form 20-F. This information, and all other financial information in this Form 20-F, is stated in Canadian dollars unless otherwise noted.

The financial information is presented on the basis of International Financial Reporting Standards as issued by the International Accounting Standards Board.

On March 15, 2016, the Company completed a share consolidation on the basis of thirty pre-consolidation common shares for each post consolidation common share. As such, all current and comparative share amounts have been restated to account for the 30 to 1 common share consolidation.

Period ended FYE 2016 FYE 2015 FYE 2014 FYE 2013 FYE 2012
  (IFRS) (IFRS) (IFRS) (IFRS (IFRS)
Total Revenues $Nil $Nil $Nil $Nil $Nil
Net loss and Comprehensive Loss ($452,288) $179,673 ($693,645) ($740,846) ($605,468)
Basic and diluted loss per share (0.09) $0.13 ($0.56) ($0.81) ($0.84)
Weighted average shares 5,175,946 1,351,500 1,248,561 918,732 721,240

 

Year ended FYE 2016 FYE 2015 FYE 2014 FYE 2013 FYE 2012
  (IFRS) (IFRS) (IFRS) (IFRS) (IFRS)
Total assets $1,608,280 $14,696 $67,315 $287,004 $206,533
Net Assets 1,468,473 (609,410) ($875,761) ($440,144) ($430,990)
Share capital $3,292,175 $2,800,010 $2,760,010 $2,669,210 $1,995,716
Shares committed for issuance $Nil $4,800 $Nil $Nil $Nil
Equity component of convertible note $Nil $1,080 $Nil $Nil $Nil
Share subscriptions received $1,602,257 $Nil $30,000 $Nil $30,000
Contributed surplus $563,568 $121,939 $289,766 $123,704 $206,212
Deficit accumulated ($3,989,527) ($3,537,239) ($3,955,537) ($3,263,058) ($2,662,918)

Common Shares Issued and Outstanding

6,735,885 1,365,887 1,299,221 1,248,554 761,894
Dividends $Nil $Nil $Nil $Nil $Nil

1





Currency

The following table sets out exchange rates, based on the noon buying rates in New York City, for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York, referred to as the "Noon Buying Rate", for the conversion of dollars to Canadian dollars in effect at the end of the following periods, the average exchange rates during these periods (based on daily Noon Buying Rates) and the range of high and low exchange rates for the periods indicated:

          Years Ended December 31,        
  2016   2015   2014   2013   2012
          ($/C$)        
End of period 0.7448   0.7226   0.8620   0.9401   1.0042
High for period 0.6853   0.7148   0.8588   0.9348   0.9600
Low for period 0.7972   0.8529   0.9423   1.0164   1.0299
Average for period 0.7558   0.7830   0.9060   0.9712   1.0007

On September 5, 2017, the most recent weekly publication of the Noon Buying Rate before the date of this Form 20-F reported that, as of September 1, 2017, the Noon Buying Rate for the conversion of dollars to Canadian dollars was $0.8083 per Canadian dollar.

B. Capitalization and indebtedness.

Not Applicable.

C. Reasons for the offer and use of proceeds.

Not Applicable.

D. Forward-Looking Statement and Risk factors.

Forward-Looking Statements

This Form 20-F and the documents incorporated herein by reference contain forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential” or “continue” or the negative of these or similar terms.

In evaluating these forward-looking statements, you should consider the following factors, as well as those described in “Risk Factors” below:

  • changes to existing or new tax laws or methodologies impacting the Company’s international operations, fees directed specifically at the ownership and operation of communications sites or international acquisitions, any of which may be applied or enforced retroactively, or failure to obtain an expected tax status for which the Company has applied;

  • laws or regulations that tax or otherwise restrict repatriation of earnings or other funds or otherwise limit distributions of capital;

  • changes in a specific country’s or region’s political or economic conditions, including inflation or currency devaluation;

  • changes to zoning regulations or construction laws, which could be applied retroactively to existing communications sites;

  • expropriation or governmental regulation restricting foreign ownership or requiring reversion or divestiture;

  • actions restricting or revoking the Company’s customers’ spectrum licenses or suspending or terminating business under prior licenses;

  • failure to comply with anti-bribery laws or similar local anti-bribery laws;

  • material site security issues;

  • significant increase in or implementation of new license surcharges on the Company’s revenue;

  • price setting or other similar laws or regulations for the sharing of passive infrastructure;

  • uncertain or inconsistent laws, regulations, rulings or results from legal or judicial systems, which may be enforced

2





    retroactively, and delays in the judicial process; and

  • changes in foreign currency exchange rates, including those arising from the Company’s operations, investments and financing transactions related to its international business.

These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this Form 20-F and the documents incorporated by reference herein may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. Unless required by applicable law, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Risk Factors

An investment in the Common Shares of the Company must be considered highly speculative due to the nature of the Company’s business. The risk and uncertainties below are not the only risks and uncertainties the Company may have. Additional risks and uncertainties not presently known to the Company or that the Company currently considers immaterial may also impair the business, operations and future prospects of the Company and cause the price of the Common Shares to decline. If any of the following risks actually occur, the business of the Company may be harmed and its financial condition and results of operations may suffer significantly. In addition to the risks described elsewhere and the other information in this Form 20-F, the Company notes the following risk factors:

Company Risks

The Company’s business depends on the demand for wireless communication services and wireless infrastructure, and it may be adversely affected by any slowdown in such demand. Additionally, a reduction in carrier network investment may materially and adversely affect the Company’s business (including reducing demand for new tenant additions or network services).

Demand for the Company’s wireless infrastructure depends on the demand for antenna space from its customers, which, in turn, depends on the demand for wireless communication services by their customers. The willingness of the Company’s customers to utilize its wireless infrastructure, or renew or extend existing leases on its wireless infrastructure, is affected by numerous factors, including:

  • consumer demand for wireless connectivity;

  • availability or capacity of wireless infrastructure or associated land interests;

  • location of wireless infrastructure;

  • financial condition of customers, including their profitability and availability or cost of capital;

  • willingness of customers to maintain or increase their network investment or changes in their capital allocation strategy;

  • availability and cost of spectrum for commercial use;

  • increased use of network sharing, roaming, joint development, or resale agreements by customers;

  • mergers or consolidations among customers;

  • changes in, or success of, customers' business models;

  • governmental regulations, including local or state restrictions on the proliferation of wireless infrastructure;

  • cost of constructing wireless infrastructure;

  • technological changes, including those (1) affecting the number or type of wireless infrastructure needed to provide wireless connectivity to a given geographic area or which may otherwise serve as substitute or alternative to wireless infrastructure or (2) resulting in the obsolescence or decommissioning of certain existing wireless networks; or

  • the ability to efficiently satisfy customers' service requirements.

A slowdown in demand for wireless connectivity or wireless infrastructure may negatively impact the Company’s growth or otherwise have a material adverse effect on the Company. If the Company’s customers or potential customers are unable to raise adequate capital to fund their business plans, as a result of disruptions in the financial and credit markets or otherwise, they may reduce their spending, which could adversely affect the Company’s anticipated growth or the demand for the Company’s wireless infrastructure or network services. The amount, timing, and mix of the Company’s customers' network investment is variable and can be significantly impacted by the various matters described in these risk factors. Changes in carrier network investment typically impact the demand for its wireless infrastructure. As a result, changes in carrier plans such as delays in the implementation of new systems, new technologies (including small cells), or plans to expand coverage or capacity may reduce demand for its wireless infrastructure. Furthermore, the wireless industry could experience a slowdown or slowing growth rates as a result of numerous factors, including a reduction in consumer demand for wireless connectivity or general economic conditions. There can be no assurances that weakness or uncertainty in the economic

3





environment will not adversely impact the wireless industry, which may materially and adversely affect the Company’s business, including by reducing demand for its wireless infrastructure or network services. In addition, a slowdown may increase competition for site rental customers or network services. A wireless industry slowdown or a reduction in carrier network investment may materially and adversely affect the Company’s business.

New technologies may reduce demand for wireless infrastructure or negatively impact revenues.

Improvements in the efficiency, architecture, and design of wireless networks may reduce the demand for the Company’s wireless infrastructure. For example, new technologies that may promote network sharing, joint development, or resale agreements by its customers, such as signal combining technologies or network functions virtualization, may reduce the need for the Company’s wireless infrastructure. In addition, other technologies, such as WiFi, DAS, femtocells, other small cells, or satellite (such as low earth orbiting) and mesh transmission systems may, in the future, serve as substitutes for, or alternatives to, leasing that might otherwise be anticipated or expected on wireless infrastructure had such technologies not existed. In addition, new technologies that enhance the range, efficiency, and capacity of wireless equipment could reduce demand for the Company’s wireless infrastructure. Any significant reduction in demand for the Company’s wireless infrastructure resulting from the new technologies may negatively impact the Company’s revenues or otherwise have a material adverse effect on the Company.

The expansion or development of the Company’s business, including through acquisitions, increased product offerings or other strategic growth opportunities, may cause disruptions in the Company’s business, which may have an adverse effect on the Company’s operations or financial results.

The Company may seek to expand and develop its business, including through acquisitions, increased product offerings (such as small cells and fiber), or other strategic growth opportunities. In the ordinary course of business, the Company may review, analyze, and evaluate various potential transactions or other activities in which it may engage. Such transactions or activities could cause disruptions in, increase risk or otherwise negatively impact its business. Among other things, such transactions and activities may:

  • disrupt the Company’s business relationships with its customers, depending on the nature of or counterparty to such transactions and activities;

  • direct the time or attention of management away from other business operations;

  • fail to achieve revenue or margin targets, operational synergies or other benefits contemplated;

  • increase operational risk or volatility in the Company’s business; or

  • result in current or prospective employees experiencing uncertainty about their future roles with the Company, which might adversely affect the Company’s ability to retain or attract key managers or other employees.

If the Company fails to retain rights to its wireless infrastructure, including the land interests, the Company’s business may be adversely affected. The property interests on which the Company’s wireless infrastructure resides, including the land interests under its towers, consist of leasehold interests. A loss of these interests may interfere with the Company’s ability to conduct its business or generate revenues. For various reasons, the Company may not always have the ability to access, analyze, or verify all information regarding titles or other issues prior to purchasing wireless infrastructure. Further, the Company may not be able to renew ground leases on commercially viable terms. The Company’s ability to retain rights to the land interests on which its towers reside depends on its ability to purchase such land, including fee interests and perpetual easements, or renegotiate or extend the terms of the leases relating to such land. If the Company is unable to retain rights to the property interests on which its wireless infrastructure resides, its business may be adversely affected.

Political, economic and other uncertainties in countries where the Company operates could negatively effect the company’s business

The Company’s business operations are currently located in Colombia. Although Colombia has a long-standing tradition of respecting the rule of law, which has been bolstered in recent years by the present government’s policies and programs, no assurance can be given that the Company’s plans and operations will not be adversely affected by future developments in Colombia. The Company’s existing assets and proposed activities in Colombia are subject to political, economic and other uncertainties, including the risk of expropriation, nationalization, renegotiation or nullification of existing contracts, licenses and permits or other agreements, changes in laws or taxation policies, currency exchange restrictions, changing political conditions, and international monetary fluctuations. Future government actions concerning the economy, taxation, or the operation and regulation of nationally important facilities such as communications could have a significant effect on the Company. Any changes in regulations or shifts in political attitudes are beyond the Company’s control and may adversely affect its business. The Company’s business may be affected in varying degrees by government regulations with respect to restrictions on future expansion, price controls, export controls, foreign exchange controls, earnings repatriation, income

4





and/or business taxes or expropriations.

In particular, operating in Columbia presents the following unique risks to the Company’s business and operations:

Legal System

As a civil law jurisdiction, Colombia has a legal system different from the common law jurisdictions of Canada. There can be no assurance that licenses, permits, applications or other legal arrangements will not be adversely affected by changes in governments, the actions of government authorities or others, or the effectiveness and enforcement of such arrangements.

Permits and Licenses

The Company’s business activities in Colombia are dependent on receipt of government approvals or permits to develop its business. Any delays in receiving government approvals or permits or no objection certificates may delay the Company’s operations or may affect the status of the Company’s contractual arrangements or its ability to meet its contractual obligations.

Repatriation of Earnings

Currently there are no restrictions on the repatriation from Colombia of capital and distribution of earnings from Colombia to foreign entities. However, there can be no assurance that restrictions on repatriation of capital or distributions of earnings from Colombia will not be imposed in the future.

Foreign Currency Fluctuations

The Company’s current and proposed business operations in Colombia render it subject to foreign currency fluctuations, which may materially affect its financial position. The Company holds Canadian and U.S. dollars and sends funds to Colombia in U.S. dollars, which are then converted into Colombian pesos. The important exchange rates for the Company are those for the U.S. dollar, Canadian dollar and Colombian peso. While the Company is funding operations in Colombia, its results could be impaired by adverse changes in the U.S. dollar and Canadian dollar relative to the Colombian peso exchange rate. Prior and future equity financings result in the generation of Canadian dollar proceeds to fund the Company’s activities, which are mostly incurred in U.S. dollars or Colombian pesos. To the extent funds from such financings are maintained in Canadian dollars, the Company’s results can be significantly impacted by adverse changes in exchange rates between the Canadian dollar, the U.S. dollar and the Colombian peso.

The Company’s operations may also be adversely affected by laws and policies of Canada affecting foreign trade, taxation and investment. In the event of a dispute arising in connection with the Company’s operations in Colombia, the Company may be subject to the exclusive jurisdiction of foreign courts or tribunals, or may not be successful in subjecting foreign persons to the jurisdictions of the courts of Canada or enforcing Canadian judgments in such other jurisdictions. Company may also be hindered or prevented from enforcing its rights with respect to a governmental body because of the doctrine of sovereign immunity. Accordingly, the Company’s business activities in Colombia could be substantially affected.

Security and guerrilla activity in Colombia could negatively impact the Company’s business

Colombia has had a publicized history of security problems associated with certain narcotics crime organizations and other terrorist groups. A 40-year armed conflict between the government forces of Colombia and anti-government insurgent groups and illegal paramilitary groups, both thought to be funded by the drug trade, continues in Colombia. Insurgents continue to attack civilians and violent guerrilla activity continues in many parts of the country.

There have been peace negotiations between the government and the Fuerzas Armadas Revolucionarias de Colombia (FARC) guerrillas for many years. A recent settlement has been reached to end the conflict, which is intended to bring further institutional strengthening and development, particularly to rural regions. The government’s biggest challenge is to maintain a lasting peace and that demobilized members of the FARC rejoin civilian life, rather than regrouping in criminal bands.

Continuing attempts to reduce or prevent guerrilla activity may disrupt the Company’s operations in the future. The Company may not be able to establish or maintain the safety of its operations and personnel in Colombia and this violence may affect its operations in the future. Any increase in kidnapping and/or terrorist activity in Colombia generally may disrupt supply chains and discourage qualified individuals from being involved in the Company’s operations. Additionally, the perception that matters have not improved in Colombia may hinder the Company’s ability to access capital in a timely or cost effective manner.

5





Social Disruptions and Instability in Columbia could disrupt the Company’s Operations

Generally, companies operating in the telecommunications industry in Columbia have experienced various degrees of interruptions to their operations as a result of social instability. This uncertainty may affect operations in unpredictable ways, including disruptions of access of the Company’s operators to the Company’s towers. There can be no assurance that the Company will be successful in protecting itself against these risks and the related financial consequences. Further, these risks may not in any part be insurable in the event the Company does suffer damage.

The application of anti-bribery or corruption laws could impact the Company’s operations

The Company’s operations are governed by the laws of many jurisdictions, which generally prohibit bribery and other forms of corruption. It is possible that the Company, or some of its subsidiaries, employees or contractors, could be charged with bribery or corruption as a result of the unauthorized actions of its employees or contractors. If the Company is found guilty of such a violation, which could include a failure to take effective steps to prevent or address corruption by its employees or contractors, the Company could be subject to onerous penalties and reputational damage. A mere investigation itself could lead to significant corporate disruption, high legal costs and forced settlements (such as the imposition of an internal monitor). In addition, bribery allegations or bribery or corruption convictions could impair the Company’s ability to work with governments or nongovernmental organizations. Such convictions or allegations could result in the formal exclusion of the Company from a country or area, national or international lawsuits, government sanctions or fines, project suspension or delays, reduced market capitalization and increased investor concern.

If the Company fails to comply with laws or regulations which regulate its business and which may change at any time, the Company may be fined or even lose its right to conduct some of its business.

A variety of laws and regulations apply to the Company’s business, including the laws of Colombia. Failure to comply with applicable requirements may lead to civil penalties or require the Company to assume indemnification obligations or breach contractual provisions. The Company cannot guarantee that existing or future laws or regulations will not adversely affect its business, or result in additional costs. These factors may have a material adverse effect on the Company.

The Company’s industry is heavily regulated and thus the Company is subject to substantial regulatory risks

The activities of the Company are subject to intense regulation by governmental authorities. Achievement of the Company’s business objectives are contingent, in part, upon compliance with regulatory requirements enacted by these governmental authorities and obtaining all regulatory approvals. The Company cannot predict the time required to secure all appropriate regulatory approvals for its products, or the extent of testing and documentation that may be required by governmental authorities. Any delays in obtaining, or failure to obtain regulatory approvals could have a material adverse effect on the business, results of operations and financial condition of the Company. The business of the Company is subject to rapid regulatory changes. Failure to keep up with such changes may adversely affect the business of the Company and have a detrimental impact on the Company’s business.

Changes in current or future laws or regulations could restrict its ability to operate its business as it currently does

The Company’s business and that of its tenants are subject to various laws and regulations. In certain jurisdictions, these regulations could be applied or enforced retroactively, which could require that the Company modify or dismantle existing towers. Since the Company’s operating subsidiary, Tower Three SAS (“Tower Three”), is incorporated in Colombia it is thus it is subject to the laws of such jurisdiction. The Colombian Ministry of Communications has a protocol aimed to explain to local authorities and communities the existence of environmental impacts and negative effects on the health of the people. Zoning authorities and community organizations are often opposed to construction of communications sites in their communities, which can delay, prevent or increase the cost of new tower construction, modifications, additions of new antennas to a site or site upgrades, thereby limiting the Company’s ability to respond to tenant demands. The regulations about distance of cell towers to schools, hospitals, and residences, depend on local authorities, as in Colombia the mayors of municipalities have the power to regulate in an autonomous way the matters related to telecommunication infrastructure. Existing regulatory policies may materially and adversely affect the timing or cost of construction projects associated with the Company’s communications sites and new regulations may be adopted that increase delays or result in additional costs to the Company, or that prevent such projects in certain locations, and noncompliance could result in the imposition of fines or an award of damages to private litigants. In certain jurisdictions, there may be changes to zoning regulations or construction laws based on site location, which may result in increased costs to modify certain of the Company’s existing towers or decreased revenue due to the removal of certain towers to ensure compliance with such changes. These factors could materially and adversely affect the Company’s business, results of operations or financial condition.

6





Changes to the tax laws in Colombia could negatively impact the Company’s business and operations.

The introduction of new tax laws, regulations or rules, or changes to, or differing interpretation of, or application of, existing tax laws, regulations or rules in Colombia, could result in an increase in the Company’s taxes, or other governmental charges, duties or impositions. No assurance can be given that new tax laws, regulations or rules will not be enacted or that existing tax laws, regulations or rules will not be changed, interpreted or applied in a manner which could result in any of the Company’s profits being subject to additional taxation or which could otherwise have a material adverse effect on the Company.

If radio frequency emissions from wireless handsets or equipment on wireless infrastructure are demonstrated to cause negative health effects, potential future claims could adversely affect the Company’s operations, costs or revenues.

The potential connection between radio frequency emissions and certain negative health effects, including some forms of cancer, has been the subject of substantial study by the scientific community in recent years. The Company cannot guarantee that claims relating to radio frequency emissions will not arise in the future or that the results of such studies will not be adverse to the Company. Public perception of possible health risks associated with cellular or other wireless connectivity services may slow or diminish the growth of wireless companies, which may in turn slow or diminish the Company’s growth. In particular, negative public perception of, and regulations regarding, these perceived health risks may slow or diminish the market acceptance of wireless services. If a connection between radio frequency emissions and possible negative health effects were established, the Company’s operations, costs, or revenues may be materially and adversely affected. The Company currently does not maintain any significant insurance with respect to these matters.

The Company may be vulnerable to security breaches that could adversely affect its operations, business, operations, and reputation.

The Company’s wireless infrastructure may be vulnerable to damage, disruptions, or shutdowns due to unauthorized access, computer viruses, cyber-attacks, and other security breaches. An attack attempt or security breach could potentially result in (1) interruption or cessation of certain of the Company’s services to its customers, (2) the Company’s inability to meet expected levels of service, or (3) data transmitted over the Company’s customers' networks being compromised. The Company cannot guarantee that its security measures will not be circumvented, resulting in customer network failures or interruptions that could impact its customers' network availability and have a material adverse effect on its business, financial condition, or operational results. The Company may be required to expend significant resources to protect against or recover from such threats. If an actual or perceived breach of its security occurs, the market perception of the effectiveness of its security measures could be harmed, and the Company could lose customers. Further, the perpetrators of cyber-attacks are not restricted to particular groups or persons. These attacks may be committed by the Company’s employees, contractors or external actors operating in any geography. Any such events could result in legal claims or penalties, disruption in operations, misappropriation of sensitive data, damage to the Company’s reputation, negative market perception, or costly response measures, which could adversely affect its business.

If the Company is unable to protect its rights to the land under its towers, its business and operating results would be adversely effected

The Company’s real property interests relating to its towers consist primarily of leasehold and sub-leasehold interests. A loss of these interests at a particular tower site may interfere with the Company’s ability to operate tower sites and generate revenues. For various reasons, the Company may not always have the ability to access, analyze and verify all information regarding titles and other issues prior to completing an acquisition of communications sites, which can affect its rights to access and operate a site. From time to time the Company may also experience disputes with landowners regarding the terms of ground agreements for land under towers, which may affect the Company’s ability to access and operate tower sites. Further, for various reasons, landowners may not want to renew their ground agreements with the Company, they may lose their rights to the land, or they may transfer their land interests to third parties, including ground lease aggregators, which could affect the Company’s ability to renew ground agreements on commercially viable terms. The Company’s inability to protect its rights to the land under its towers may have a material adverse effect on its business and operating results.

The Company could have liability under environmental and occupational safety and health laws.

The Company’s operations are subject to the requirements of environmental and occupational safety and health laws and regulations, including municipal zoning regulations and height restrictions imposed by the Colombian DAAC-FAN (Colombia’s FAA). Many of these laws and regulations contain information reporting and record keeping requirements. The Company may not be at all times in compliance with all environmental requirements. The Company may be subject to

7





potentially significant fines or penalties if it fail to comply with any of these requirements. The requirements of these laws and regulations are complex, change frequently and could become more stringent in the future. In certain jurisdictions these laws and regulations could be applied or enforced retroactively. It is possible that these requirements will change or that liabilities will arise in the future in a manner that could have a material adverse effect on the Company’s business, results of operations or financial condition.

The Company’s towers, data centers or computer systems may be affected by natural disasters and other unforeseen events for which the Company’s insurance may not provide adequate coverage.

The Company’s towers are subject to risks associated with natural disasters, such as ice and wind storms, tornadoes, floods, hurricanes and earthquakes, as well as other unforeseen events, such as acts of terrorism. Any damage or destruction to, or inability to access, its towers or data centers may impact its ability to provide services to its tenants and lead to tenant loss, which could have a material adverse effect on its business, results of operations or financial condition.

As part of the Company’s normal business activities, it relies on information technology and other computer resources to carry out important operational, reporting and compliance activities and to maintain its business records. The Company’s computer systems could fail on their own accord and are subject to interruption or damage from power outages, computer and telecommunications failures, computer viruses, security breaches (including through cyber-attack and data theft), usage errors, catastrophic events such as natural disasters and other events beyond its control. Although the Company has disaster recovery programs and security measures in place, if the Company’s computer systems and its backup systems are compromised, degraded, damaged, or breached, or otherwise cease to function properly, it could suffer interruptions in its operations or unintentionally allow misappropriation of proprietary or confidential information (including information about its tenants or landlords), which could damage the Company’s reputation and require the Company to incur significant costs to remediate or otherwise resolve these issues.

While the Company maintains insurance coverage for natural disasters, the Company may not have adequate insurance to cover the associated costs of repair or reconstruction for a major future event. Further, the Company may be liable for damage caused by towers that collapse for any number of reasons including structural deficiencies, which could harm the Company’s reputation and require it to incur costs for which it may not have adequate insurance coverage.

The Company’s operations are primarily in jurisdictions outside of Canada or the United States and consequently the Company is subject to the risks of foreign operations generally

Currently the Company’s operations are conducted in foreign jurisdictions including, but not limited to Colombia. The Company expects that receivables with respect to foreign sales will continue to account for a significant portion of its total accounts and receivables outstanding. As such, the Company’s operations may be adversely affected by changes in foreign government policies and legislation or social instability and other factors which are not within the control of the Company including, but not limited to, recessions in foreign economies, expropriation, nationalization and limitation or restriction on repatriation of earnings, longer receivables collection periods and greater difficulty in collecting accounts receivable, changes in consumer tastes and trends, renegotiation or nullification of existing contracts or licenses, regulatory requirements or the personnel administering them, currency fluctuations and devaluations, exchange controls, economic sanctions and royalty and tax increases, risk of terrorist activities, revolution, border disputes, implementation of tariffs and other trade barriers and protectionist practices, taxation policies, including royalty and tax increases and retroactive tax claims, volatility of financial markets and fluctuations in foreign exchange rates, difficulties in the protection of intellectual property, labor disputes and other risks arising out of foreign governmental sovereignty over the areas in which the Company’s operations are conducted. The Company’s operations may also be adversely affected by social, political and economic instability and by laws and policies of such foreign jurisdictions affecting foreign trade, taxation and investment. If the Company’s operations are disrupted and/or the economic integrity of its contracts is threatened for unexpected reasons, its business may be harmed.

In the event of a dispute arising in connection with the Company’s operations in a foreign jurisdiction where the Company conducts its business, the Company may be subject to the exclusive jurisdiction of foreign courts or may not be successful in subjecting foreign persons to the jurisdictions of the courts of Canada or enforcing Canadian judgments in such other jurisdictions. The Company may also be hindered or prevented from enforcing its rights with respect to a governmental instrumentality because of the doctrine of sovereign immunity. Accordingly, the Company’s activities in foreign jurisdictions could be substantially affected by factors beyond the Company’s control, any of which could have a material adverse effect on the Company.

Some countries in which the Company may operate may be considered politically and economically unstable and in some cases, failure to follow certain formalities or obtain relevant evidence may call into question the validity of the entity or the actions taken by the Company. Management of the Company is unable to predict the effect of additional corporate and

8





regulatory formalities which may be adopted in the future including whether any such laws or regulations would materially increase the Company’s cost of doing business or affect its operations in any area.

The Company may in the future enter into agreements and conduct activities outside of the jurisdictions where it currently carries on business, which expansion may present challenges and risks that the Company has not faced in the past, any of which could adversely affect the results of operations and/or financial condition of the Company.

The Company has a limited operating history

The Company will be subject to all of the business risks and uncertainties associated with any new business enterprise, including under-capitalization, cash shortages, limitations with respect to personnel, financial and other resources, lack of revenue and the risk that it will not achieve its growth objective. There can be no assurance that the Company’s operations will be profitable in the future or will generate sufficient cash flow to satisfy its working capital requirements. Even if the Company does achieve profitability, it cannot predict the level of such profitability. If the Company sustains losses over an extended period of time, it may be unable to continue its business.

A substantial portion of our revenue is derived from our relationship with one tenant

A substantial portion of our total operating revenues is derived from our leasing agreements with Millicom International Cellular SA. If they are unwilling or unable to perform their obligations under our agreements with them, our revenues, results of operations, financial condition and liquidity would be materially and adversely affected. Additionally, due to the long-term nature of our tenant leases with Millicom International Cellular SA, we depend on the continued financial strength of them. If our current tenant or any future tenants are unable to raise adequate capital to fund their business plans, they may reduce their spending, which could materially and adversely affect demand for our communications sites and our services business. If, as a result of a prolonged economic downturn or otherwise, one or more of our significant tenants experiences financial difficulties or files for bankruptcy, it could result in uncollectible accounts receivable. The loss of our current tenant, or the loss of all or a portion of our anticipated lease revenues from this tenant or future tenants, could have a material adverse effect on our business, results of operations or financial condition.

The Company is reliant on its management and key personnel

The success of the Company is dependent upon the ability, expertise, judgment, discretion and good faith of its senior management. While employment agreements are customarily used as a primary method of retaining the services of key employees, these agreements cannot assure the continued services of such employees. The Company attempts to enhance its management and technical expertise by recruiting qualified individuals who possess desired skills and experience in certain targeted areas. The Company’s inability to retain employees and attract and retain sufficient additional employees as well as, engineering, and technical support resources could have a material adverse impact on the Company’s financial condition and results of operation. Any loss of the services of such individuals could have a material adverse effect on the Company’s business, operating results or financial condition.

The Company conducts business in countries with a history of corruption and transactions with foreign governments and doing so increases the risks associated with our international activities.

As we operate internationally, we are subject to the United States’ Foreign Corrupt Practices Act and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties by the United States and other business entities that have securities registered in the United States for the purpose of obtaining or retaining business. We have operations and agreements with third parties in countries known to experience corruption. Further international expansion may involve more exposure to such practices. Our activities in these countries create the risk of unauthorized payments or offers of payments by our employees or consultants that could be in violation of various laws including the Foreign Corrupt Practices Act, even though these parties are not always subject to our control. It is our policy to implement safeguards to discourage these practices by our employees and consultants. However, our existing safeguards and any future improvements may prove to be less than effective and our employees or consultants may engage in conduct for which we might be held responsible. Violations of the Foreign Corrupt Practices Act may result in criminal or civil sanctions and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition.

The Company has never paid dividends and has no intention of paying dividends

The Company has no earnings or dividend record, and does not anticipate paying any dividends on the common shares in the

9





foreseeable future. Dividends paid by the Company would be subject to tax and, potentially, withholdings. The payment of future cash dividends, if any, will be reviewed periodically by the Company’s board of directors and will depend upon, among other things, conditions then existing including earnings, financial condition and capital requirements, restrictions in financing agreements, business opportunities and conditions and other factors.

The Company is subject to a going-concern risk

The Company’s financial statements have been prepared on a going concern basis under which an entity is considered to be able to realize its assets and satisfy its liabilities in the ordinary course of business. The Company’s future operations are dependent upon the identification and successful completion of equity or debt financing and the achievement of profitable operations at an indeterminate time in the future. There can be no assurances that the Company will be successful in completing an equity or debt financing or in achieving profitability. The financial statements do not give effect to any adjustments relating to the carrying values and classification of assets and liabilities that would be necessary should the Company be unable to continue as a going concern.

Item 4. Information on the Company

A. History and Development of the Company

Name and Incorporation

The Company was incorporated under the British Columbia Business Corporations Act (“BCBCA”) on September 12, 2005 as “Pacific Therapeutics Ltd.” On January 12, 2017, in connection with the completion of the Tower Three Transaction (defined below) the Company changed its name to “Tower One Wireless Corp.”

The head office and registered and records office of the Company is located at Suite 600-535 Howe Street, Vancouver, BC V6C 2Z4 Canada. The Company’s phone number is (604) 559-8051 and its web site is www.toweronewireless.com. The information on our website does not form a part of this Form 20-F.

The Company is a reporting Company in British Columbia and Ontario and its shares are listed for trading on the CSE, the Frankfort Stock Exchange and are quoted on the OTC Pink Sheets.

General Development of Business

Before the completion of the Tower Three Transaction, the Company was a development stage specialty pharmaceutical company focused on developing late stage clinical therapies and in-licensed novel compounds for fibrosis, erectile dysfunction (ED) and other indications. On July 24, 2015 the Company entered into a purchase and sale agreement (the “Forge Agreement”) with Forge Therapeutics Inc. (“Forge”) of Wyoming, pursuant to which the Company agreed to sell certain of its technology assets (related to fibrosis and erectile dysfunction) to Forge in return for 15,000,000 common shares of Forge. The Company also entered into a 50-50 joint-venture with Truevita Supplements in March 2016 to develop an early stage immune boosting herbal supplement, known as BP120. This herbal supplement is aimed at the treatment of immune deficiency and hypertension.

Significant Acquisitions and Dispositions

On March 6, 2016, the company incorporated Cabbay Holdings Corp. (“Cabbay”) as a wholly-owned subsidiary. The Company entered into an arrangement agreement Cabbay, dated April 18, 2016 and amended on April 21, 2016 (the “Arrangement Agreement”) in order to effect a plan of arrangement (the “Arrangement”) under the BCBCA. As part of the Arrangement, Cabbay issued its common shares in exchange for a special class of reorganization shares of the Company held by shareholders of the Company, which were subsequently redeemed by the Company in exchange for the assignment of the Forge Agreement and $1,000. The Arrangement Agreement and the Arrangement were approved by the Company’s shareholders on May 20, 2016 and approved by the British Columbia Supreme Court on May 31, 2016. Upon completion of the Arrangement, Cabbay was no longer a subsidiary of the Company. The Arrangement effectively resulted in the spin out of Cabbay to the Company’s shareholders and the transfer of the Forge Agreement to Cabbay. In connection with the restructuring, $440,549 of the Company’s debt in the form of accounts payable, convertible note and amounts due to related parties was assigned to Cabbay.

On January 12, 2017, the Company completed a “fundamental change” transaction (the “Tower Three Transaction”), with Tower Three, a limited liability company formed under the laws of the Republic of Colombia on December 30, 2015,

10





pursuant to a share exchange agreement made effective as of October 19, 2016, as amended (the “Acquisition Agreement”) among the Company, Tower Three and the shareholders of Tower Three (the “Selling Shareholders”), whereby the Company acquired 100% of the securities of Tower Three from the Selling Shareholders, by issuing 30,000,000 common shares of the Company to the Selling Shareholders on a pro-rata basis, following the completion of which, Tower Three is now a wholly-owned subsidiary of the Company. Following the completion of the Tower Three Transaction, the Company began conducting the principal business of Tower Three.

The Company’s board of directors (the Board”) was reconstituted in conjunction with the closing of the Tower Three Transaction. The Board is now comprised of four (4) members, being Alejandro Ochoa, Fabio Alexander Vasquez, Robert Horsley, and Brian Gusko. The Company’s senior management now consists of Alejandro Ochoa (President and Chief Executive Officer), Abbey Abdiye (Chief Financial Officer), and Octavio De La Espriella (Chief Operating Officer). See “Directors and Officers” below for further information.

Inter-Corporate Relationships

Upon the completion of the Tower Three Transaction, Tower Three became a wholly-owned subsidiary of the Company. Tower Three also has a wholly-owned subsidiary, Fundacion Communicar Para Educar” (“FCPE”) a Columbia Foundation, which is a non-profit initiative established with the goal of creating and distributing educational devices for the developing world.

Additionally, in February 2017, the Company incorporated a wholly-owned subsidiary in Argentina called Tower Three SAS and in March 2017, the Company incorporated a subsidiary in Columbia called Tower Two SAS, which is intended to purchase and own the real estate on which the Company’s planned cellular towers in Columbia will be built.

Private Placement

Concurrent with the closing of the Tower Three Transaction, the Company completed a private placement (the “Private Placement”) of units (the “Units”), at a price of $0.15 per Unit for gross proceeds of $2,322,737. Each Unit consisted of one share of the Company’s common stock ( a “Common Share”) and one transferable Common Share purchase warrant ( a “Warrant”), with each whole Warrant entitling the holder to purchase, for a period of 12 months from the date of issue, one additional Common Share at an exercise price of $0.40 per Common Share. The Warrants also have an acceleration clause whereby if the closing price of the Common Shares is greater than $0.60 per Common Share for a period of ten (10) consecutive trading days, the Company will have the right to accelerate the expiry of the Warrants by giving notice to the holders of the Warrants by news release or other form of notice permitted by the certificate representing the Warrants that the Warrants will expire at 4:30 p.m. (Vancouver time) on a date that is not less than ten (10) days from the date notice is given. As compensation for raising proceeds under the Private Placement, eligible finders and brokers received cash commission of 8% of the gross proceeds raised in the Private Placement and compensation Warrants (the “Financing Warrants”) entitling the finder or broker to purchase Common Shares up to 8% of the number of Placement Units sold in the Private Placement, exercisable at a price of $0.40(Cdn) per Common Share for a period of 12 months from the date of issuance of the Financing Warrants, subject to an acceleration provision.

B. Business Overview

Current Operations

Upon the closing of the Tower Three Transaction, Tower Three became a wholly-owned subsidiary of the Company. The primary business of the Company is now the business of Tower Three, which is to develop, own and operate multitenant communications real estate primarily in Latin America. Tower Three was founded in 2015 as a Columbian corporation with a mission to own and operate cellular network infrastructure sites in specific Latin and South American markets that Tower Three believes are experiencing strong usage growth. Tower Three currently has six (6) cellular towers with four (4) located in Velledupar, Colombia, one (1) in Soledad, Colombia, and one (1) in Bogota, Colombia. Tower Three focuses primarily on building towers in municipalities where there is limited or no cellular coverage and is currently focused on 4G LTE infrastructure expansion in Colombia.

The Company’s revenues primarily come from the leasing of space on its communications sites to wireless service providers, radio and television broadcast companies, wireless data providers, government agencies and municipalities and tenants in a number of other industries. Tower Three has established a business relationship with Millicom International Cellular SA (“Millicom”) a large international telecommunications and media company, whereby Millicom has agreed to rent each of the Company’s six cellular towers for a period of 13 years. Since the rental contracts are non-exclusive, Tower Three can enter into additional rental agreements for each tower so that multiple service providers can rent space on the same tower, thereby

11





increasing the revenue generated per tower.

The Company also operates FCPE, a wholly-owned subsidiary of Tower Three, which is a non-profit initiative established with the goal of creating and distributing educational devices for the developing world.

Products and Services

Our revenue is primarily derived from tenant leases on the six cellular towers we own and operate in Columbia. The amount of rental payments we receive from these towers depend upon tower location, amount, type and position of tenant equipment on the tower, ground space required by the tenant and remaining tower capacity. Our costs typically include ground rent and power and fuel costs, some or all of which may be passed through to our tenants, as well as property taxes and repairs and maintenance expenses. We currently have leased each of our six towers to Millicom under separate 13 year leases, which expire in 2029. Under the terms of each of these leases Millicom pays a monthly $1,000 (USD) per tower fee to Tower Three to use the towers by installing antennas on such towers.

Currently, all of the Company’s operating revenues are derived from Tower Three’s operations in Columbia.

Business Strategy

Tower Development

After the completion of the Tower Three Transaction, the Company now focuses primarily on building cellular towers in municipalities where there is limited or no cellular coverage and is currently focused on 4G LTE infrastructure expansion in Colombia. The Company currently intends to complete the construction of a total of 15 cellular towers at a total cost $800,000 by the end of December 2017. Tower Three works with local and regional government departments to ensure that its locations and properties can be licensed quickly and effectively by carriers and operators or even shared. Tower Three’s objective is to build each site within thirty days and have the operator hopefully up and running within sixty days. Tower Three’s towers and sites will be home to cellular and wireless, radio and television broadcast, microwave and two-way radio communications equipment

Tower Three has identified the coverage needs of a variety of Colombia-based cellular operators, and intends to develop cellular site plans in several target cities in Columbia including the following:

  • Cali;

  • Cartagena;

  • Santa Marta;

  • Bucaramanga; and

  • Cucuta / Barranquilla.

The Company intends to use the proceeds from the Private Placement for tower construction, sales and marketing and general working capital. This funding expected to enable Tower Three to hire full time employees and consultants immediately and over the next 12 months.

Vertical Partnerships

We believe that demand for our communication services is primarily drive by incumbent wireless service providers investing in existing voice networks to improve or expand their coverage and increase capacity and increasing the availability of lower cost smartphones. It is our belief that in order to invest in the coverage, quality and capacity of their networks, wireless carriers in Latin America will continue to outsource their communications site infrastructure needs as a means to accelerate network development, rather than construct and operate their own communications sites.

The Company plans to continue to build joint venture “market vertical” partners with wireless service providers such as Millicom. The Company intends to leverage its relationship with Millicom, which has operations throughout the world, and other wireless carriers so as to enable them to deploy 4G LTE networks in Columbia as quickly and cost-effectively as possible.

Community Involvement

In addition, it is the intention of the Company that every Tower Three tower will offer the local community free WiFi and

12





help to create community websites so as to enhance community well-being and integration. Integral to Tower Three’s business penetration strategy is its planned role as being a leading corporate citizen helping local markets. Consequently, Tower Three attempts to combine social and community efforts (free Wifi, programs, prizes, etc.) with its current business operations in local cities and towns so as to bolster its reputation and corporate involvement.

The Telecommunications Market in Latin America

General

Despite considerable progress in building out mobile broadband networks in Latin America over recent years (there are currently over 160,000 towers in Latin America), approximately 10% of the population, or approximately 64 million people, still have no access to a mobile broadband network in the region. Latin America is characterized by densely populated and sprawling cities, but also by vast, sparsely populated areas, mountain ranges, rainforests and islands. Although most people live in urban or suburban areas, it is the small proportion of people living in rural areas (20% of the population) that are most likely to currently be without access to mobile broadband. Although the business model utilized by mobile carriers has so far proven effective in expanding coverage to current levels, the Company believes that moving further into remote areas through traditional network deployment is a much greater challenge, owing to the sparsely populated unconnected areas, the difficult economic situation in many Latin American countries, the high cost of investment with limited potential for return, and a challenging market environment that often makes coverage expansion uneconomical. As a result, mobile operators are increasingly adopting alternative methods, notably infrastructure sharing and partnerships with other ecosystem players, to complement traditional network deployments. The Company believes that governments in the region want to make access to and use of mobile broadband universal, a goal shared by mobile operators, which the Company expects will require a multidimensional approach and collaboration between governments and the mobile industry, with the former supporting industry-led initiatives with policies and programs that create the right incentives and an enabling environment for extending connectivity to underserved areas. The Company also believes that in many cases mobile operators’ efforts to improve coverage are hampered by inefficient and arduous regulation from governments and policymakers, including onerous coverage obligations, strict quality-of-service (“QoS”) expectations, and restrictive planning laws around new infrastructure deployment which, together, make for a challenging regulatory environment.

Additionally, of the 90% of the population of Latin America who have access to mobile broadband services, just over 160 million people, or approximately a quarter of the population, subscribed to such services. This means that three-quarters of the population do not currently subscribe to mobile broadband services, primarily due to affordability and/or consumer challenges.

The Columbian Market

With an estimated 48 million people in 2015, Colombia is the third-most populous country in Latin America, after Brazil and Mexico. It is also home to the third-largest number of Spanish speakers in the world after Mexico and the United States.

Mobile operators in Latin America face a tough balancing act in allocating capital across multiple divergent needs: investing in network expansion projects to meet coverage obligations, or boosting network capacity in existing service areas to address QoS expectations (most countries in Latin America have more than 3,500 connections per base station, compared to around 1,000 or fewer in the US and other developed markets). The Company believes that this puts an additional burden on mobile operators and inadvertently weakens the business case for investment in coverage expansion. We believe that tower firms –like Tower Three – have a role to play in creating and sustaining an enabling environment for effective investment in infrastructure deployment for carriers and operators. Tower Three’s infrastructure sharing is intended to enable mobile operators to deploy networks more efficiently, optimize asset utilization and reduce running costs compared with standalone deployment by the carrier. It is also designed to minimizes duplication of infrastructure, which has come under the spotlight in many countries due to growing environmental and public safety concerns. There are two broad forms of infrastructure sharing: passive and active. With passive infrastructure sharing, tower firms allow operators to share physical components of a cell site (e.g. installing multiple antennas on a single tower). With active infrastructure sharing, tower firms enable operators to share the radio access network (RAN) or, at a more advanced level, the core network. Tower Three engages in both types of infrastructure sharing.

Competition

The Company operates in a very competitive industry, with a number of competitors who vary in size from very small organizations to large public companies. We believe that price, network density, speed of service, quality and site location and capacity are the primary competitive factors affecting companies in our industry. Although some of the Company’s competitors, such as American Tower Corp. (“AMT”), have invested large amounts of monies in telecommunications

13





infrastructure in Latin America; AMT has 3,500 towers in Colombia and more than 12,000 across Latin America, the Company’s management believes there is ample room for its business to serve clients in certain districts of Colombia and Latin America where local issues and situations make Tower Three’s locations more suitable than our competitors.

Seasonality

Not Applicable

Legal Proceedings

We are not currently a party to any material legal proceeding. From time to time, we may bring against others or be subject to various claims and legal actions arising in the ordinary course of business.

C. Organizational structure

The Company has the following wholly-owned subsidiaries:

Tower Three
Tower Three SAS (Argentina); and
Tower Two SAS (Columbia)

D. Property, plant and equipment.

The Company has six cellular towers with four located in Valledupar, Colombia, one in Soledad, Colombia, and one in Bogota, Colombia.

Our interests in our communications sites are comprised of a variety of ownership interests, including leases created by long-term ground lease agreements, easements, licenses or rights-of-way granted by government entities. A typical tower site consists of a compound enclosing the tower site, a tower structure and one or more equipment shelters that house a variety of transmitting, receiving and switching equipment. In addition, our sites typically include backup or auxiliary power generators and batteries. The principal types of our towers are guyed and monopole tower. A guyed tower includes a series of cables attaching separate levels of the tower to anchor foundations in the ground and can reach heights of up to 2,000 feet. A guyed tower site for a typical broadcast tower can consist of a tract of land of up to 20 acres, while a monopole tower is a tubular structure that is used primarily to address space constraints or aesthetic concerns. Monopoles typically have heights ranging from 50 to 200 feet. A monopole tower site used in metropolitan areas for a typical wireless communications tower can consist of a tract of land of fewer than 2,500 square feet

Our head office is located at 600-535 Howe Street, Vancouver, BC V6C 2Z4 Canada. We currently lease this office location.

We also maintain regional offices in Columbia at: 8A #99-22 Unit 903, Bogota, Colombia, and in Argentina at: 555 TTe. Gral Juan Domingo Peron, Piso 2, Buenos Aires, Argentina. We currently lease these office locations.

Item 4A. Unresolved Staff Comments

Not applicable.

Item 5. Operating and Financial Review and Prospects

A. Operating Results

The following discussion of our financial condition and results of operations is based upon and should be read in conjunction with our financial statements for the fiscal years ended December 31, 2016, December 31, 2015 and December 31, 2014 , have been prepared in accordance with International Financial Reporting Standards (“IFRS”). This discussion contains forward-looking statements that involve certain risks and uncertainties. We caution you that our businesses and financial performance are subject to substantial risks and uncertainties. See Item 3.D, “Key Information — Risk Factors”.

General

Prior to the Completion of the Tower Three Transaction, the Company was a development stage specialty pharmaceutical company focused on developing late stage clinical therapies and in-licensed novel compounds for Fibrosis, Erectile

14





Dysfunction (ED) and other indications. The Company’s lead compound for Fibrosis, PTL-202 is a combination of already approved drugs which have well established safety profiles. PTL-202 had completed a phase 1 drug/ drug interaction clinical trial. The Company’s previous lead product for Erectile Dysfunction PTL-2015 was an oral dissolving version of a top selling therapy for ED. PTL-2015 had completed a pilot bioavailability study in humans. Forge has committed to issue to the Company.

As discussed above, as a result of the sale of its technology assets pursuant to the Forge Agreement and the acquisitions of Tower Three’s assets in the Tower Three Transaction, the Company now focuses primarily on building cellular towers in municipalities where there is limited or no cellular coverage and is currently focused on 4G LTE infrastructure expansion in Colombia. The Company currently has six (6) cellular towers with four (4) located in Velledupar, Colombia, one (1) in Soledad, Colombia, and one (1) in Bogota, Colombia and currently intends to complete the construction of a total of 15 cellular towers at a total cost $800,000 by the end of December 2017. The Company’s current revenue is primarily derived from tenant leases on the six cellular towers they own and operate in Columbia (the Company currently have leased each of its six towers to Millicom under separate 13 year leases, which expire in 2029).

Corporate Highlights

During the twelve months of 2016 the Issuer accomplished the following:

  • On February 1, 2016 the Company announced it appointed Robert “Nick” Horsley to the Company’s Board of Directors.

  • On March 7, 2016 the Company announced it entered into a joint-venture to develop an early stage immune boosting herbal supplement with TrueVita Supplements.

  • On March 15, 2016, the Company completed a share consolidation on the basis of thirty pre-consolidation shares of common stock for each post consolidation common share. Following such consolidation, the Company had approximately 1,379,887 common shares issued and outstanding, and continued to trade on the CSE under the existing symbol “PT”.

  • On March 30, 2016 completed a private placement of 4,089,332 shares at $0.06 per share for gross proceeds of $245,360.

  • On March 30, 2016, the Company appointed Robert “Nick” Horsley as the chief executive officer, replacing Derick Sinclair who remained a director and the Company’s chief financial officer.

  • On July 26, 2016, the Company entered into a letter of intent (the “LOI”) with Tower Three to acquire all of the issued and outstanding membership interests of Tower Three.

  • On October 14, 2016, the Company announced that the previously announced Arrangement with Cabbay was completed. In connection with the Arrangement, $440,549 of indebtedness was assigned to and assumed by Cabbay.

  • On October 20, 2016, the Company announced that it has entered into a definitive agreement in connection with the Tower Three Transaction.

  • On January 12, 2017, the Company completed the Tower Three Transaction.

Results of Operations

The following table sets forth certain selected operating results and other financial information for each of the years ended December 31, 2016, 2015 and 2014:

          Change
      Change   from
  2016 2015 from 2015 2014 2014 to
      to 2016   2015
  $ $ $ $ $
Revenue Nil Nil Nil Nil Nil
Gain on debt forgiveness - 535,077 (535,077) - 535,077
Wages and Benefits - 106,667 (106,667) 160,947 (54,280)
Professional Fees 307,414 85,486 221,928 168,490 (83,004)
Advertising and Promotion - 22,386 (22,386) 67,923 (45,537)

15





Share based Payments 75,505 11,998 63,507 152,028 (140,030)
Insurance 19,631 9,707 9,924 30,194 (20,488)
Rent and Occupancy - 3,172 (3,172) 14,543 (11,371)
Bank Charges and Interest Expense 766 4,077 (3,311) 10,047 (5,970)
Total Other Income (Expenses) 521 464,536 464,015 (2,612) 467,148
Net and Comprehensive income (loss) (452,288) 179,673 (631,961) (693,645) 873,318

The Company’s net loss for the year ended December 31, 2016, totaled $452,288 or $0.09 per share compared to net income of $179,673 or $0.13 per share for the year ended December 31, 2015 and a net loss of $693,645 or $0.56 per share for the year ended December 31, 2014. The decrease in net income in 2016 from 2015 (and the increase in net income in 2015 compared to 2014) was primarily the result of the Company assigning a significant amount of its debt to Forge, which resulted in income recognized by a one-time $535,077 forgiveness of debt in 2015.

Revenues

The Company has not generated any revenue from the sale of drug therapies. The Company has not recognized any revenue since inception through December 31, 2016. As a result of the Tower Three Transaction, the Company expects to generate revenues in 2017 mostly through monthly fees paid by Millicom in connection with the six towers currently leased to Millicom, as well as from similar lease agreements for other towers the Company plans to construct in 2017.

Expenses

Prior to the completion of the Tower Three Transaction, the Company’s expenses consisted primarily of general and administrative costs such as personnel related costs, non-intellectual property related legal costs, accounting costs and other professional and administrative costs associated with general corporate activities.

During the year ended December 31, 2016, total expenses for the Company were $452,809 as compared to the year ended December 31, 2015 where total expenses were $284,863. The increased expenses in 2016 compared to the prior year was mainly the result of increased professional fees of $221,928, increased office and miscellaneous expenses of $30,509 and share based payments of $63,507, being partially offset by reduced wages and benefits of $106,667 during the current year compared to 2015. Expenses incurred from share based payments in 2016 primarily resulted from the issuance of 500,000 stock options to employees in August 2016, while the increase in professional fees in 2016 compared to the prior year was mainly the result of increased, financial, accounting and legal fees incurred by the Company in connection with the Tower Three Transaction, the Arrangement and the Private Placement. The increase in office and miscellaneous expenses in 2016 compared to the prior year was primarily the result of expenses related to permits and related expenses in connection with the building the Company’s towers in 2016.

During the year ended December 31, 2014, total expenses for the Company were $691,033, which was $406,170 higher than the total expenses incurred during the year ended December 31, 2015. Expenses decreased in 2015 compared to 2014 primarily due to a decrease in share based payments of $140,030 in 2015 compared to 2014, a decrease in professional fees of $83,004 in 2015 compared to 2014 and a decrease in wages in benefits of $54,280 in 2015 compared to 2014. These decreases in expenses were mostly the result of a reduction in the Company’s operating activities in 2015, primarily the result of the sale of certain of the Company’s technological assets to Forge during that year.

Intellectual Property and Intangible Assets

All license and option fees paid to licensors for intellectual property licenses are capitalized to intangible assets on the Company’s financial statements. In addition, any expenses for intellectual property protection including patent lawyers services fees and any filing fees with government agencies or the World Intellectual Property Organization are accrued to intangible assets. Since all of the Company’s patents were assigned to Forge, and the Company completed the Tower Three Transaction, the Company does not anticipate patent costs to be a significant expense of the Company moving forward.

16





Interest Income

Interest income consists of interest earned on the Company’s cash and cash equivalents. There was interest income in 2016 of $Nil (2015- $Nil, 2014 – $Nil).

Impact of Inflation

We do not believe that inflation has had a material impact on our revenues or income over the past two fiscal years. However, increases in inflation could result in increases in our expenses, which may not be readily recoverable in the price of goods or services provided to our clients. To the extent that inflation results in rising interest rates and has other adverse effects on capital markets, it could adversely affect our financial position and profitability.

Foreign Currency Fluctuations

Foreign exchange risk is the risk arising from changes in foreign currency fluctuations. Foreign currency fluctuations have not previously had a material impact on the Company’s financial results. Consequently, the Company does not use any derivative instruments to reduce its exposure to fluctuations in foreign currency rates. It is the opinion of management that the foreign exchange risk to which the Company is exposed is currently minimal.

However, with the completion of the Tower Three Transaction, the Company anticipates that the fluctuations of the Columbian Peso may impact the Company’s financial results moving forward. The Company intends to monitor such potential impact and will possibly develop a hedging policy if such fluctuations become material.

Critical Accounting Estimates

The Company’s accounting policies are presented in Note 3 of the audited financial statements for the years ended December 31, 2016 and 2015. The preparation of financial statements in accordance with International Financial Reporting Standards (IFRS) requires management to select accounting policies and make estimates. Such estimates may have a significant impact on the financial statements. Actual amounts could differ materially from the estimates used and, accordingly, affect the results of the operations. These include:

  • the assumptions used for the determination of the impairment of intangible assets;

  • the assumptions used for the determination of the useful life of intangible assets; and

  • the assumptions used for the determination of the value share based payments and compensation.

Regulation

Our tower leasing business is subject to Columbian national, state and local regulatory requirements with respect to the construction, registration, marking and maintenance of our towers. Colombia is divided into 32 departments and one capital district, which is treated as a department (Bogotá also serves as the capital of the department of Cundinamarca). Departments are subdivided into municipalities, each of which is assigned a municipal seat, and municipalities are in turn subdivided into corregimientos in rural areas and into comunas in urban areas. Each department has a local government with a governor and assembly directly elected to four-year terms, and each municipality is headed by a mayor and council. There is a popularly elected local administrative board in each of the corregimientos or comunas. In addition to the capital four other cities have been designated districts (in effect special municipalities), on the basis of special distinguishing features. These are Barranquilla, Cartagena, Santa Marta and Buenaventura. Some departments have local administrative subdivisions, where towns have a large concentration of population and municipalities are near each other (for example in Antioquia and Cundinamarca). Where departments have a low population (for example Amazonas, Vaupés and Vichada), special administrative divisions are employed, such as “department corregimientos”, which are a hybrid of a municipality and a corregimiento. The majority of existing infrastructure in remote areas, including buildings, open spaces such as parks and squares, legacy fixed-line telecoms infrastructure and public utilities, is owned by governments and public institutions.

For infrastructure deployment and antenna siting, mobile operators and tower companies need to obtain local approvals from municipalities for each antenna or tower site. The absence of a clear national policy can lead to each municipality adopting its own policy and procedures that are sometimes in conflict with the technical requirements of deploying mobile networks.

17





B. Liquidity and Capital Resources.

Overview

The Company is a development stage company and prior to the completion of the Tower Three Transaction in 2017 had no regular cash inflows. Selected financial data pertaining to liquidity and capital resources for the fiscal years ended December 31, 2016, 2015 and 2014 is presented below.

Comparison of Years Ended December 31, 2016, 2015 and 2014

Period ended 2016 2015   2014  
$ $ $ Change
between
2016 and
2015
$ $ Change
between 2015
and 2014
Cash and Cash Equivalents 1,378,183 Nil $1,378,183 1,513 (1,513)
Current Assets 1,608,280 14,695 1,593,585 2,825 11,871
Current Liabilities 139,807 624,106 (484,299) 943,076 (318,970)
Working Capital 1,468,473 (609,411) 2,077,883 (940,251) 330,841
Accumulated deficit 3,989,527 3,537,239 452,288 3,955,537 (418,298)
Cash used in operations 396,259 161,460 234,799 366,769 (205,309)
Cash flows from financing Activities 1,774,582 165,376 1,609,206 197,785 (32,409)
Interest Income Nil Nil Nil Nil Nil

As of December 31, 2016, the Company had cash and cash equivalents of $1,378,183 (compared with $nil for fiscal year 2015 and $1,513 for fiscal year 2014) and working capital of $1,468,473 (compared with ($609,410) for fiscal year 2015 and ($940,251) for fiscal year 2014). Working capital is calculated as current assets less current liabilities.

Since prior to the completion of the Tower Three Transaction the Company had not generated cash from its operations, the Company’s cash inflows primarily resulted from financing activities that included cash proceeds from the issuance of shares of our common stock, cash subscriptions received for shares of our common stock, the repayment of a convertible note, a new convertible note and amounts loaned to the Company from the Company’s shareholders. Cash and cash equivalents increased by $1,378,183 in fiscal year 2016 compared to 2015 primarily due to cash subscriptions received combined with the cash proceeds received from the issuance of shares of our common stock during 2016 in connection with several private placements of our shares of common stock we completed in 2016. Cash and cash equivalents decreased slightly in 2015 compared to 2014.

Working Capital increased by $2,077,883 in fiscal year 2016 compared to fiscal year 2015 primarily due to cash received through share subscriptions received and shares issued for cash during 2016. Working capital increased by $330,841 in 2015 compared to 2014 mainly as a result of a decrease in current liabilities in 2015 compared to the prior year. Current liabilities decreased by $484,299 for the fiscal year ended December 31, 2016 when compared to the current liabilities for the fiscal year ended December 31, 2015 primarily due to the assignment of $440,549 of the Company’s debt to Cabbay as part of the Arrangement. Current liabilities decreased in 2015 compared to 2014 by $318,970, mainly as a result of the forgiveness of certain debts owed by the Company to the Company’s Chief Financial Officer and former Chief Executive Officer in 2015.

Contributed Surplus

Contributed Surplus, which arises from the recognition of the estimated fair value of stock options and warrants, was

18





$563,568 for fiscal year 2016, compared with $121,939 for fiscal year 2015 and $289,766 for fiscal year 2014. The increase in contributed surplus in 2016 from the prior year periods was primarily due to $440,549 in debt forgiveness being recorded in 2016 mostly in connection with the assignment of the Company’s debt to Cabbay as part of the Arrangement, being partially offset by the exercise of options during the year. Additionally, in 2015 contributed surplus was reduced by $238,625 in connection with the expiration of unexercised options and warrants during the year.

Convertible Notes

On September 11, 2014, the Company issued a convertible note for $50,000 due on September 11, 2015 with an interest rate of 1% per month payable quarterly. On September 11, 2015, the Company was unable to repay the amount owing consisting of principal of $50,000 and unpaid interest of $6,000. The note holder and the Company agreed to accept a penalty of $5,000 bringing the total owing to $61,000. On September 11, 2015 the Company issued an unsecured convertible note in the amount of $61,000 due on September 11, 2016 convertible at the option of the holder into shares of the Company’s common stock at $1.50 per share with the same term. During the year ended December 31, 2016, the Company repaid $5,000 to the note holder. The remaining balance of the note was assigned to Cabbay as part of the Arrangement.

Share Capital

At December 31, 2016, the Company’s share capital was $3,292,175 comprising 6,735,885 issued and outstanding common shares and Nil issued and outstanding preferred shares (FYE 2015 - $2,800,010 comprising 1,365,887 issued and outstanding common shares and Nil issued and outstanding preferred shares).

Operating Activities

Cash utilized in operating activities during fiscal year 2016 was $396,259 (compared with $161,460 for fiscal year 2015 and $366,769 for fiscal year 2014). The increase in cash utilized in operations during fiscal year 2016 as compared to fiscal year 2015 was primarily due to an increase in professional fees mostly related to the Company the completion of several significant transactions during that year, being partially offset by reductions in cash used in connection with the Company’s ongoing operation functions such as wages and benefits, travel, research and development, as well as computer expenses, mostly as a result of the sale of the Company’s technology assets in Forge in 2015. The decrease in cash utilized in operations during 2015 as compared to 2014 was primarily due to a decrease in advertising and promotion, investor relations and professional fees in 2015. This decrease was partially offset by an increase in expenses for insurance and transfer agent fees during 2015 compared to the prior year

Investing Activities

Investing activities primarily include additions to fixed assets and intangible assets. Net cash used in investing activities was $Nil, $5,570, and $10,195 in fiscal year ended December 31, 2016, 2015 and 2014, respectively.

Financing Activities

The Company’s cash inflows from financing activities was $1,774,582 and comprised proceeds from issuances of our shares of common stock and cash share subscriptions received in several private placements during the year, as well as stock options exercises for cash. Cash flows from financing activities in 2015 and 2014 was $165,376 and $197,785, respectively, and mostly consisted of cash received in connection with related party transactions during those years.

Capital Expenditures

There was no capital expenditure incurred in 2016, 2015 and 2014.

Future Liquidity

Prior to the completion of the Tower Three Transaction, the Company’s operations did not generate cash inflows and its financial success was dependent on management’s ability to continue to obtain sufficient funding to sustain operations through the development stage and successfully bring the Company’s technologies to the point that they may be out licensed. As a result of the Tower three Transaction, the Company now expects to generate revenues from its operations, while also incurring additional costs in connection with the operations of Tower Three.

Based upon the current level of our operations and our current expectations for future periods in light of the current economic environment, we believe that cash flow from our operations and available cash, together with available borrowings, will be

19





adequate to finance the capital requirements for our business during the next 12 months. In the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources will be required. Depending on the size of a transaction, the capital resources that will be required can be substantial. The necessary resources will be generated from cash flow from operations, cash on hand, borrowing against our assets or the issuance of securities.

In order to finance the Company’s future operations and to cover administrative and overhead expenses the Company may raise money through equity sales. Many factors influence the Company’s ability to raise funds, including the Company’s track record, and the experience and calibre of its management. Actual funding requirements may vary from those planned due to a number of factors. Management believes it will be able to raise equity capital as required in the long term, but recognizes there will be risks involved that may be beyond their control. Should those risks fully materialize, it may not be able to raise adequate funds to continue its operations.

C. Trend Information

Other than as disclosed elsewhere in this Form 20-F, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial conditions.

D. Off Balance Sheet Arrangements

The Company is not a party to any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on the Company’s financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.

E. Tabular Disclosure of Contractual Obligations

The Company has no known contractual obligations specified in Item 5.F.1 as of the latest fiscal year end balance sheet date.

Item 6. Directors, Senior Management and Employees

Directors and Senior Management

The following table sets forth certain information relating to our directors and executive officers:

Name and Principal Occupation for Past Five Date of Common Shares Percentage of
Position Years Appointment to Held Common
    Office   Shares
        Outstanding (1)
Alejandro Ochoa
President,
Chief Executive Officer &
Director
Founder and CEO of Tower Three SAS; and consultant to Mackie Research Capital Corporation’s investment banking practice with a Latin American focus January 12, 2017 12,000,000 18.84%
Abbey Abdiye,
Chief Financial Officer and
Corporate Secretary
CFO of Biomark Diagnostics Inc. from 2014 to present Chief Financial Officer since March 30, 2016 April 27, 2016; Nil Nil
Fabio Alexander Vasquez
Director
Co-founder of Tower Three, and has been engaged in the Florida aviation business for over 25 years. January 12, 2017 12,000,000 18.84%

20





Name and Principal Occupation for Past Five Date of Common Shares Percentage of
Position Years Appointment to Held Common
    Office   Shares
        Outstanding (1)
Brian Gusko,
Director,
Chairman of the Board
Partner at Howe & Bay Financial Corporation; CFO of Vodis Pharmaceuticals; Director of Lomiko Metals; Director Arco Resources Corp.;
Director Robix Alternative Fuels;
Director Newnote Financial Corporation and Director of Cloud Nine Education Group.
August 25, 2015 1,911,971 3.00%
Octavio De La Espriella
Chief Operating Officer
Chief Operating Officer of Tower Three SAS; former Chief Operating Officer of Continental Towers Company. January 12, 2017 Nil Nil
Robert Horsley
Director
Director of Evolving Gold Corp (Since March 4, 2014)
Owner of Marksman Geological Ltd Owner of Cervus Business Management Inc.
Partner in Howe And Bay Financial Corp Former Chief Executive Officer of the Company.
February 1, 2016 1,841,666 2.89%

 

(1)     

As of August 21, 2017 we had 63,942,365 shares of common stock outstanding

Each of our directors will serve until the next annual meeting of our shareholders. None of our directors have service contracts with the Company or any of its subsidiaries providing for benefits upon termination of employment.

The Company’s Audit Committee consists of Alejandro Ochoa, Robert Horsley, and Brian Gusko.

The Company’s Compensation Committee consists of Robert Horsley, Brian Gusko and Fabio Alexander Vasquez.

Set forth below is certain biographical information furnished to us by our directors and executive officer. There are no family relationships among any of our current directors or executive officers. No director or executive officer was appointed as a director or officer of the Company pursuant to any arrangement or understanding with any major shareholder, customer, supplier or other person.

Alejandro Ochoa – President & Chief Executive Officer and Director (Age: 36)

Mr. Ochoa has over 18 years of experience working within the financial services industry. He has worked with such firms as Morgan Stanley, Prudential Securities and Raymond James. Mr. Ochoa currently serves as consultant to Mackie Research Capital Corporation’s Investment Banking Practice with a Latin America focus. Mr. Ochoa is fluent in Spanish and has an understanding of the South American capital markets.

Dedicated to Latin America, his areas of expertise include mining and energy transactions in advisory, capital raisings and strategic assets sales with Latin American transactions in Colombia, Mexica, and Peru. He has also covered telecom infrastructure companies from the United States, Argentina, and Colombia. Mr. Ochoa has a Bachelors in Science with a focus in Finance from Florida International University. Mr. Ochoa is a citizen of Colombia who decades of experience working in Colombia

Abbey Abdiye, Chief Financial Officer and Corporate Secretary (Age: 42)

Mr. Abdiye has extensive experience in the financial sector in both public and private companies. He is currently the chief financial officer of the following Canadian public companies: Ceylon Graphite Corp. (since January 20, 2017), Biomark Diagnostics Inc. (since October 30, 2014), and Fortify Resources Inc. (since November 15, 2016) He is also a Chartered Professional Accountant (CPA). As the Company’s Chief Financial Officer, Mr. Abdiye provides leadership and coordination in the administrative, business planning, reporting, and budgeting efforts of the Company. He oversees the

21





Company’s financial reporting, internal controls, corporate governance management systems, annual audit and regulatory compliance matters. Mr. Abdiye is also on the board of directors of Lomiko Metals (since October 2012) a TSX-V listed company. He obtained Bachelor of Business Administration degree from Simon Fraser University and a Co-op Education certificate.

Fabio Alexander Vasquez, Director (Age: 50)

Mr. Vasquez, a co-founder of Tower Three and has been engaged in the Florida aviation business for over 25 years. He has been instrumental in the development and expansion of Miami Executive Aviation, a successful luxury charter aviation business which services Latin American clients. Mr. Vasquez is a citizen of Colombia who has decades of experience working in Colombia.

Robert Horsley, Director (Age: 35)

Mr. Robert “Nick” Horsley has over 10 years of public markets experience focused in finance, investor relations, marketing management and merger & acquisitions. Mr. Horsley has served as a director and a consultant to several public and private companies and has worked in a variety of industries including: consumer goods, energy, mining, oil & gas, nutraceuticals & pharmaceuticals, and technology. He is also a director of Evolving Gold Corp. (since March 15, 2015) and is the chief executive officer of Fortify Resources Inc. (since November 15, 2015), each a CSE listed company.

Brian Gusko, Director (Age: 50)

Mr. Gusko has significant international telecommunication business experience at the highest level. His international experience includes working in Corporate Planning with a Mitsubishi group company in Tokyo, Product Management at a Vodafone spin-off in the Netherlands, and being Managing Director of Palm’s South African wireless affiliate; he helped launched wireless data services in Africa for Palm’s new smart phones. He also was a research associate with the U.S. Department of Commerce at an embassy posting, researching telecom and technology companies. Mr. Gusko held management positions at Telus Advanced Communications, and Telus Planet Internet in Alberta Canada where his portfolio was responsible for the majority of TELUS web hosting and internet traffic, respectively. He is also currently on the Board of Directors of Lomiko Metals and Cloud Nine Education Group, Ltd. Previously he has served on the boards of Robix Alternative Fuels, Inc. (from February 2014 to February 2015), Vodis Pharmaceuticals Inc. (from July 2014 to September 2014) and Arco Resources (from June 2015 to May 2016) . Previously he has served as chief financial officer of the following Canadian public companies: UC Resources Ltd. (from August 2007 to August 2009), Vodis Pharmaceuticals Inc. (from July 2014 to November 2015), and First Choice Products Inc. from September 2015 to November 2015).

Octavio De La Espriella, Chief Operating Officer (Age: 50)

Mr. De La Espriella is the Chief Operating Officer of Tower Three. He was formerly the Chief Operating Officer of Continental Towers Company where he helped expand the portfolio to over 200 towers in a two-year period. His role today is the interface of Tower Three with the four principal carriers/operators within Colombia (i.e., Claro, Tigo, Avantel, and Movistar). He has a Bachelor of Science degree in Finance from Colegio de Estudios Superiores de Administración CESA.

B. Compensation.

Remuneration and Borrowing

The Company’s Board of Directors (the “Board”) may determine remuneration to be paid to the directors. The Compensation Committee of the Board (the “Compensation Committee”) assists the Board in reviewing and approving the compensation structure for the directors. The Board may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and uncalled capital, and to issue debentures or other securities whether outright or as security for any debt obligations of the Company or of any third party.

Compensation of Directors and Executive Officers

In 2016, we paid aggregate cash compensation of approximately $nil to our directors and executive officers as a group. We do not pay or set aside any amounts for pension, retirement or other benefits for our officers and directors.

We provide directors and officer’s liability and company reimbursement insurance to cover all of our directors and officers against losses arising from claims we indemnify for. Our current insurance coverage is scheduled to expired on January 24, 2018, and we renewed the insurance upon its expiration

22





Stock Option Plan

The Board adopted a stock option plan (the “Option Plan”), which was approved by shareholders on May 20, 2016 at the Company’s Annual General Meeting. The purpose of the Option Plan is to provide incentives to attract, retain and motivate executive officers, directors and employees whose present and future contributions are important to the Company. The maximum number of the Company’s shares of common stock reserved for issuance pursuant to stock options granted under the Option Plan will, at any time, be 10% of the number of the Company’s shares of common stock then outstanding. The number of the Company’s shares of common stock that may be issued to any one person shall not exceed 5% of the Company’s total issued and outstanding shares of common stock on a non-diluted basis. The price at which the Company’s shares may be issued under the stock option plan will be determined from time to time by the Board in compliance with the rules and policies of any stock exchange upon which the Company’s shares of common stock are listed. The vesting of options granted under the Option Plan will be determined by the Board at the time of the grant. Options granted under the Option Plan may be exercisable over a maximum period of five years. They will generally have a term of 5 years and vest over four years, 25% on each of the first four anniversaries of the date of grant, provided the optionee is in continuous service to the Company. The Board may amend the terms of the Option Plan from time to time, to the extent permitted by the Option Plan and any rules and policies of any stock exchange on which the Company’s shares of common stock are listed, or terminate it at any time. If the Company accepts any offer to amalgamate, merge or consolidate with any other company (other than a wholly-owned subsidiary) or if holders of greater than 50% of the Company’s shares of commons stock accept an offer made to all or substantially all of the holders of the Company’s shares of common stock to purchase in excess of 50% of our current issued and outstanding shares of commons stock, any then-unvested options will automatically vest in full.

Equity Compensation Plan Information as of December 31, 2016

Plan Category Column (a) Column (b) Column (c)
  Number of securities to Weighted-average Number of securities remaining
  be issued upon exercise exercise price of available for future issuance
  of outstanding options outstanding options under equity compensation plans
Equity compensation plans approved by security holders Nil Nil 673,588
Equity compensation plans not approved by security holders N/A N/A N/A
Total Nil Nil 673,588

Employment Agreements

The Company currently does not have any employment agreements with any of its executive officers.

Corporate Governance

Composition of the Board

The Board facilitates its exercise of independent supervision over management by ensuring that the Board is composed of a majority of independent directors. Directors are considered to be independent if they have no direct or indirect material relationship with the Company. A “material relationship” is a relationship which could, in the view of the Board, be reasonably expected to interfere with the exercise of a director’s independent judgment. The Board has four directors, of which Mr. Gusko is considered to be independent for the purposes of NI 58-101.

The mandate of the Board is to act in the best interests of the Company and to supervise management. The Board is responsible for approving long-term strategic plans and annual operating budgets recommended by management. Board consideration and approval is also required for material contracts and business transactions, and all debt and equity financing transactions. Any responsibility which is not delegated to management or to the committees of the Board remains with the Board. The Board meets on a regular basis consistent with the state of the Company’s affairs and also from time to time as deemed necessary to enable it to fulfill its responsibilities.

The Chairman of the Board is Brian Gusko, who is an independent director.

23





Duties of Directors

Under British Columbia law, our directors have a duty of loyalty to act honestly in good faith with a view to our best interest. Our directors also have a duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. In fulfilling their duty of care to us, our directors must ensure compliance with our amended and restated memorandum and articles of association. A shareholder has the right to seek damages if a duty owed by our directors is breached.

The functions and powers of our Board include, among others:

  • convening shareholders’ annual general meetings and reporting its work to shareholders at such meetings;

  • issuing authorized but unissued shares of common stock and redeeming or purchasing outstanding shares of common stock of our Company;

  • declaring dividends and distributions;

  • appointing officers and determining the term of office and compensation of officers;

  • exercising the borrowing powers of our Company and mortgaging the property of our Company; and

  • approving the transfer of shares of common stock of our company, including the registering of such shares of common stock in our share register.

Position Descriptions

The Board has not developed written position descriptions for the chair or the chair of any Board committees or for the CEO. Given the size of the Company and the existence of only a small number of officers, the Board does not feel that it is necessary at this time to formalize position descriptions in order to delineate their respective responsibilities.

Nomination of Directors

The Company does not have a formal process or committee for proposing new nominees for election to the Board. The nominees are generally the result of recruitment efforts by the Board members, including both formal and informal discussions among Board members.

Qualification

There is no shareholding qualification for directors.

Orientation and Continuing Education

When new directors are appointed, they receive orientation, commensurate with their previous experience, on the Company’s technologies, business and industry and on the responsibilities of directors. New directors also receive historical public information about the Company and the mandates of the committees of the Board. Board meetings may also include presentations by the Company’s management and employees to give the directors additional insight into the Company’s business. In addition, new directors are encouraged to visit and meet with management on a regular basis and to pursue continuing education opportunities where appropriate.

Assessments

The Board regularly assesses its own effectiveness and the effectiveness and contribution of each Board committee member and director.

Interested Transactions

A director may vote with respect to any contract or transaction in which he or she is interested, provided that the nature of the interest of any director in such contract or transaction is disclosed by him or her at or prior to its consideration and any vote in that matter.

Board Committees

Our Board has established an Audit Committee and a Compensation Committee.

24





Audit Committee

The Audit Committee has various responsibilities as set forth in Multilateral Instrument 52-110 (“MI 52-110”). The Audit Committee oversees the accounting and financial reporting practices and procedures of the Company and the audits of the Company’s financial statements. The principal responsibilities of the Audit Committee include: (i) overseeing the quality, integrity and appropriateness of the internal controls and accounting procedures of the Company, including reviewing the Company’s procedures for internal control with the Company’s auditors and Chief Financial Officer; (ii) reviewing and assessing the quality and integrity of the Company’s internal and external reporting processes, its annual and quarterly financial statements and related management discussion and analysis, and all other material continuous disclosure documents; (iii) establishing separate reviews with management and external auditors of significant changes in procedures or financial and accounting practices, difficulties encountered during auditing, and significant judgments made in management's preparation of financial statements; (iv) monitoring compliance with legal and regulatory requirements related to financial reporting; (v) reviewing and pre-approving the engagement of the auditor of the Company and independent audit fees; and (vi) assessing the Company’s accounting policies, and considering, approving, and monitoring significant changes in accounting principles and practices recommended by management and the auditor.

Audit Committee Charter

The Audit Committee Charter is filed as an exhibit to this Form 20-F.

Composition of the Audit Committee

As noted above, the members of the Audit Committee are Alejandro Ochoa, Robert Horsley, and Brian Gusko, all of whom are considered independent pursuant to NI 52-110, except for Mr. Ochoa. All members of the Audit Committee are considered to be financially literate.

A member of the Audit Committee is independent if the member has no direct or indirect material relationship with the Company. A material relationship means a relationship which could, in the view of the Board, reasonably interfere with the exercise of a member’s independent judgment.

A member of the Audit Committee is considered financially literate if he or she has the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Company.

Relevant Education and Experience

Please see above for the biographies of Alejandro Ochoa, Robert Horsley, and Brian Gusko.

Pre-Approval Policies on Certain Exemptions

The Audit Committee has not adopted specific policies and procedures for the engagement of non-audit services. The Company’s auditors have not provided any material non-audit services.

Compensation Committee

The Company current does not have a compensation committee as the Board performs the functions that a compensation committee would normally perform.

D. Employees

As of December 31, 2016 the Company had the following number of employees and contractors:

Location Full Time Employees Contractors
Vancouver, British Columbia 0 2

The Company has previously utilized consultants and contractors to carry on many of its activities and, in particular, to supervise and conduct pre-clinical scientific experiments, assay development and validation. Other functions the Company have previously decided to outsource include assay development, formulation, clinical trials and manufacturing. As the Company expands its activities, it is probable that it will hire additional employees, especially in connection with its operations upon completion of the Tower three Transaction. .

25





E. Share Ownership.

The following table sets forth, as of June 1, 2017: (a) the names of each beneficial owner of more than five percent (5%) of our common stock known to us, the number of shares of common stock beneficially owned by each such person, and (b) the names of each director and officer, the number of shares our common stock beneficially owned, and the percentage of our common stock so owned, by each such person, and by all of our directors and executive officers as a group. Each person has sole voting and investment power with respect to the shares of our common stock, except as otherwise indicated. Beneficial ownership consists of a direct interest in the shares of common stock, except as otherwise indicated. Individual beneficial ownership also includes shares of common stock that a person has the right to acquire within 60 days from June 1, 2017. Unless otherwise indicated, the address of the person’s below is the Company’s address at 600-535 Howe Street, Vancouver, BC V6C 2Z4 Canada.

Name and Municipality of Residence and Position Common Shares Held Percentage of Common Shares Outstanding (1) Percentage of Votes Hold
Alejandro Ochoa
President,
Chief Executive Officer &
Director
12,000,000 18.84% 18.84%
Abbey Abdiye,
Chief Financial Officer and
Corporate Secretary
Nil Nil Nil
Fabio Alexander Vasquez
Director
12,000,000 18.84% 18.84%

Brian Gusko,
Director

1,911,971 3.60% 3.60%
Octavio De La Espriella
Chief Operating Officer
Nil Nil Nil
Robert Horsley
Director
1,841,666 2.89% 2.89%
Directors and Officers as a Group 27,753,637 43,57% 43.57%

 

(1)     

Based on 63,942,365 shares of common stock outstanding on August 21, 2017.

Item 7. Major Shareholders and Related Party Transactions

A . Major Shareholders.

Please refer to Item 6.E, “Share Ownership”.

B. Related Party Transactions.

Other than as disclosed herein, to the best of our knowledge, in the year ended December 31, 2016, there were no material transactions or loans between our company and: (a) enterprises that directly or indirectly through one or more intermediaries control or are controlled by, or are under common control with, our company; (b) associates; (c) individuals owning, directly or indirectly, an interest in the voting power of our company that gives them significant influence over our company, and close members of any such individual’s family; (d) key management personnel of our company, including directors and senior management of our company and close members of such individuals’ families; or (e) enterprises in which a substantial interest in the voting power is owned, directly or indirectly, by any person described in (c) or (d) or over which such a person is able to exercise significant influence.

In the normal course of operations, we enter into transactions with related parties, which include, among others, affiliates whereby we have a significant equity interest (10% or more) in the affiliates or have the ability to influence the affiliates’ or our operating and financing policies through significant shareholding, representation on the board of directors, corporate charter and/or bylaws. The affiliates also include certain of our directors, President and Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and their close family members.

Payments or accruals for related party services provided to the Company during the years ended December 31, 2016 and December 31, 2015 were:

26





  2016   2015  
  $   $  
Salary paid to a former chief executive officer and director -   106,667  
Consulting fees paid to company controlled by a director 78,571   24,000  
Accounting fees paid to a company controlled by the CFO 15,714   7,500  
Legal fees paid to a director -   1,334  
Share-based payments for options issued to a director -   4,500  
  94,285   144,001  

The consulting fees described above were paid to Howe and Bay Financial Corp., (“Howe and Bay”) a related party of the Company, of which Brian Gusko and Robert Horsley are directors in connection with services provided to the Company from Howe and Bay consisting of corporate communication advice and office services management.

During the year ended December 31, 2015, the Company assigned certain loans from related parties to Cabbay pursuant to the Arrangement.

During the year ended December 31, 2015, the Company entered into debt settlement agreements with officers and directors of the Company, through which an aggregate of $535,077 due to related parties was forgiven.

On March 21, 2016 the Company entered settlement agreements with related parties that included as well as other parties whereby the Company would issue Common Shares at a deemed price of $0.06 per Common Share for the settlement amounts owing to such creditors. Pursuant to these settlement agreements, $43,000 would be settled and a total of approximately 716,666 Common Shares would be issued to these creditors. Of the 716,666 Common Shares to be issued in connection with the debt settlement, 666,666 Common Shares were issued to Howe and Bay. The indebtedness settled or released related to consulting services and money owed to the Creditors. The disinterested directors of the Company approved this debt settlement with the related party.

As at December 31, 2016, the only balances the Company had with related parties were $189,468 due from Tower Three. These balances reflected short term loans to Tower Three by the related parties in order to fund the construction of Tower Three’s towers . These short term loans were all unsecured, non-interest bearing and payable on demand. As of March 31, 2017, those balances were all $nil. There are no further proposed related party transactions.

There are no amounts due to the Company from companies that have directors in common with the Company or have a partner who is a director of the Company.

C . Interests of Experts and Counsel.

Not applicable.

Item 8. Financial Information

A. Consolidated Statements and Other Financial Information

The consolidated financial statements of the Company included with this Form 20-F have been prepared in compliance with International Financial Reporting Standards, as adopted by the International Accounting Standards Board. See “Item 18: Financial Statements”.

Legal Proceedings

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

Dividend Distributions

We did not declare or pay any dividends to our shareholders in 2016. The actual timing, payment and amount of dividends paid on our shares of common stock is determined by our Board, based upon things such as our cash flow, results of operations and financial condition, the need for funds to finance ongoing operations and such other business considerations as our Board considers relevant.

27





B. Significant Changes

Please refer to “Item 4: Information on the Company – A. History and Development of the Company” for a discussion of significant events that have occurred after December 31, 2016.

Item 9. The Offer and Listing

A. Offer and Listing Details

The Company’s Common Shares are listed for trading on the CSE under the symbol of “TO”.

The high and low sale prices on the CSE of our Common Shares for the five most recent full financial years:

Year Ended High Sales Price Low Sales Price
2012 $0.17 $0.03
2013 $0.16 $0.04
2014 $0.08 $0.02
2015 $0.04 $0.01
2016 $0.44 $0.01

The quarterly high and low sales prices on the CSE for our Common Shares for the two most recently completed full financial years and any subsequent quarters are:

Quarters Ended High Sales Price Low Sales Price
March 31, 2015 $ 0.03 $ 0.01
June 30, 2015 $ 0.02 $ 0.01
September 30, 2015 $ 0.02 $ 0.01
December 31, 2015 $ 0.01 $ 0.01
March 31, 2016 $ 0.10 $ 0.10
June 30, 2016 $ 0.16 $ 0.16
September 30, 2016 $ 0.32 $ 0.32
December 31, 2016 $ 0.40 $ 0.40
March 31, 2017 $ 0.51 $ 0.33

The monthly high and low sales prices on the CSE of our Common Shares for the six most recent months are:

Month High Sales Price Low Sales Price
December 2016 $ 0.40 $ 0.40
January 2017 $ 0.51 $ 0.45
February 2017 $ 0.45 $ 0.34
March 2017 $ 0.51 $ 0.33
April 2017 $ 0.415 $ 0.20
May 2017 $ 0.29 $ 0.19

On August 21, 2017, the closing price of our Common Shares was $0.22 per share

The transfer of our shares of common stock is managed by our transfer agent, Computershare Trust Company of Canada.

B. Plan of Distribution

Not applicable.

28





C. Markets

The Company’s shares of Common Stock are currently traded on the CSE under the symbol “TO”, the Frankfort Stock Exchange under the symbol “1PSN” and are quoted on the OTC Pink Sheets under the symbol “TOWTF”.

D. Selling Shareholders

Not applicable.

E. Dilution

Not Applicable.

F. Expense of the Issue

Not Applicable.

Item 10. Additional Information

A. Share Capital

As of December 31, 2016, the Company has the following shares authorized and issued:

Class of Share Number of Authorized Shares Number of Issued Shares
Class A common shares without par value Unlimited 6,735,885

As of August 21, 2017, the Company had 63,942,365 Common Shares outstanding, 12,575,563 warrants outstanding and 769,565 stock options outstanding.

The Company has financed its operations through the issuance of Common Shares through private placement, the exercise of warrants issued in the private placements, and the exercise of stock options. The changes in the Company’s share capital during the last 3 fiscal years are as follows:

  • On January 6, 2014, the Company extended the expiry date of 224,333 share purchase warrants exercisable to purchase one Common Share of the Company at an exercise price of $4.50 per share from the original expiry date of January 31, 2014 to July 31, 2014;

  • On January 6, 2014, the Company extended the expiry date of 600,000 share purchase warrants exercisable to purchase one Common Share of the Company at an exercise price of $0.15 per share from the original expiry date of May 16, 2014 to November 16, 2014;

  • On January 6, 2014, the Company extended the expiry date 2,000 share purchase warrants exercisable to purchase one Common Share of the Company at an exercise price of $7.50 per share from the original expiry date of February 28, 2014 to August 28, 2014;

  • On January 10, 2014, the Company granted 13,333 stock options to advisors and consultants of the Company to purchase Common Shares of the Company for proceeds of $0.10 per common share expiring January 10, 2017;

  • On March 7, 2014 the Company issued 525,000 stock options to directors, officers, advisors and consultants of the Company to purchase common shares of the Company for proceeds of $3.00 per common share expiring March 7, 2019;

  • On May 7, 2014 the Company announced that it had entered into an advisory agreement with TriPoint Global Equities LLC (“TriPoint”) and issued to TriPoint warrants to purchase 23,333 shares at a price of $3.00 per share.
    The warrants expire on February 28, 2016;

  • On June 14, 2014 the Company issued 16,667 options to purchase Common Shares to a director and officer. The options may be exercised at a price of $1.80 per share for a period of one (1) year;

29





  • On October 2, 2014 the Company closed the first tranche of a non-brokered private placement and issued 50,667 units for gross proceeds of $76,000 (including $6,000 in cash proceeds and $70,000 to settle outstanding accounts payable). 50,667 warrants were issued with an expiration date of October 3, 2015. Each unit is comprised of one Common Share and one share purchase warrant, each warrant being exercisable for one common share at an exercise price of $0.15;

  • On October 28, 2014 the Company issued to consultants a total of 16,667 stock options to purchase Common Shares with an exercise price of $3.00, 6,667 of the options will expire on October 28, 2015; 3,333 of the options will expire on October 28, 2018; and 6,667 will expire October 28, 2020;

  • On February 2, 2015, the Company issued a total of 13,333 stock options to purchase Common Shares to a director and a consultant;

  • On March 20, 2015 the Company closed the second tranche of a non-brokered private placement and issued 66,666 units at $1.50 per unit for cash proceeds of $41,000 (of which $30,000 was received in 2014 and $11,000 received in 2015) and to retire debts totaling $59,000. Each unit is comprise of one common share and one share purchase warrant exercisable for one common share at an exercise price of $4.50 until March 20, 2016;

  • On April 1, 2015, the Company received regulatory approval to re-price its warrants outstanding as at March 30, 2015 to an exercise price of $0.90 for a period of 30 days;

  • On May 20, 2015, the Company received $3,600 for the exercise of 4,000 warrants at an exercise price of $0.90. The shares were not issued until after December 31, 2015;

  • On February 16, 2016, the Company issued 4,000 Common Shares in connection with the exercise of warrants for $0.90 per share for gross proceeds of $3,600;

  • On March 4, 2016, the Company issued 10,000 Common Shares at price of $0.45 per share pursuant to an agreement with an unrelated third party that was not pursued;

  • On March 30, 2016, the Company completed a private placement of 4,855,998 Common Shares at $0.06 per share for gross proceeds of $291,360 (including $245,360 in cash proceeds and $46,000 to settle outstanding debt);

  • In September 2016, the Company issued 500,000 Common Shares in connection with the exercise of stock options at $0.25 per share for gross proceeds of $120,000;

  • During the year ended December 31, 2016 13,333 stock options and 458,333 warrants outstanding were cancelled.

  • On January 9, 2017, in connection with the Tower Three Transaction, the Company completed a private placement of 15,484,912 Units at a price of $0.15 per Unit for gross proceeds of $2,322,737. Each Unit consisted of one Common Share and one warrant with each whole warrant entitling the holder to purchase, for a period of 12 months from the date of issue, one additional Common Share at an exercise price of $0.40 per Common Share. The Company paid finders and brokers cash commissions of $87,767 and issued 585,177 broker warrants;

  • On January 11, 2017, the Company issued 30,000,000 Common Shares in connection with the Tower Three Transaction;

  • On March 17, 2017, the Company issued a total of 700,000 stock options to directors, officers and consultants of the Company with an expiry of five years and an exercise price of $0.45 per share;

  • On April 18, 2017, the Company issued 500,000 Common Shares pursuant to an agreement with an unrelated company to take assignment of the company’s assets, trade secrets and receivables;

  • On May 4, 2017, the Company issued a total of 1,050,000 stock options to consultants and an officer of the Company with an expiry date of five years and an exercise price of $0.23 per share;

  • On June 13, 2017, the Company issued a total of 4,000,000 stock options to consultants of the Company with an expiry date of five years and an exercise price of $0.23 per share;

30





  • On June 19, 2017, the Company issued 1,500,000 Common Shares to consultants of the Company who assisted in the transaction with Evolution Technology SA;

  • On June 21, 2017, the Company issued 1,000,000 Common Shares to a consultant of the Company to settle outstanding debt of $230,000;

  • From May to July 2017, the Company issued 4,980,435 Common Shares for the exercise of stock options at an exercise price of $0.24 and for total proceeds of $1,145,450; and

  • In July 2017, the Company issued 3,494,466 Common Shares for the exercise of warrants at an exercise price of $0.30 and for total proceeds of $1,048,340.

Stock Options:

As at December 31, 2016 and 2015 the following stock options were outstanding and exercisable:

  December 31, 2016   December 31, 2015  
      Weighted       Weighted  
  Underlying   Average Exercise   Underlying   Average Exercise  
  Shares   Price   Shares   Price  
      $       $  
Stock options outstanding, beginning 13,333   3.00   122,500   3.36  
Granted 500,000   0.24   13,333   3.00  
Exercised (500,000 ) 0.24   -   -  
Expired / Cancelled (13,333 ) 3.00   (122,500 ) (3.66 )
Stock options outstanding, ending -   -   13,333   3.00  

Warrants

As at December 31, 2016 and 2015 the following share purchase warrants were issued and outstanding:

  December 31, 2016   December 31, 2015  
      Weighted       Weighted  
  Underlying   Average Exercise   Underlying   Average Exercise  
  Shares   Price   Shares   Price  
      $       $  
Warrants outstanding, beginning 458,333   3.22   519,000   3.68  
Issued -   -   66,667   4.50  
Exercised -   -   (4,000 ) 4.50  
Expired / Cancelled (458,333 ) (3.22 ) (123,334 ) 5.24  
Warrants outstanding, ending -   -   458,333   3.22  

B. Memorandum and Articles of Association

We are organized under the laws of the Province of British Columbia, Canada and have been assigned the number BC1056802.

Our Articles do not contain a description of our objects and purposes.

Our Articles do not restrict a director’s power to vote on a proposal, arrangement or contract in which the director is materially interested, vote on compensation to themselves or any other members of their body in the absence of an independent quorum or exercise borrowing powers. There is no mandatory retirement age for our directors and our directors are not required to own securities of our company in order to serve as directors.

Our authorized capital consists of an unlimited number of Class A common shares without par value. The holders of Common Shares are entitled to vote at all meetings of the Company’s shareholders, to receive dividends, if, as and when declared by the Board, and, subject to the rights of holders of any shares ranking in priority to, or on parity with the Common Shares, to participate ratably in any distribution of property or assets upon the liquidation, winding-up, or other dissolution of

31





the Company. The Common Shares are not subject to any future call or assessments and do not have any pre-emptive rights or redemption rights.

There are no limitations specific to the rights of non-Canadians to hold or vote our common shares under the laws of Canada or British Columbia, or in our charter documents.

Our Articles provide for the election of directors at each annual general meeting. Each director holds office until the next annual general meeting of our shareholders or until his successor is elected or appointed, unless his office is earlier vacated in accordance with our Articles or with the provisions of the BCBCA.

An annual meeting of shareholders must be held at such time in each year that is not later than 15 months after the last preceding annual meeting and at such place as our Board may from time to time determine. The quorum for the transaction of business at any meeting of shareholders is two persons who are entitled to vote at the meeting in person or by proxy and who hold in aggregate at least 5% of the issued shares entitled to be voted at the meeting. Only persons entitled to vote, our directors and auditors and others who, although not entitled to vote, are otherwise entitled or required to be present, are entitled to be present at a meeting of shareholders.

Other than not specifically providing a mechanism for shareholders to call a special meeting, our do Articles contain any provisions that would have an effect of delaying, deferring or preventing a change in control of our Company. Our Articles also do not contain any provisions that would operate only with respect to a merger, acquisition or corporate restructuring of our Company.

Our Articles do not contain any provisions governing the ownership threshold above which shareholder ownership must be disclosed.

Our Articles are not significantly different from the requirements of the BCBCA and the conditions imposed by our Articles governing changes in capital are not more stringent than what is required by the BCBCA.

C. Material Contracts

Except for contracts entered into by the Company in the ordinary course of business, the only material contracts entered into by the Company in the previous two years are the following:

(a)     

On October 19, 2016, the Company entered into the Tower Three Agreement to acquire all of the issued and outstanding securities of Tower Three. Pursuant to the terms of the Tower Three Agreement, the Company would acquire 100% of the securities of Tower Three from the shareholders of Tower Three, by issuing 30,000,000 Common Shares to the shareholders of Tower Three on a pro rate basis. These Common Shares were to be held in escrow pursuant to the terms of an escrow agreement which provided they were to subject to the following escrow restrictions: (i) restrictions based on certain performance milestones; (ii) time-based release restrictions prescribed under Canadian securities laws, and (iii) voluntary escrow restrictions;

 

 
(b)     

On April 18, 2016, the Company entered the Arrangement Agreement (as amended on April 21, 2016) in order to effect the Arrangement under the BCBCA. The Arrangement Agreement provided that Cabbay was to issue, 379,887 common shares to the Company’s shareholders on a pro-rata basis in exchange for a special class of reorganization shares of the Company held by shareholders of the Company. Agreement, the transfer of the Forge Agreement to Cabbay and the assignment of $435,360 of the Company’s debt to Cabbay.

 

 
(c)     

On July 24, 2015 the Company entered into the Forge Agreement pursuant to which the Company agreed to sell certain of its technology assets (related to fibrosis and erectile dysfunction) to Forge in return for 15,000,000 common shares of Forge.

 

 
(d)     

On March 21, 2016, the Company entered a settlement agreement with Howe and Bay Financial Corp. (“Howe”) pursuant to which 666,666 Common Shares were to be issued to Howe in exchange for the release of monies owing to Howe for consulting services previously provided by Howe to the Company.

D. Exchange Controls

32





There are no laws, decrees or regulations in Canada relating to restrictions on the export or import of capital, or affecting the remittance of interest, dividends or other payments to non-resident holders of our shares of Common Stock.

E. Taxation

Canada

Canadian Federal Income Tax Information for United States Residents

The following is a discussion of material Canadian federal income tax considerations generally applicable to holders of our common shares who, for purposes of the Income Tax Act (Canada) and the regulations thereunder, or the Canadian Tax Act:

  • deal at arm’s length and are not affiliated with us;

  • hold such shares as capital property;

  • do not use or hold (and will not use or hold) and are not deemed to use or hold our common shares, in or in the course of carrying on business in Canada;

  • have not been at any time residents of Canada; and

  • are, at all relevant times, residents of the United States, or U.S. Residents, under the Canada-United States Income Tax Convention (1980), or the Convention.

TAX MATTERS ARE VERY COMPLICATED AND THE CANADIAN FEDERAL INCOME TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON SHARES WILL DEPEND UPON THE STOCKHOLDER’S PARTICULAR SITUATION. THE SUMMARY OF MATERIAL CANADIAN FEDERAL INCOME TAX CONSEQUENCES SET FORTH BELOW IS INTENDED TO PROVIDE ONLY A GENERAL SUMMARY AND IS NOT INTENDED TO BE A COMPLETE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL CANADIAN FEDERAL INCOME TAX CONSEQUENCES.

THIS DISCUSSION DOES NOT INCLUDE A DESCRIPTION OF THE TAX LAWS OF ANY PROVINCE OR TERRITORY WITHIN CANADA. ACCORDINGLY, HOLDERS AND PROSPECTIVE HOLDERS OF OUR COMMON SHARES ARE ENCOURAGED TO CONSULT WITH THEIR OWN TAX ADVISERS ABOUT THE TAX CONSEQUENCES TO THEM HAVING REGARD TO THEIR OWN PARTICULAR CIRCUMSTANCES, INCLUDING ANY CONSEQUENCES OF PURCHASING, OWNING OR DISPOSING OF OUR COMMON SHARES ARISING UNDER CANADIAN FEDERAL, CANADIAN PROVINCIAL OR TERRITORIAL, U.S. FEDERAL, U.S. STATE OR LOCAL TAX LAWS OR TAX LAWS OF JURISDICTIONS OUTSIDE THE UNITED STATES OR CANADA.

This summary is based on the current provisions of the Canadian Income Tax Act, proposed amendments to the Canadian Income Tax Act publicly announced by the Minister of Finance (Canada) prior to the date hereof (the “Proposed Amendments”), and the provisions of the Convention as in effect on the date hereof. No assurance can be given that the Proposed Amendments will be entered into law in the manner proposed, or at all. No advance income tax ruling has been requested or obtained from the Canada Revenue Agency to confirm the tax consequences of any of the transactions described herein.

This summary is not exhaustive of all possible Canadian federal income tax consequences for U.S. Residents, and other than the Proposed Amendments, does not take into account or anticipate any changes in law, whether by legislative, administrative, governmental or judicial decision or action, nor does it take into account Canadian provincial, U.S. or foreign tax considerations which may differ significantly from those discussed herein. No assurances can be given that subsequent changes in law or administrative policy will not affect or modify the opinions expressed herein.

A U.S. Resident will not be subject to tax under the Canadian Tax Act in respect of any capital gain on a disposition of our common shares unless such shares constitute “taxable Canadian property”, as defined in the Canadian Tax Act, of the U.S. Resident and the U.S. Resident is not eligible for relief pursuant to the Convention. Our common shares will not constitute “taxable Canadian property” if, at any time during the 60-month period immediately preceding the disposition of the common shares, the U.S. Resident, persons with whom the U.S. Resident did not deal at arm’s length, or the U.S. Resident together with all such persons, did not own 25% or more of the issued shares of any class or series of shares of our capital stock. In addition, the Convention generally will exempt a U.S. Resident who would otherwise be liable to pay Canadian income tax in respect of any capital gain realized by the U.S. Resident on the disposition of our common shares, from such liability provided that the value of our common shares is not derived principally from real property situated in Canada, Canadian Resource Property and Canadian Timber Resource Property. However, where the US resident and

33





purchaser are related the purchaser must generally report the transaction to the Canada Revenue Agency within 30 days of the transaction date to benefit from the Convention. The Convention may not be available to a U.S. Resident that is a U.S. LLC which is not subject to tax in the U.S.

Amounts in respect of our common shares paid or credited or deemed to be paid or credited as, on account or in lieu of payment of, or in satisfaction of, dividends to a U.S. Resident will generally be subject to Canadian non-resident withholding tax at the rate of 25%. Currently, under the Convention the rate of Canadian non-resident withholding tax will generally be reduced to:

  • 5% of the gross amount of dividends if the beneficial owner is a company that is resident in the U.S. and that owns at least 10% of our voting shares; or

  • 15% of the gross amount of dividends if the beneficial owner is some other resident of the U.S.

Generally, the Convention does not apply to US resident LLC’s that are fiscally transparent. However, the Convention may apply to afford reduced withholding tax rates on dividends attributed to a US resident member of a US resident fiscally transparent LLC to the extent of the dividend being consider to have been received by that member.

United States Federal Income Tax Information for United States Holders.

The following is a general discussion of material U.S. federal income tax consequences of the ownership and disposition of our Common Shares by U.S. Holders (as defined below). This discussion is based on the United States Internal Revenue Code of 1986, as amended, Treasury regulations promulgated thereunder, and judicial and administrative interpretations thereof, all as in effect at the date hereof and all of which are subject to change, possibly with retroactive effect. This discussion only addresses the tax consequences for U.S. Holders that will hold their common shares as a “capital asset” and does not address U.S. federal income tax consequences that may be relevant to particular U.S. Holders in light of their individual circumstances or U.S. Holders that are subject to special treatment under certain U.S. federal income tax laws, such as:

  • tax-exempt organizations and pension plans;

  • persons subject to alternative minimum tax;

  • banks and other financial institutions;

  • insurance companies;

  • partnerships and other pass-through entities (as determined for United States federal income tax purposes);

  • broker-dealers;

  • persons who hold their common shares as a hedge or as part of a straddle, constructive sale, conversion transaction, and other risk management transaction; and

  • persons who acquired their common shares through the exercise of employee stock options or otherwise as compensation.

As used herein, the term “U.S. Holder” means a beneficial owner of our common shares that is:

  • an individual citizen or resident of the United States;

  • a corporation, a partnership or entity treated as a corporation or partnership for U.S. federal income tax purposes, that is created or organized in or under the laws of the United States or any political subdivision thereof;

  • an estate the income of which is subject to U.S. federal income taxation regardless of its source; and

  • a trust if both: a United States court is able to exercise primary supervision over the administration of the trust; and one or more United States persons have the authority to control all substantial decisions of the trust.

TAX MATTERS ARE VERY COMPLICATED AND THE UNITED STATES FEDERAL INCOME TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON SHARES WILL DEPEND UPON THE STOCKHOLDER’S PARTICULAR SITUATION. THE SUMMARY OF MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES SET FORTH BELOW IS INTENDED TO PROVIDE ONLY A GENERAL SUMMARY AND IS NOT INTENDED TO BE A COMPLETE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES.

NOTE THAT THIS DISCUSSION DOES NOT INCLUDE A DESCRIPTION OF THE TAX LAWS OF ANY STATE OR LOCAL GOVERNMENT WITHIN THE UNITED STATES. ACCORDINGLY, HOLDERS AND PROSPECTIVE HOLDERS OF OUR COMMON SHARES ARE ENCOURAGED TO CONSULT THEIR TAX ADVISORS ABOUT THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON SHARES.

34





Ownership of Shares

The gross amount of any distribution received by a U.S. Holder with respect to our common shares generally will be included in the U.S. Holder’s gross income as a dividend to the extent attributable to our current and accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder’s pro rata share of our current and accumulated earnings and profits, it will be treated first as a tax-free return of capital and reduce (but not below zero) the adjusted tax basis of the U.S. Holder’s shares. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder’s shares, the remainder will be taxed as capital gain (the taxation of capital gain is discussed under the heading “Sale of Shares” below).

For taxable years beginning before January 1, 2009, dividends received by non-corporate U.S. Holders from a qualified foreign corporation are taxed at the same preferential rates that apply to long-term capital gains. A foreign corporation is a “qualified foreign corporation” if it is eligible for the benefits of a comprehensive income tax treaty with the United States (the income tax treaty between Canada and the United States is such a treaty) or the shares with respect to which such dividend is paid is readily tradable on an established securities market in the United States (such as the Nasdaq Capital Market). Notwithstanding satisfaction of one or both of these conditions, a foreign corporation is not a qualified foreign corporation if it is a passive foreign investment company (“PFIC”) for the taxable year of the corporation in which the dividend is paid or the preceding taxable year. (Whether a foreign corporation is a PFIC is discussed below under the heading “Passive Foreign Investment Companies”). A foreign corporation that is a PFIC for any taxable year within a U.S. person’s holding period generally is treated as a PFIC for all subsequent years in the U.S. person’s holding period. Although we have not been, are not now, and do not expect to be a PFIC, and we don’t expect to pay dividends, you should be aware of the following matters in the event that we do become a PFIC and do pay dividends.

If we were to become a PFIC, then U.S. Holders who acquire our common shares may be treated as holding shares of a PFIC throughout their holding period for the purpose of determining whether dividends received from us are dividends from a qualified foreign corporation. As a consequence, dividends received by U.S. Holders may not be eligible for taxation at the preferential rates applicable to long-term capital gains.

If a distribution is paid in Canadian dollars, the U.S. dollar value of such distribution on the date of receipt is used to determine the amount of the distribution received by a U.S. Holder. A U.S. Holder who continues to hold such Canadian dollars after the date on which they are received, may recognize gain or loss upon their disposition due to exchange rate fluctuations. Generally such gains and losses will be ordinary income or loss from U.S. sources.

U.S. Holders may deduct Canadian tax withheld from distributions they receive for the purpose of computing their U.S. federal taxable income (or alternatively a credit may be claimed against the U.S. Holder’s U.S. federal income tax liability as discussed below under the heading “Foreign Tax Credit”). Corporate U.S. Holders generally will not be allowed a dividend received deduction with respect to dividends they receive from us.

Foreign Tax Credit

Generally, the dividend portion of a distribution received by a U.S. Holder will be treated as income in the passive income category for foreign tax credit purposes. Subject to a number of limitations, a U.S. Holder may elect to claim a credit against its U.S. federal income tax liability (in lieu of a deduction) for Canadian withholding tax deducted from its distributions. The credit may be claimed only against U.S. federal income tax attributable to a U.S. Holder’s passive income that is from foreign sources.

If we were to become a qualified foreign corporation with respect to a non-corporate U.S. Holder, dividends received by such U.S. Holder will qualify for taxation at the same preferential rates that apply to long-term capital gains. In such case, the dividend amount that would otherwise be from foreign sources is reduced by multiplying the dividend amount by a fraction, the numerator of which is the U.S. Holder’s preferential capital gains tax rate and the denominator of which is the U.S. Holder’s ordinary income tax rate. The effect is to reduce the dividend amount from foreign sources, thereby reducing the U.S. federal income tax attributable to foreign source income against which the credit may be claimed. Canadian withholding taxes that cannot be claimed as a credit in the year paid may be carried back to the preceding year and then forward 10 years and claimed as a credit in those years, subject to the same limitations referred to above.

The rules relating to the determination of the foreign tax credit are very complex. U.S. Holders and prospective U.S. Holders should consult their own tax advisors to determine whether and to what extent they would be entitled to claim a foreign tax credit.

35





Sale of Shares

Subject to the discussion of the “passive foreign investment company” rules below, a U.S. Holder generally will recognize capital gain or loss upon the sale of our shares equal to the difference between: (a) the amount of cash plus the fair market value of any property received; and (b) the U.S. Holder’s adjusted tax basis in such shares. This gain or loss generally will be capital gain or loss from U.S. sources, and will be long-term capital gain or loss if the U.S. Holder held its shares for more than 12 months. Generally, the net long-term capital gain of a non-corporate U.S. Holder from the sale of shares is subject to taxation at a top marginal rate of 15%. A Capital gain that is not long-term capital gain is taxed at ordinary income rates. The deductibility of capital losses is subject to certain limitations.

Passive Foreign Investment Companies

We will be a PFIC if, in any taxable year either: (a) 75% or more of our gross income consists of passive income; or (b) 50% or more of the value of our assets is attributable to assets that produce, or are held for the production of, passive income. Subject to certain limited exceptions, if we meet the gross income test or the asset test for a particular taxable year, our shares held by a U.S. Holder in that year will be treated as shares of a PFIC for that year and all subsequent years in the U.S. Holder’s holding period, even if we fail to meet either test in a subsequent year.

If we were a PFIC in the future, gain realized by a U.S. Holder from the sale of PFIC Shares and certain dividends received on such shares would be subject to tax under the excess distribution regime, unless the U.S. Holder made one of the elections discussed below. Under the excess distribution regime, federal income tax on a U.S. Holder’s gain from the sale of PFIC Shares would be calculated by allocating the gain ratably to each day the U.S. Holder held its shares. Gain allocated to years preceding the first year in which we were a PFIC in the U.S. Holder’s holding period, if any, and gain allocated to the year of disposition would be treated as gain arising in the year of disposition and taxed as ordinary income. Gain allocated to all other years would be taxed at the highest tax rate in effect for each of those years. Interest for the late payment of tax would be calculated and added to the tax due for each of the PFIC Years, as if the tax was due and payable with the tax return filed for that year. A distribution that exceeds 125% of the average distributions received on PFIC Shares by a U.S. Holder during the 3 preceding taxable years (or, if shorter, the portion of the U.S. Holder’s holding period before the taxable year) would be taxed in a similar manner.

A U.S. Holder may avoid taxation under the excess distribution regime by making a qualified electing fund (“QEF”) election. For each year that we would meet the PFIC gross income test or asset test, an electing U.S. Holder would be required to include in gross income, its pro rata share of our net ordinary income and net capital gains, if any. The U.S. Holder’s adjusted tax basis in our shares would be increased by the amount of such income inclusions. An actual distribution to the U.S. Holder out of such income generally would not be treated as a dividend and would decrease the U.S. Holder’s adjusted tax basis in our shares. Gain realized from the sale of our shares covered by a QEF election would be taxed as a capital gain. U.S. Holders will be eligible to make QEF elections, only if we agree to provide to the U.S. Holders, which we do, the information they will need to comply with the QEF rules. Generally, a QEF election should be made by the due date of the U.S. Holder’s tax return for the first taxable year in which the U.S. Holder held our shares that includes the close of our taxable year for which we met the PFIC gross income test or asset test. A QEF election is made on IRS Form 8621.

A U.S. Holder may also avoid taxation under the excess distribution regime by timely making a mark-to-market election. An electing U.S. Holder would include in gross income the increase in the value of its PFIC Shares during each of its taxable years and deduct from gross income the decrease in the value of its PFIC Shares during each of its taxable years. Amounts included in gross income or deducted from gross income by an electing U.S. Holder are treated as ordinary income and ordinary deductions from U.S. sources. Deductions for any year are limited to the amount by which the income inclusions of prior years’ exceed the income deductions of prior years. Gain from the sale of PFIC Shares covered by an election is treated as ordinary income from U.S. sources while a loss is treated as an ordinary deduction from U.S. sources only to the extent of prior income inclusions. Losses in excess of such prior income inclusions are treated as capital losses from U.S. sources. A mark-to-market election is timely if it is made by the due date of the U.S. Holder’s tax return for the first taxable year in which the U.S. Holder held our shares that includes the close of our taxable year for which we met the PFIC gross income test or asset test. A mark-to-market election is also made on IRS Form 8621.

As noted above, a PFIC is not a qualified foreign corporation and hence dividends received from a PFIC are not eligible for taxation at preferential long-term capital gain tax rates. Similarly, ordinary income included in the gross income of a U.S. Holder who has made a QEF election or a market-to-market election, and dividends received from corporations subject to such election, are not eligible for taxation at preferential long-term capital gain rates. The PFIC rules are extremely complex and could, if they apply, have significant, adverse effects on the taxation of dividends received and gains realized by a U.S. Holder. Accordingly, prospective U.S. Holders are strongly urged to consult their tax adviser concerning the potential application of these rules to their particular circumstances.

36





Controlled Foreign Corporation

Special rules apply to certain U.S. Holders that own stock in a foreign corporation that is classified as a “controlled foreign corporation” (“CFC”). We do not expect to be classified as a CFC. However, future ownership changes could cause us to become a CFC. Prospective U.S. Holders are urged to consult their tax advisor concerning the potential application of the CFC rules to their particular circumstances.

Information Reporting and Backup Withholding

United States information reporting and backup withholding requirements may apply with respect to distributions to U.S. Holders, or the payment of proceeds from the sale of shares, unless the U.S. Holder: (a) is an exempt recipient (including a corporation); (b) complies with certain requirements, including applicable certification requirements; or (c) is described in certain other categories of persons. The backup withholding tax rate is currently 28%. Any amounts withheld from a payment to a U.S. Holder under the backup withholding rules may be credited against any U.S. federal income tax liability of the U.S. Holder and may entitle the U.S. Holder to a refund.

F. Dividends and Paying Agents

Not applicable.

G. Statements by Experts

Not applicable.

H. Documents on Display

Not applicable.

I. Subsidiary Information

Not applicable

Item 11. Quantitative and Qualitative Disclosures about Market Risk

Market risk is the risk of loss related to changes in market prices, including interest rates and foreign exchange rates, of financial instruments that may adversely impact our consolidated financial position, results of operations or cash flows.

Inflation-related risks

We do not believe that inflation has had a material impact on our revenues or income over the past two fiscal years. However, increases in inflation could result in increases in our expenses, which may not be readily recoverable in the price of goods or services provided to our clients. To the extent that inflation results in rising interest rates and has other adverse effects on capital markets, it could adversely affect our financial position and profitability.

Foreign currency exchange risk

Foreign exchange risk is the risk arising from changes in foreign currency fluctuations. Foreign currency fluctuations have not previously had a material impact on the Company’s financial results. Consequently, the Company does not use any derivative instruments to reduce its exposure to fluctuations in foreign currency rates. It is the opinion of management that the foreign exchange risk to which the Company is exposed is currently minimal.

However, with the completion of the Tower Three Transaction, the Company anticipates that the fluctuations of the Columbian Peso may impact the Company’s financial results moving forward. The Company intends to monitor such potential impact and will possibly develop a hedging policy if such fluctuations become material.

Item 12. Description of Securities Other Than Equity Securities

Not applicable.

37





Part II

Item 13. Defaults, Dividend Arrearages and Delinquencies

Not applicable.

Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds

Not applicable.

Item 15. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

As of the end of the period covered by this report, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) under the Securities Exchange Act of 1934). Our principal executive and financial officers supervised and participated in this evaluation. Based on this evaluation, our principal executive and financial officers each concluded that our disclosure controls and procedures were effective in timely alerting them to material information required to be included in our periodic reports to the Securities and Exchange Commission. The design of any system of controls is based in part upon various assumptions about the likelihood of future events, and there can be no assurance that any of our plans, products, services or procedures will succeed in achieving their intended goals under future conditions.

Changes in Internal Control

There were no changes in the Company’s internal controls over financial reporting (as defined in Rule 13a-15f and 15d-15(f) of the Securities Exchange Act of 1934) that occurred during the period covered by this report that have materially affected, or are likely to materially affect, the Company’s internal control over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Management of the Company is responsible for establishing and maintaining internal control over financial reporting as defined in Rules 13a-15(f) and 15(d)-15(f) of the Securities Exchange Act of 1934. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2016. In making this assessment management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control – Integrated Framework . Based on our assessment and the criteria discussed above, management believes that, as of December 31, 2016, the Company maintained effective internal control over financial reporting.

Item 16A. Audit Committee Financial Experts

Our Board has determined that Brian Gusko qualifies as an “audit committee financial expert” and is “independent”, as such terms are used in Section 303A.02 of the NYSE Listed Company Manual.

Item 16B. Code of Ethics

The Board has approved a Code of Business Conduct and Ethics (the “Code”), which is filed herewith as an exhibit to this Form 20-F to be followed by the Company’s directors, officers, employees and principal consultants and those of its subsidiaries. The Code is also to be followed, where appropriate, by the Company’s agents and representatives, including

38





consultants where specifically required. The purpose of the Code is to, among other things, promote honest and ethical conduct, avoid conflicts of interest, protect confidential or proprietary information and comply with the applicable government laws and securities rules and regulations. The Board does not actively monitor compliance with the Code, but requires prompt notification of apparent or actual breaches so that it may investigate and take action. The Code has been circulated to all employees.

Item 16C. Principal Accountant Fees and Services

The following table presents fees for professional audit services for the audit of the Company’s annual financial statements for fiscal year 2016 and 2015 and fees billed for other services rendered during 2016 and 2015.

  Fiscal 2016 Fiscal 2015
  Manning Elliott Davidson &
  LLP   Company LLP
Type of Service/Fee        
Audit Fees (1) $ 32,000 $ 18,000
Audit Related Fees (2) $ - $ 360
Tax Fees (3) $ - $ 3,576
All Other Fees $ - $ -

(1) Audit Fees consist of fees for professional services rendered for the audit of the company's consolidated financial statements included in its Annual Report on 20-F, the review of the interim financial statements included in its reports filed with the Canadian securities regulators, and for the services that are normally provided in connection with regulatory filings or engagements.

(2) Includes fees associated with assurance and related services that are reasonably related to the performance of the audit or review of the Company's financial statements. This category includes fees related to consultation regarding generally accepted accounting principles.

(3) Tax Fees consist of fees for tax compliance, tax advice and tax planning. The fee includes the preparation of the Company's income tax returns, franchise tax reports, and other tax filings.

Although our Audit Committee currently does not have a formal policy in place to pre-approve all audit and non-audit services provided by our independent auditor and the fees for such non-audit services, the Company's audit committee has adopted a policy to review on an annual basis the performance, objectivity and independence of our independent auditor.

Item 16D. Exemptions from the Listing Standards for Audit Committees

Not applicable.

Item 16E. Purchases of Equity Securities by the Company and Affiliated Purchasers

None.

Item 16F. Change in Registrant’s Certifying Accountant

Fiscal Year 2015

Resignation of James Stafford

Upon mutual agreement, James Stafford, Inc. ("James Stafford") resigned as our principal accountant effective April 16, 2015 and we appointed Davidson & Company LLP as our independent registered public accounting firm for the year ended December 31, 2014.

Our Audit Committee and Board considered and approved the decision to change accountants. The audit report of James Stafford on our financial statements for the fiscal year ended December 31, 2013 prepared in accordance with IFRS did not contain an adverse opinion, a disclaimer of opinion, a modification or a qualification.

39





During our most recent fiscal year and any subsequent interim period preceding such resignation, there were no disagreements with James Stafford on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of James Stafford, would have caused it to make reference to the subject matter of the disagreements in connection with its report. None of the following events occurred within our two most recent fiscal years and any subsequent interim period preceding James Stafford’s resignation:

  (A)     

James Stafford advised us that the internal controls necessary for us to develop reliable financial statements did not exist;

   

 
  (B)     

James Stafford advised us that information came to James Stafford’s attention that has led it to no longer be able to rely on our management’s representations, or that had made it unwilling to be associated with the financial statements prepared by our management;

   

 
  (C)     

James Stafford advised us of the need to expand significantly the scope of its audit, or that information came to James Stafford’s attention during our two most recent fiscal years and any subsequent interim period, that if further investigated may:

   

 
  (i)     

materially impact the fairness or reliability of either: a previously issued audit report or the underlying financial statements, or the financial statements issued or to be issued covering the fiscal period(s) subsequent to the date of the most recent financial statements covered by an audit report (including information that may prevent it from rendering an unqualified audit report on those financial statements); or

   

 
  (ii)     

cause it to be unwilling to rely on our management’s representations or be associated with our financial statements; and

due to James Stafford’s resignation (due to audit scope limitations or otherwise), or for any other reason, James Stafford did not so expand the scope of its audit or conduct such further investigation; or

  (D)     

James Stafford advised us that information came to James Stafford’s attention that it had concluded materially impacts the fairness or reliability of either:

   

 
  (i)     

a previously issued audit report or the underlying financial statements, or

   

 
  (ii)     

the financial statements issued or to be issued covering the fiscal period(s) subsequent to the date of the most recent financial statements covered by an audit report (including information that, unless resolved to James Stafford’s satisfaction, would prevent it from rendering an unqualified audit report on those financial statements); and

due to James Stafford’s resignation (due to audit scope limitations or otherwise), or for any other reason, the issue had not been resolved to James Stafford’s satisfaction prior to its resignation.

Appointment of Davidson & Company LLP

Our board of directors appointed Davidson & Company LLP to be our principal accountant effective April 16, 2015.

We did not consult Davidson & Company LLP regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements, or (ii) any matter that was either the subject of a disagreement or a reportable event as described in Item 16F(a)(1)(v) of Form 20-F.

Fiscal Year 2017

On March 9, 2017, the Company’s former auditor Davidson & Company LLP resigned at the Company’s request.

Resignation of Davidson & Company LLP

Upon mutual agreement, Davidson & Company LLP, resigned as our principal accountant effective March 9, 2017 and we appointed Manning Elliott LLP as our independent registered public accounting firm for the year ended December 31, 2016. Our Audit Committee and Board considered and approved the decision to change accountants.

40





The audit report of Davidson & Company LLP on our financial statements for the fiscal years ended December 31, 2015 prepared in accordance with IFRS did not contain an adverse opinion, a disclaimer of opinion, a modification or a qualification.

During our most recent fiscal year and any subsequent interim period preceding such resignation, there were no disagreements with Davidson & Company LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Davidson & Company LLP, would have caused it to make reference to the subject matter of the disagreements in connection with its report.

None of the following events occurred within our two most recent fiscal years and any subsequent interim period preceding Davidson & Company LLP’s resignation:

  (A)     

Davidson & Company LLP advised us that the internal controls necessary for us to develop reliable financial statements did not exist;

   

 
  (B)     

Davidson & Company LLP advised us that information came to Davidson & Company LLP’s attention that has led it to no longer be able to rely on our management’s representations, or that had made it unwilling to be associated with the financial statements prepared by our management;

   

 
  (C)     

Davidson & Company LLP advised us of the need to expand significantly the scope of its audit, or that information came to Davidson & Company LLP’s attention during our two most recent fiscal years and any subsequent interim period, that if further investigated may:

   

 
  (i)     

materially impact the fairness or reliability of either: a previously issued audit report or the underlying financial statements, or the financial statements issued or to be issued covering the fiscal period(s) subsequent to the date of the most recent financial statements covered by an audit report (including information that may prevent it from rendering an unqualified audit report on those financial statements); or

 

 
  (ii)     

cause it to be unwilling to rely on our management’s representations or be associated with our financial statements; and

due to Davidson & Company LLP’s resignation (due to audit scope limitations or otherwise), or for any other reason, Davidson & Company LLP did not so expand the scope of its audit or conduct such further investigation; or

  (D)     

Davidson & Company LLP advised us that information came to Davidson & Company LLP’s attention that it had concluded materially impacts the fairness or reliability of either:

   

 
  (i)     

a previously issued audit report or the underlying financial statements, or

   

 
  (ii)     

the financial statements issued or to be issued covering the fiscal period(s) subsequent to the date of the most recent financial statements covered by an audit report (including information that, unless resolved to Davidson & Company LLP’s satisfaction, would prevent it from rendering an unqualified audit report on those financial statements); and

due to Davidson & Company LLP’s resignation (due to audit scope limitations or otherwise), or for any other reason, the issue had not been resolved to Davidson & Company LLP’s satisfaction prior to its resignation.

Appointment of Manning Elliott LLP

Our board of directors appointed Manning Elliott LLP to be our principal accountant effective March 9, 2017.

We did not consult Manning Elliott LLP regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements, or (ii) any matter that was either the subject of a disagreement or a reportable event as described in Item 16F(a)(1)(v) of Form 20-F.

Item 16G. Corporate Governance

Not applicable.

Item 16H. Mine Safety Disclosure

Not applicable.

41





Part III

Item 17. Financial Statements

In lieu of responding to this item, we have responded to Item 18 of this annual report.

Item 18. Financial Statements

The Company’s audited financial statements for fiscal year ended December 31, 2016 as required under Item 18 are attached hereto starting on page F-1 of this Form 20-F. All of the financial information is presented herein in accordance with International Financial Reporting Standards, as issued by the International Accounting Standards Board.

Item 19. Exhibits

Exhibit Description of Exhibit
Number  
1.1 Articles of the Company.*
1.2 Certificate of Change of Name dated December 28, 2016.
4.1 Stock Option Plan.*
4.3 The Arrangement Agreement between the Company and Cabbay Holdings Corp. dated April 18, 2016 and amended on April 21, 2016.
4.4 Share Exchange Agreement dated October 19, 2016, between the Company, Tower Three SAS, and the shareholders of Tower Three SAS.
8.1 List of significant subsidiaries of the Company as of August 21, 2017.
11.1 Code of Business Conduct and Ethics.*
12.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
12.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
13.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
13.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
15.1 Letter dated September 8, 2017 by James Stafford, Inc. Chartered Accountants as required by Item 16F of Form 20-F
15.2 Letter dated September 8, 2017 by Davidson & Company LLP Chartered Professional Accountants as required by Item 16F of Form 20-F
15.3 Audit Committee Charter*

*Filed with previous Form 20-Fs

42





SIGNATURE

The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this registration statement on its behalf.

  TOWER ONE WIRELESS CORP.
   
Date: September 8, 2017 By: /s/ Alejandro Ochoa
  Name: Alejandro Ochoa
  Title: Chief Executive Officer
   
  By: /s/ Abbey Abdiye
  Name: Abbey Abdiye
  Title: Chief Financial Officer

43




Exhibit 99.1

TOWER ONE WIRELESS CORP.
(Formerly PACIFIC THERAPEUTICS LTD.)
FINANCIAL STATEMENTS

Years Ended
December 31, 2016, 2015 and 2014
(Expressed in Canadian Dollars)





INDEPENDENT AUDITORS’ REPORT

To the Shareholders of
Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.)

We have audited the accompanying financial statements of Tower One Wireless Corp. which comprise the statement of financial position as at December 31, 2016, and the statements of comprehensive income (loss), changes in equity and cash flows for the year then ended, and the related notes comprising a summary of significant accounting policies and other explanatory information.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

Auditors’ Responsibility

Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with Canadian generally accepted auditing standards and the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we comply with ethical requirements, and plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained based on our audit is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements present fairly, in all material respects, the financial position of Tower One Wireless Corp. as at December 31, 2016, and its financial performance and its cash flows for the year then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Emphasis of Matter

Without qualifying our opinion, we draw attention to Note 1 in the financial statements which indicates the existence of a material uncertainty that may cast significant doubt on the ability of Tower One Wireless Corp. to continue as a going concern.

Other Matter

The financial statements of Tower One Wireless Corp. 20F filing for the years ended December 31, 2015 and 2014 were audited by another auditor who expressed unmodified opinions on those statements on April 4, 2016 and April 30, 2015 respectively.

/s/ Manning Elliot LLP

CHARTERED PROFESSIONAL ACCOUNTANTS
Vancouver, British Columbia
August 23, 2017






REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Directors of
Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.)

We have audited the accompanying financial statements of Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.), which comprise the statements of financial position as of December 31, 2015 and 2014, and the related statements of comprehensive income (loss), changes in shareholders’ deficiency, and cash flows for the years then ended, and a summary of significant accounting policies and other explanatory information.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

Auditors’ Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with Canadian generally accepted auditing standards and the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditors’ judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained in our audits is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, these financial statements present fairly, in all material respects, the financial position of Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.) as at December 31, 2015 and 2014 and its financial performance and its cash flows for the years then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.






Emphasis of Matter

Without qualifying our opinion, we draw attention to Note 1 in the financial statements which indicates that Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.) has suffered recurring losses from operations and has a net capital deficiency. These matters, along with the other matters set forth in Note 1, indicate the existence of material uncertainties that raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

“DAVIDSON & COMPANY LLP”

Chartered Professional Accountants

Vancouver, Canada

September 7, 2017





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Statements of Financial Position
As at December 31, 2016 and 2015
(Expressed in Canadian Dollars)

 

    Note      2016      2015  
      $   $  
 
Current Assets            
Cash     1,378,183   -  
Amounts receivable     14,439   1,744  
Due from related parties 7   189,468   -  
Prepaid expenses and deposits          26,190      12,951  
      1,608,280   14,695  
Other receivable    5      -      1  
           1,608,280      14,696  
 
Current Liabilities            
Bank overdraft     -   141  
Accounts payable and accrued liabilities     133,507   333,034  
Convertible note 6   -   62,460  
Due to related parties    7      6,300      228,472  
           139,807      624,106  
 
Shareholders’ Equity (Deficiency)            
Share capital 8   3,292,175   2,800,010  
Shares committed for issuance 8   -   4,800  
Shares subscriptions received 13(b) 1,602,257   -  
Equity component of convertible note 6   -   1,080  
Contributed surplus     563,568   121,939  
Deficit          (3,989,527 )    (3,537,239 )
           1,468,473      (609,410 )
           1,608,280      14,696  

Nature of operations and going concern (Note 1)
Subsequent events (Note 13)

Approved on behalf of the Board of Directors:

“Alejandro Ochoa”   “Brian Gusko”

The accompanying notes are an integral part of these financial statements.





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Statements of Comprehensive Income (Loss)
For the Years Ended December 31, 2016, 2015 and 2014
(Expressed in Canadian Dollars)

 

    Note     2016     2015     2014  
    $   $   $  
Expenses              
Advertising and promotion   -   22,386   67,923  
Amortization of property and equipment   -   -   1,216  
Amortization of intangible assets   -   2,993   5,618  
Bank charges and interest   766   4,077   10,047  
Donation   -   -   500  
Insurance   19,631   9,707   30,194  
Interest accretion 6 -   25,503   11,005  
Investor relations   -   -   25,075  
Office and miscellaneous   32,175   1,666   5,428  
Professional fees   307,414   85,486   168,490  
Rent and occupancy costs   -   3,172   14,543  
Share-based payments 8 75,505   11,998   152,028  
Telephone and utilities   -   1,516   2,006  
Transfer agent   17,318   9,462   24,107  
Travel     -   230   11,906  
Wages and benefits         -     106,667     160,947  
    (452,809 ) (284,863 ) (691,033 )
Other Income (Expenses)              
Foreign exchange   5,711   (28,269 ) 440  
Gain on debt settlement 7 -   535,077   -  
Gain on derivative liability   -   36,188   -  
Impairment of intangible assets   -   (67,065 ) -  
Interest on convertible notes 6 (5,190 ) (6,395 ) (1,825 )
Loss on retirement assets 6 -   -   (1,227 )
Loss on settlement of convertible note   6     -     (5,000 )   -  
          521     464,536     (2,612 )
   
Net income (loss) and comprehensive income (loss)     (452,288 )   179,673     (693,645 )
   
Income (loss) per common share – basic and diluted     (0.09 )   0.13     (0.56 )
     
Weighted average number of common shares         5,175,946     1,351,500     1,248,561  

The accompanying notes are an integral part of these financial statements.





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Statement of Changes in Equity
(Expressed in Canadian Dollars)

 

          Shares   Equity              
  Number of   Share   committed   component              
  Common Share subscriptions   for   of convertible   Contributed          
    shares     capital     received     issuance     note     surplus     Deficit     Total  
    $ $   $   $   $   $   $  
 
Balance at December 31, 2013 1,248,554 2,699,210 -   -   -   123,704   (3,263,058 ) (440,144 )
Shares issued for cash 4,000 4,800 -   -   -   1,200   -   6,000  
Shares exchanged for debt 46,667 56,000 -   -   -   14,000   -   70,000  
Subscription received for shares - - 30,000   -   -   -   -   30,000  
Share-based payments - - -   -   -   152,028   -   152,028  
Options expired unexercised - - -   -   -   (1,166 ) 1,166   -  
Comprehensive loss   -     -     -     -     -     -     (693,645 )   (693,645 )
 
Balance at December 31, 2014 1,299,221 2,760,010 30,000   -   -   289,766   (3,955,537 ) (875,761 )
Units issued for debt @$1.50 39,333 23,600 -   -   -   35,400   -   59,000  
Units issued for cash @$1.50 27,333 16,400 (30,000 ) -   -   24.600   -   11,000  
Shares committed for issuance on exercise of warrants - - -   4,800   -   (1,200 ) -   3,600  
Share-based payments - - -   -   -   11,998   -   11,998  
Fair value of conversion feature on convertible note - - -   -   1,080   -   -   1,080  
Options and warrants expired and unexercised - - -   -   -   (238,625 ) 238,625   -  
Comprehensive income   -     -     -     -     -     -     179,673     179,673  
 
Balance at December 31, 2015 1,365,887 2,800,010 -   4,800   1,080   121,939   (3,537,239 ) (609,410 )
Shares issued for cash @$0.06 4,089,332 245,360 -   -   -   -   -   245,360  
Shares issued for debt settlement 766,666 46,000 -   -   -   -   -   46,000  
Exercise of warrants 4,000 4,800 -   (4,800 ) -   -   -   -  
Shares issued to True Vita 10,000 500 -   -   -   -   -   500  
Exercise of options 500,000 195,505 -   -   -   (75,505 ) -   120,000  
Share-based payments - - -   -   -   75,505   -   75,505  
Subscriptions received - - 1,602,257   -   -   -   -   1,602,257  
Transfer of convertible note - - -   -   (1,080 ) 1,080   -   -  
Debt forgiveness - - -   -   -   440,549   -   440,549  
Comprehensive loss   -     -     -     -     -     -     (452,288 )   (452,288 )
 
Balance at December 31, 2016   6,735,885     3,292,175   1,602,257     -     -     563,568     (3,989,527 )   1,468,473  

The accompanying notes are an integral part of these financial statements.





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Statements of Cash Flows
For the Years Ended December 31, 2016, 2015 and 2014
(Expressed in Canadian Dollars)

 

    2016     2015     2014  
  $   $   $  
 
Cash flows from operating activities            
Net (loss) income (452,288 ) 179,673   (693,645 )
Items not affection cash:            

Amortization of property and equipment

-   -   1,216  

Amortization of intangible assets

-   2,993   5,618  

Accretion

-   25,503   11,005  

Interest expense on convertible note

3,730   6,395   1,825  

Gain on derivative liability

-   (36,188 ) -  

Share-based payments

75,505   11,998   152,028  

Impairment of intangible assets

-   67,065   -  

Gain on forgiveness of debt

-   (535,077 ) -  

Loss on investment

500   -   -  

Loss on retirement of assets

-   -   1,227  

Loss on settlement of convertible note

  -     5,000     -  
  (372,553 ) (272,638 ) (520,726 )
 
Changes in non-cash working capital item:            

Amounts receivable

(12,695 ) (432 ) 6,079  

Prepaid expenses

(13,239 ) (12,951 ) 36,605  

Accounts payable and accrued liabilities

  2,228     124,561     111,273  
    (396,259 )   (161,460 )   (366,769 )
 
Cash flows from investing activity            

Additions to intangible assets

  -     (5,570 )   (10,195 )
 
Cash flows from financing activities            

Advances from (to) related parties

(188,035 ) 150,776   142,685  

Exercise of stock options

120,000   -   -  

Repayment of convertible note

(5,000 ) -   -  

Shares issued for cash

245,360   14,600   6,000  

Subscriptions received

1,602,257   -   30,000  

Convertible note

-   -   50,000  

Repayment of convertible note

  -     -     (30,900 )
    1,774,582     165,376     197,785  
 
Change in cash and cash equivalents 1,378,324   (1,654 ) (179,179 )
Cash and cash equivalents (bank overdraft), beginning   (141 )   1,513     180,692  
 
Cash and cash equivalents (bank overdraft), ending   1,378,183     (141 )   1,513  
 
Supplemental disclosure of cash flow information:            

Cash paid for interest

-   -   -  

Cash paid for income taxes

  -     -     -  

Supplemental Cash Flow Information (Note 12)

The accompanying notes are an integral part of these financial statements.





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

1.      

NATURE OF OPERATIONS AND GOING CONCERN

Tower One Wireless Corp. (formerly Pacific Therapeutics Ltd.) (the “Company") was incorporated under the laws of the Province of British Columbia, Canada on September 12, 2005. On October 14, 2011, the Company became a reporting company in British Columbia and was approved by the Canadian Securities Exchange (“CSE”) and commenced trading on November 16, 2011. The Company’s registered office is located at Suite 605, 815 Hornby Street, Vancouver, BC, Canada V6Z 2E6.

On March 6, 2016, the Company incorporated Cabbay Holdings Corp. (“Cabbay”), a wholly owned subsidiary. On April 21, 2016, the Company entered into a plan of arrangement (“Arrangement”) with Cabbay and its shareholders. Under the Arrangement, Cabbay issued its common shares in exchange for special Class of reorganization shares of the Company held by the shareholders of the Company. The Company then redeemed the special Class of reorganization shares held by Cabbay in exchange for the Asset Purchase Agreement with Forge Therapeutics Inc., described in Note 5 and $1,000. The Arrangement was approved by the Company’s shareholders on May 20, 2016 and by the Supreme Court of British Columbia on May 31, 2016. Upon completion of the Arrangement, Cabbay was no longer a subsidiary of the Company. In connection with the restructuring, $440,549 of the Company’s debt in the form of accounts payable, convertible note and amounts due to related parties was assigned to Cabbay. As a result of the assignment and the Arrangement, the Company recorded $440,549 in contributed surplus for the year ended December 31, 2016.

These financial statements have been prepared on the basis of accounting principles applicable to a going concern, and accordingly, do not purport to give effect to adjustments which may be required should the Company be unable to achieve the objectives above as a going concern. The net realizable value of the Company’s assets may be materially less than the amounts recorded in these financial statements should the Company be unable to realize its assets and discharge its liabilities in the normal course of business. At December 31, 2016, the Company had an accumulated deficit of $3,989,527 which has been funded primarily by the issuance of equity. Ongoing operations of the Company are dependent upon the Company’s ability to receive continued financial support, complete equity financings and ultimately the generation profitable operations in the future. These factors raise significant doubt about the Company’s ability to continue as a going concern.

2.      

STATEMENT OF COMPLIANCE AND BASIS OF PRESENTATION

 

(a)      

Statement of Compliance

These financial statements of the Company for the years ended December 31, 2016 and 2015 have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

These financial statements were approved and authorized for issue by the Board of Directors on August 23, 2017.

(b)      

Basis of Presentation

These financial statements were prepared on a historical cost basis, except for financial instruments classified as fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information. The financial statements are presented in Canadian dollars which is the Company’s functional currency.

7





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

2.      

STATEMENT OF COMPLIANCE AND BASIS OF PRESENTATION (CONTINUED)

 

(c)      

Use of Estimates

The Company makes estimates and assumptions about the future that affect the reported amounts of assets and liabilities. Estimates and judgments are continually evaluated based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates and assumptions.

The effect of a change in an accounting estimate is recognized prospectively by including it in comprehensive income in the period of the change, if the change affects that period only, or in the period of the change and future periods, if the change affects both. Significant assumptions about the future and other sources of estimation uncertainty that management has made at the statement of financial position date, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions that have been made that relate to the following key estimates:

Intangible Assets – impairment

The application of the Company’s accounting policy for intangible assets expenditures requires judgment in determining whether it is likely that future economic benefits will flow to the Company, which may be based on assumptions about future events or circumstances. Estimates and assumptions may change if new information becomes available. If, after expenditures are capitalized, information becomes available suggesting that the recovery of expenditures is unlikely, the amount capitalized is written off in profit or loss in the period the new information becomes available.

Intangible Assets – useful lives

Following initial recognition, the Company carries the value of intangible assets at cost less accumulated amortization and any accumulated impairment losses. Amortization is recorded on a straight-line basis based upon management’s estimate of the useful life and residual value. The estimates are reviewed at least annually and are updated if expectations change as a result of technical obsolescence or legal and other limits to use. A change in the useful life or residual value will impact the reported carrying value of the intangible assets resulting in a change in related amortization expense.

Share-based payments and compensation

The Company has applied estimates with respect to the valuation of shares issued for non-cash consideration. Shares are valued at the fair value of the equity instruments granted at the date the Company receives the goods or services.

The Company measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining the most appropriate inputs to the valuation model including the fair value of the underlying common shares, the expected life of the share option, volatility and dividend yield and making assumptions about them. The fair value of the underlying common shares is assessed as the most recent issuance price per common share for cash proceeds. The assumptions and models used for estimating fair value for share-based payment transactions are discussed in Note 8.

8





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

3.      

SIGNIFICANT ACCOUNTING POLICIES

The following is a summary of significant accounting policies used in the preparation of these financial statements:

(a)      

Cash and cash equivalents

Cash and cash equivalents are comprised of cash on hand, deposits in banks and highly liquid investments having original terms to maturity of 90 days or less.

(b)      

Income per share

Basic income per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. To compute diluted loss per share, adjustments are made to common shares outstanding. The weighted average number of common shares outstanding is adjusted to include the number of additional common shares that would be outstanding if, at the beginning of the period or at time of issuance, all options and warrants were exercised. The proceeds from exercise are assumed to be used to purchase the Company’s common shares at their average market price during the period. For the periods presented, this calculation proved to be anti-dilutive.

(c)      

Intangible assets

Technology licenses acquired from third parties that include licenses and rights to technologies are initially recorded at fair value based on consideration paid and amortized on a straight-line basis over the estimated useful life of the underlying technologies.

Patent costs associated with the preparation, filing, and obtaining of patents are capitalized and amortized on a straight-line basis over the useful lives of the underlying technologies and patents, usually for a period not exceeding 15 years.

Management evaluates the recoverability of technology licenses and patents on an annual basis based on the expected utilization of the underlying technologies. If the estimated net recoverable value for each cash-generating unit, calculated based on undiscounted future cash flows, is less than the carrying value, the asset is written down to its fair value. The amounts shown for technology licenses and patent costs do not necessarily reflect present or future values and the ultimate amount recoverable will be dependent upon the successful development and commercialization of products based on these rights.

9





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

3.      

SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(d)      

Impairment

Non-financial assets are tested for impairment whenever events or changes in circumstances indicate that an asset’s carrying amount may be less than its recoverable amount. Management uses judgment to estimate these inputs and any changes to these inputs could have a material impact on the impairment calculation. For impairment testing, non-financial assets that do not generate independent cash flows are grouped together into cash-generating units (CGUs), which represent the levels at which largely independent cash flows are generated. An impairment loss is recognized in earnings to the extent that the carrying value of an asset, CGU or group of CGU’s exceeds its estimated recoverable amount. The recoverable amount of an asset, CGU or group of CGU’s is the greater of its value in use and its fair value less cost to sell. Value in use is calculated as the present value of the estimated future cash flows discounted at appropriate discount rates. An impairment loss relating to a specific asset reduces the carrying value of the asset. An impairment loss relating to a group of CGU’s is allocated on a pro-rata basis to reduce the carrying value of the assets in the units comprising the group. A previously recognized impairment loss related to non-financial assets is assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss related to non-financial assets is reversed if there is a subsequent increase in the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying value does not exceed the carrying value that would have been determined, net of depreciation or amortization, if no loss had been recognized.

(e)      

Share capital

Common shares are classified as equity. Transaction costs directly attributable to the issue of common shares and share options are recognized as a deduction from equity, net of any tax effects. Common shares issued for consideration other than cash, are valued based on their market value at the date the shares are issued.

The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the more easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The Company considers the fair value of common shares issued in a private placement to be the more easily measurable component and the common shares are valued at their fair value, as determined by the closing quoted bid price on the announcement date. The balance, if any, is allocated to the attached warrants. Any fair value attributed to the warrants is recorded as reserves.

(f)      

Share-based payments

Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The offset to the recorded cost is to warrants and options reserve. Consideration received on the exercise of stock options is recorded as share capital and the related amount in warrants and options reserve is transferred to share capital. Charges for options that are forfeited before vesting are reversed from share-based payments reserve. For those options that expire or are forfeited after vesting, the recorded value is transferred to deficit.

10





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

3.      

SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(g)      

Income taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets result from unused loss carry-forwards, resource related pools and other deductions. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be utilized.

Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

(h)      

Provisions

Provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resourced embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made. The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the statement of financial position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.

(i)      

Financial instruments

 

(a)     

Financial assets

The Company classifies its financial assets in the following categories: held-to-maturity, fair value through profit or loss (“FVTPL”), loans and receivables, and available-for-sale (“AFS”). The classification depends on the purpose for which the financial assets were acquired. The Company's accounting policy for each category is as follows:

Fair value through profit or loss

This category comprises derivatives, or assets acquired or incurred principally for the purpose of selling or repurchasing it in the near term. They are carried in the statement of financial position at fair value with changes in fair value recognized through profit or loss.

Loans and receivables

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are carried at amortized cost less any provision for impairment. Individually significant receivables are considered for impairment when they are past due or when other objective evidence is received that a specific counterparty will default.

11





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

3.      

SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(i)      

Financial instruments (continued)

 

(a)     

Financial assets (continued)

Held-to-maturity

These assets are non-derivative financial assets with fixed or determinable payments and fixed maturities that the Company's management has the positive intention and ability to hold to maturity. These assets are measured at amortized cost using the effective interest method. If there is objective evidence that the investment is impaired, determined by reference to external credit ratings and other relevant indicators, the financial asset is measured at the present value of estimated future cash flows. Any changes to the carrying amount of the investment, including impairment losses, are recognized through profit or loss.

Available-for-sale

Non-derivative financial assets not included in the above categories are classified as available-for- sale. They are carried at fair value with changes in fair value recognized directly in equity. Where a decline in the fair value of an available-for-sale financial asset constitutes objective evidence of impairment, the amount of the loss is removed from equity and recognized through other comprehensive income (loss).

The Company has classified its cash and cash equivalents at fair value through profit or loss. The Company’s due from related parties are classified as loans and receivables.

Impairment of financial assets

A financial asset is assessed at each reporting date to determine whether there is any objective evidence that it is impaired. A financial asset could be impaired if objective evidence indicates that one or more events have had a negative effect on the estimated future cash flows of that asset.

An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows, discounted at the original effective interest rate.

Individually significant financial assets are tested for impairment on an individual basis. The remaining financial assets are assessed collectively in groups that share similar credit risk characteristics.

An impairment loss is reversed if the reversal can be related objectively to an event occurring after the impairment loss was recognized. For financial assets measured at amortized cost, this reversal is recognized in profit or loss.

12





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

3.      

SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(i)      

Financial instruments (continued)

 

(b)     

Financial liabilities

The Company classifies its financial liabilities into one of two categories, depending on the purpose for which the liability was acquired. The Company's accounting policy for each category is as follows:

Fair value through profit or loss - This category comprises derivatives, or liabilities acquired or incurred principally for the purpose of selling or repurchasing it in the near term. They are carried in the statement of financial position at fair value with changes in fair value recognized through profit or loss.

Other financial liabilities: This category consists of liabilities carried at amortized cost using the effective interest method.

The Company’s accounts payable, convertible note and due to related parties are classified as other financial liabilities. The Company’s derivative liability component of the convertible note is classified as fair value through profit or loss.

(j)      

Adoption of new pronouncements

The Company did not adopt any new or amended accounting standards during the year ended December 31, 2016 which had a significant impact on the Financial Statements.

4.      

RECENT ACCOUNTING PRONOUNCEMENTS

Certain new standards, interpretations and amendments to existing standards have been issued by the IASB that are mandatory for future accounting periods. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.

Standard effective for annual periods beginning on or after January 1, 2018

IFRS 9 Financial Instruments - In November 2009, as part of the IASB project to replace IAS 39 Financial Instruments: Recognition and Measurement , the IASB issued the first phase of IFRS 9, that introduces new requirements for the classification and measurement of financial assets. The standard was revised in October 2010 to include requirements regarding classification and measurement of financial liabilities. In November 2013 the standard was revised to add the new general hedge accounting requirements. The standard was finalized in July 2014 and was revised to add a new expected loss impairment model and amends the classification and measurement model for financial assets by adding a new fair value through other comprehensive income (“FVOTCI”) category for certain debt instruments and additional guidance on how to apply the business model and contractual cash flow characteristics test.

13





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

4.      

RECENT ACCOUNTING PRONOUNCEMENTS (CONTINUED)

IFRS 15 - Revenue from Contracts with Customers - On May 28, 2014 the IASB issued IFRS 15, “Revenue from contracts with customers”. IFRS 15 will replace IAS 11, “Construction contracts”, IAS 18, “Revenue”, IFRIC 13, “Customer loyalty programmes”, IFRIC 15, “Agreements for the construction of real estate”, IFRIC 18, “Transfers of assets from customers” and SIC 31, “Revenue – barter transactions involving advertising services”. The standard contains a single model that applies to contracts with customers and two approaches to recognizing revenue: at a point in time; or over time. The model features a contract-based five-step analysis of transactions to determine whether, how much and when revenue is recognized. New estimates and judgmental thresholds have been introduced, which may affect the amount and/or timing of revenue recognized. The new standard applies to contracts with customers. It does not apply to insurance contracts, financial instruments or lease contracts, which fall in the scope of other IFRSs.

Standard effective for annual periods beginning on or after January 1, 2019

IFRS 16 – Leases - On January 13, 2016 the IASB issued IFRS 16, “Leases”. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. This standard substantially carries forward the lessor accounting requirements of IAS 17, while requiring enhanced disclosures to be provided by lessors. Other areas of the lease accounting model have been impacted, including the definition of a lease.

The new standard is effective for annual periods beginning on or after January 1, 2019. Earlier application is permitted for entities that apply IFRS 15, “Revenue from contracts with customers” at or before the date of initial adoption of IFRS 16.

The extent of the impact of adoption of these above standards on the financial statements of the Company has not yet been determined.

5.      

SALE OF INTANGIBLE ASSETS

On July 24, 2015 (effective on August 25, 2015 with shareholder approval) the Company entered into a definitive agreement (the “Agreement”) with Forge Therapeutics Inc. ("Forge") - a private US company -to sell the Company’s patents in the area of the development of therapies for fibrosis and erectile dysfunction. Proceeds from the sale were a commitment by Forge to issue 15,000,000 common shares.

Subject to the terms of the Agreement, if the 15,000,000 shares are not issued to the Company within 3 years, then the Company may trigger the issuance of the shares, and if at the end of 5 years the shares have not been issued then Forge must return the assets to the Company. In the event of a sale by Forge to a third party of the assets purchased under the Agreement, the Company will receive 6% of the value of that transaction, subject to certain conditions. The Company has assessed that the fair value of the right to receive the shares from Forge is not determinable and accordingly has recorded a nominal value of $1. As a result of the disposal, the Company recognized impairment on its intangible assets in the amount of $67,065 for the year ended December 31, 2015.

A condition of the sale was that Forge will pay to the Company an annual maintenance fee of $50,000. In the Company’s judgement, no portion of this amount will be recognized until collection can be assured. During the year ended December 31, 2016, no maintenance fee was collected. This Agreement has been assigned to Cabbay upon the Arrangement as described in Note 1.

14





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

6.      

CONVERTIBLE NOTES AND DERIVATIVE LIABILITY

On September 11, 2014, the Company issued a convertible note for $50,000 due on September 11, 2015 with an interest rate of 1% per month payable quarterly. On September 11, 2015, the Company was unable to repay the amount owing consisting of principal of $50,000 and unpaid interest of $6,000. The note holder and the Company agreed to accept a penalty of $5,000 bringing the total owing to $61,000. On September 11, 2015 the Company issued an unsecured convertible note in the amount of $61,000 due on September 11, 2016 convertible at the option of the holder into common shares at $1.50 per share with the same term. The fair value of the conversion feature was classified as equity and valued at $1,080. The present value of the debenture was assessed as $59,920 based on the face value of $61,000, term of 1 year, interest of 12% per annum and the discount rate of 14%.

During the year ended December 31, 2016, the Company repaid $5,000 to the note holder. The remaining balance of the note was assigned to Cabbay as part of the Arrangement described in Note 1. At December 31, 2016 and 2015 the Company’s convertible notes were valued as follows:

    2016     2015  
  $   $  
Opening balance 62,460   26,642  
Accrued interest 5,190   6,395  
Repayment (5,000 ) -  
Penalty on settlement of convertible note -   5,000  
Amount transferred on Arrangement Agreement (62,560 ) -  
Equity component -   (1,080 )
Accretion   -     25,503  
Ending balance   -     62,460  

 

7.      

RELATED PARTY TRANSACTIONS AND BALANCES

Due from (to) related Parties

Due from (to) related parties consists of short term amounts loaned, services rendered and expenses paid on behalf of the Company by shareholders of the Company that are unsecured, non-interest bearing, and payable on demand. As at December 31, 2016 and 2015, the Company has the following balances with related parties:

    2016     2015  
Due to related parties: $   $  
Amounts owing to the CFO and director (6,300 ) (23,986 )
Amounts owing to former directors -   (31,328 )
Amounts owing to a former CEO and director   -     (173,157 )
    (6,300 )   (228,471 )
Due from related party:        
Tower Three SAS   189,468     -  

Included in prepaid expense was the prepaid consulting fee to a company controlled by a director.

15





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

7.      

RELATED PARTY TRANSACTIONS AND BALANCES

Related Party Transactions and Key Management and Personnel Compensation

Payment or accruals for related party services provided to the company were:

    2016     2015     2014  
  $ $ $
Salary paid to a former CEO and director - 106,667 160,000
Consulting fees paid to a company controlled by a director 78,571 24,000 36,000
Accounting fees paid to a company controlled by the CFO 15,714 7,500 6,000
Legal fees paid to a director -   1,334   3,121
Share-based payments for options issued to a director   -     4,500     67,835  
    94,285     144,001     272,956  

During the year ended December 31, 2015, the Company assigned certain loans from related parties to Cabbay. See Note 1.

During the year ended December 31, 2015, the Company entered into debt settlement agreements with officers and directors of the Company through which $535,077 in due to related parties was forgiven.

8.      

SHARE CAPITAL

Authorized:

Unlimited Class A common shares without par value
1,500,000 Class B Series I preferred shares without par value
1,000,000 Class B Series II preferred shares without par value

Issued and outstanding during 2016 and 2015:

During the year ended December 31, 2016, the Company issued the following common shares:

(a)     

On March 15, 2016, the Company completed a share consolidation on the basis of thirty pre- consolidation common shares for each post consolidation common share. As such, all current and comparative share amounts have been restated to account for the 30 to 1 common share consolidation.

 

(b)     

In September 2016, 500,000 common shares were issued for the exercise of stock options at $0.25 per option for total proceeds of $120,000. $75,505 was also reversed from contributed surplus.

 

(c)     

On March 30, 2016, the Company completed a private placement of 4,089,332 common shares at $0.06 per share for gross proceeds of $245,360. In addition 766,666 common shares were issued to settle debt of $46,000.

 

(d)     

The Company entered into a Joint Venture agreement dated March 4, 2016 with 0829489 B.C. Ltd. (“Truevita”). In connection with the agreement, the Company issued 10,000 common shares of the Company. The value of the shares was $500 and was included in office and miscellaneous expense. There was no activity associated with the Joint Venture and the agreement terminated during the year ended December 31, 2016.

16





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

8.      

SHARE CAPITAL (CONTINUED)

Issued and outstanding during 2016 and 2015 (continued):

(e)     

On February 16, 2016, 4,000 common shares were issued for exercise of warrants at $0.90 per warrant for total proceeds of $3,600. Contributed surplus in the amount of $1,200 was adjusted in 2015 for this exercise of warrants.

During the year ended December 31, 2015, the Company issued the following common shares:

(f)     

On March 20, 2015 the Company closed the second tranche of a non-brokered private placement and issued 66,666 units at $1.50 per unit for cash proceeds of $41,000 (of which $30,000 was received in 2014 and $11,000 received in 2015) and to retire debts totaling $59,000. Each unit is comprised of one common share and one share purchase warrant exercisable for one common share at an exercise price of $4.50 until March 20, 2016. Each share purchase warrant included was assessed a value of $0.90 based on the residual value method. As such, a total of $60,000 was allocated to warrant reserves.

Stock options and share based payments:

The Company has a Stock Option Plan (the “Plan) which provides that the number of options granted may not exceed 10% of the issued and outstanding shares. Options granted under the Plan generally have a five-year term and are granted at a price no lower than the market price of the common shares at the time of the grant.

On August 12, 2016, the Company granted 500,000 stock options to employees. All options vested immediately upon grant. Share-based compensation of $75,505 was recorded (2015 - $11,998). All these options were exercised in September 2016.

During the year ended December 31, 2015, the Company granted a total of 13,333 options to a former director of the Company. The Company also cancelled 93,333 options due to termination of consulting agreements with various consultants. In addition, 29,167 options were expired unexercised.

The fair value of share based awards is determined using the Black-Scholes Option Pricing model. The model utilizes certain subjective assumptions including the expected life of the option and expected future stock price volatility. Changes in these assumptions can materially affect the estimated fair value of the Company’s stock options. The fair value of the stock options granted during 2016 and 2015 was determined using the Black-Scholes option pricing model with the following weighted average assumptions:

    2016     2015  
Grant date fair value per option $0.15   $1.50 - $2.40  
Risk-free interest rate   0.53%   0.78% - 1.63%  
Expected dividend yield   0%   0%
Forfeiture rate   0%   4%
Expected option life   1 year   5 years  
Expected stock price volatility   179%      299%-308%  

17





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

8.      

SHARE CAPITAL (CONTINUED)

Stock options and share based payments (continued) :

As at December 31, 2016 and 2015 the following stock options were outstanding and exercisable:

  December 31, 2016 December 31, 2015  
      Weighted     Weighted  
  Underlying   Average Underlying   Average  
    Shares     Exercise Price     Shares     Exercise Price  
      $     $  
Stock options outstanding, beginning 13,333   3.00 122,500   3.36  
Granted 500,000   0.24 13,333   3.00  
Exercised (500,000 ) 0.24   -   -  
Expired / Cancelled   (13,333 )   3.00     (122,500 )   (3.66 )
Stock options outstanding, ending   -     -     13,333     3.00  

The following table summarizes the stock options outstanding and exercisable at December 31, 2015:

    Weighted Average  
Number of Options   Remaining Life of  
Outstanding and Exercisable     Exercise Price       Options     Expiry Date  
$
833 3.00 0.03 July 3, 2017
5,000 3.00 0.36 December 21, 2017
3,333 3.00 0.31   April 4, 2018
4,167     3.00     0.68     March 7, 2019  
13,333           1.72        

Warrants:

As at December 31, 2016 and 2015 the following share purchase warrants were issued and outstanding:

  December 31, 2016   December 31, 2015
      Weighted       Weighted
  Underlying   Average   Underlying   Average
    Shares      Exercise Price     Shares     Exercise Price  
      $       $
Warrants outstanding, beginning 458,333   3.22   519,000   3.68
Issued -   -   66,667   4.50
Exercised -   -   (4,000 ) 4.50
Expired / Cancelled   (458,333 )   (3.22 )   (123,334 )   5.24  
Warrants outstanding, ending   -     -     458,333     3.22   

18





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

9.      

INCOME TAXES

Deferred taxes are recognized for the future income tax consequences attributable to differences between the carrying values of assets and liabilities and their respective income tax bases. Deferred tax assets are evaluated periodically and if realization is not considered likely, a valuation allowance is provided.

The reconciliation of income tax attributable to continuing operations computed at the statutory tax rate of 26% (2015 – 26%) to income tax expense is:

    2016     2015     2014  
Canadian statutory income tax rate 26% 26% 26%
  $   $   $  

Income tax recovery at statutory rate

(117,000 ) 47,000   (180,000 )

Effect on income taxes of:

           

Change in income tax rate

-   8,000   (24,000 )

Permanent differences

53,000   (147,000 ) 40,000  

Losses not recognized

   64,000     92,000     164,000  
Income taxes recoverable   -     -     -  

The nature and effect of the Company’s unrecognized deferred tax assets is as follows:

    2016     2015  
  $ $
Equipment 1,000 1,000
Non-capital losses carried forward 1,062,000 995,000
Capital losses carried forward   8,000 8,000
Share issue costs   2,000     5,000  
    1,073,000     1,009,000  

As at December 31, 2016, the Company had non-capital losses carried forward of approximately $4,084,000 (2015 - $3,827,000) which may be applied to reduce future years’ taxable income, expiring as follows:

  $
2027 451,000
2028 245,000
2029 254,000
2030 283,000
2031 402,000
2032 436,000
2033 743,000
2034 553,000
2035 331,000
2036 386,000
  4,084,000

19





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

10.      

CAPITAL DISCLOSURE

The Company considers its capital under management to be comprised of shareholders’ equity and any debt that it may issue. The Company’s objectives when managing capital are to continue as a going concern and to maximize returns for shareholders over the long term. The Company is not subject to any capital restrictions. There has been no change in the Company’s objectives in managing its capital.

11.      

FINANCIAL INSTRUMENTS AND RISK

As at December 31, 2016, the Company’s financial instruments consist of cash, accounts payable and due from (to) related parties. The carrying value of these financial instruments approximates their fair values because of the short term nature of these instruments.

Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. To minimize the credit risk the Company places these instruments with a high credit quality financial institution.

Liquidity Risk

Liquidity risk is the risk that the Company will not meet its obligations associated with its financial liabilities as they fall due. The Company manages liquidity risk through the management of its capital structure and financial leverage, as outlined in Note 10. Management closely monitors the liquidity position and expects to have adequate sources of funding to finance the Company’s projects and operations. As at December 31, 2016, the Company had a working capital surplus of $1,515,974. All of the Company’s financial liabilities are classified as current.

Foreign Exchange Risk

The Company is not exposed to foreign exchange risk on its financial instruments.

Interest Rate Risk

Interest rate risk is the risk that future cash flows of the Company’s assets and liabilities can change due to a change in interest rates. The Company is not exposed to interest rate risk as no financial instruments are interest-bearing. It is management's opinion that the Company is not exposed to significant interest, currency or credit risk arising from the financial statements.

Fair Value

The Company provides information about financial instruments that are measured at fair value, grouped into Level 1 to 3 based on the degree to which the inputs used to determine the fair value are observable.

Cash and cash equivalents and due from related parties are measured using level 1 fair value inputs.

20





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

12.      

SUPPLEMENTAL CASH FLOW INFORMATION

During the year ended December 31, 2016, the Company had the following non-cash transactions:

During the year ended December 31, 2015 the Company had the following non-cash transactions:

13.      

SUBSEQUENT EVENTS

 

(a)     

On January 25, 2017, the Company acquired 100% of Tower Three SAS (“Tower Three”) by issuing 30,000,000 common shares of the Company to the Tower Three shareholders. The common shares will be subject to an escrow agreement and released from escrow based on certain performance conditions. Tower Three is a privately held limited liability company formed under the laws of Colombia. Tower Three focuses primarily on building towers in municipalities where there is limited or no cellular coverage in Latin and South American markets. The transaction will result in a reverse take-over for accounting purposes and Tower Three will be the continuing entity. Concurrent with this transaction, the Company changed its name from Pacific Therapeutics Ltd. to Tower One Wireless Corp., and effected a change in directors, management and business. On January 26, 2017, its common shares resumed trading on the Canadian Securities Exchange under the symbol “TO”.

 

(b)     

On January 9, 2017, the Company closed a non-brokered private placement and issued 15,484,912 units at $0.15 per unit for gross proceeds of $2,322,737. Each unit is comprised of one common share and one share purchase warrant exercisable for one common share at an exercise price of $0.40 for 12 months following the transaction. If the share price trades at $0.60 for 10 consecutive trading days then the warrant holders will receive notice from the Company to accelerate the exercise of the warrants within 10 days or they will expire. The Company paid finders and brokers cash commissions of $87,767 and issued 585,117 broker warrants with the same terms as the warrants in the private placement. As at December 31, 2016, the Company received shares subscriptions in the amount of $1,602,257 for this private placement.

 

(c)     

In February, 2017, the Company incorporated a 100% owned subsidiary in Argentina.

 

(d)     

On February 2, 2017, the Company entered into an agreement with an unrelated company whereby for the issuance of 500,000 Common Shares, the Company has taken assignment of all the company’s assets, trade secrets and receivables.

 

(e)     

On March 15, 2017, the Company incorporated a subsidiary in Columbia called Tower Two SAS which will purchase and own the real estate on which its cellular towers will be built.

21





TOWER ONE WIRELESS CORP.
(formerly PACIFIC THERAPEUTICS LTD.)
Notes to Financial Statements
Years Ended December 31, 2016, 2015 and 2014
 

 

13.      

SUBSEQUENT EVENTS (CONTINUED)

 

(f)     

On March 31, 2017, the Company signed a share purchase agreement with Evolution Technology S.A. (“Evotech”) whereby the Company purchased sixty-five percent of the issued and outstanding shares of Evotech. As consideration the Company paid US$350,000 and transferred an additional US$400,000 for operating expenses and advances of work. The Company also agreed to transfer an additional US$250,000 no later than April 17, 2017 and took on the responsibility to negotiate an outstanding debt Evotech has with a third-party. In connection with the transaction the Company issued 1,500,000 common shares to consultants of the Company.

 

(g)     

On June 19, 2016, the Company announced a warrant price reduction and exercise incentive program. Under the incentive program, the exercise price of the warrants will be reduced to $0.30 if exercised prior to July 21, 2017 and one Incentive Warrant will be granted for each warrant exercised. Each Incentive Warrant will be exercisable to acquire one common share at a price of $0.50 for one year. In July 2017, 3,774,466 warrants were exercised under this program and as a result, 3,774,466 Incentive Warrants were issued. As of August 23, 2017, proceeds of $1,048,340 were received for the exercise of warrants.

 

(h)     

On June 21, 2017, the Company granted 1,000,000 Common Shares to a third party consultant to settle an outstanding debt balance of $230,000.

 

(i)     

Subsequent to the year ended December 31, 2016, the Company granted a total of 5,750,000 stock options to directors, officers and consultants of the Company of which 5,050,000 are exercisable at $0.23 and 700,000 are exercisable at $0.45. All stock options granted have a term of five years.

 

(j)     

Subsequent to the year ended December 31, 2016, the Company issued 4,780,435 common shares for the exercise of stock options at $0.23 for total proceeds of $1,099,500.

22




Exhibit 1.2

























Exhibit 4.3

- 1 -

Amended and Restated

ARRANGEMENT AGREEMENT

This Amended and Restated AGREEMENT made as of the 21 st day of April, 2016.

BETWEEN:

PACIFIC THERAPEUTICS INC. , a company subject to the British Columbia Business Corporations Act

(“ PT ”)

AND

CABBAY HOLDINGS CORP. , a company subject to the British Columbia Business Corporations Act

(“ Newco ”)

WHEREAS PT and Newco entered into an arrangement agreement on April 18, 2016 and they wish to amend the same and restate said agreement in its entirety by including the amendments to the same,

NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and the respective covenants and agreements herein contained, the parties hereto covenant and agree as follows:

1. INTERPRETATION

1.1 Definitions

In this Agreement including the recitals hereto, unless there is something in the subject matter or context inconsistent therewith, words and terms defined in the Circular will have the same meaning when used herein and, in addition, the following terms will have the following meanings:

Arrangement ” means the arrangement under the provisions of Section 288 of the BCA among PT and the Shareholders and Newco and its shareholders on the terms and conditions set forth in the Plan of Arrangement or any amendment or variation thereto made in accordance with section 6 of this Agreement.

BCA ” means the British Columbia Business Corporations Act , as amended from time to time.

Business Day ” means any day, other than a Saturday or a Sunday, when Canadian chartered banks are open for business in the City of Vancouver.





- 2 -

Circular ” means the definitive form, together with any amendments thereto, of the management information circular of PT to be prepared and sent to Shareholders in connection with the Meeting.

Class 1 Reorganization Shares ” means the shares without par value in the capital of PT to be authorized for issuance and issued as part of the Arrangement.

Common Shares ” means the Class A common shares without par value in the capital of PT issued and outstanding immediately prior to the implementation of the Arrangement.

Court ” means the Supreme Court of British Columbia.

Dissent Rights ” means the rights of registered Shareholders to dissent in terms of the Arrangement pursuant to the BCA and the Interim Order.

Effective Date ” means the date the Plan of Arrangement becomes effective on such date as the directors of PT may determine pursuant to a resolution of the board of directors;

Exchange ” means the Canadian Securities Exchange.

Final Order ” means the final order of the Court approving the Arrangement.

Interim Order ” means the order of the Court to be applied for as contemplated in section 3.3 hereof.

Meeting ” means the annual and special general meeting of Shareholders to be held on May 20, 2016 and any adjournment thereof to consider, among other matters, the Arrangement.

New Common Shares ” means the new common shares without par value in the capital of PT to be issued as part of the Arrangement.

Plan of Arrangement ” means the plan of arrangement which is annexed as Exhibit 1 hereto and any amendment or variation thereto made in accordance with section 6 hereof.

Record Date ” means March 22, 2016.

“person" means an individual, partnership, unincorporated association, unincorporated syndicate, unincorporated organization, trust, trustee, executor, administrator or other legal representative;

Registrar ” means the Registrar of Companies appointed under section 400 of the BCA.

Share Distribution Date ” means the Record Date, unless as determined otherwise by the board of directors of PT by a resolution of such directors after the entry into this Agreement, which date establishes the Shareholders and/or former holders of Common Shares who will be entitled to ultimately receive Newco Common Shares pursuant to this Arrangement Agreement.





- 3 -

Shareholders ” means the holders of Common Shares.

Newco Common Shares ” means the Class A common shares without par value in the capital of Newco.

U.S. Securities Act ” means the United States Securities Act of 1933 , as amended.

1.2 Interpretation not Affected by Headings

The division of this Agreement into articles, sections and other portions and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement. The terms “ this Agreement ”, “ hereof ”, and “ hereunder ” and similar expressions refer to this Agreement (including the exhibit hereto) and not to any particular article, section or other portion hereof and include any agreement or instrument supplementary or ancillary hereto.

1.3 Numbers, Et Cetera

Unless the context otherwise requires, words importing the singular number only will include the plural and vice versa, words importing the use of any gender will include both genders; and words importing persons will include firms, corporations, trusts and partnerships.

1.4 Date for Any Action

In the event that any date on which any action is required to be taken hereunder by any of the parties hereto is not a Business Day in the place where the action is required to be taken, such action shall be required to be taken on the next succeeding day which is a Business Day at such place, unless otherwise agreed to.

1.5 Entire Agreement

This Agreement, together with the exhibit, schedules, agreements and other documents herein or therein referred to, constitute the entire agreement among the parties pertaining to the subject matter hereof and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, among the parties with respect to the subject matter hereof.

1.6 Currency

All sums of money which are referred to in this Agreement are expressed in lawful money of Canada unless otherwise specified.

2. REPRESENTATIONS AND WARRANTIES

2.1 Representations and Warranties of PT

PT represents and warrants to and in favour of Newco as follows:

  (a)     

PT is a company duly organized and validly existing under the BCA and has the corporate power and authority to own, operate and lease its property and assets and to

     




- 4 -

   

carry on its business as now being conducted by it, and it is duly registered, licensed or qualified to carry on business in each jurisdiction in which a material amount of its business is conducted or where the character of its properties and assets makes such registration, licensing or qualification necessary.

   

 
  (b)   

PT has the corporate power and authority to enter into this Agreement and, subject to obtaining the requisite approvals contemplated hereby, to perform its obligations hereunder.

   

 
  (c)  

The authorized capital of PT consists of an unlimited number of Class A common shares without par value, of which approximately 1,379,887 Class A common shares were issued and outstanding as at March 11, 2016, 1,500,000 Class B Series I preferred shares without par value of which zero are issued and outstanding as of the date of this Agreement and 1,000,000 Class B Series II preferred shares without par value of which zero are issued and outstanding as of the date of this Agreement.

   

 
  (d)   

The execution and delivery of this Agreement by PT and the completion of the transactions contemplated herein:

   

 
  (i)   

do not and will not result in a breach of, or violate any term or provision of, the articles of PT;

   

 
  (ii)   

subject to receiving any consent as may be necessary under any agreement by which PT is bound, do not and will not, as of the Effective Date, conflict with, result in the breach of, constitute a default under, or accelerate or permit the acceleration of the performance required by, any agreement, instrument, license, permit or authority to which PT, or to which any material property of PT is subject or result in the creation of any lien, charge or encumbrance upon any of the material assets of PT under any such agreement or instrument, or give to any person any material interest or right, including rights of purchase, termination, cancellation or acceleration, under any such agreement, instrument, license, permit or authority; and

   

 
  (iii)  

subject to receipt of necessary approvals of the Shareholders and the Court do not and will not as of the Effective Date violate any provision of law or administrative regulation or any judicial or administrative award, judgment or decree applicable and known to PT, after due inquiry, the breach of which would have a material adverse effect on PT.

 

 
  (e)   

To the best of the knowledge of PT after due inquiry, there are no actions, suits, proceedings or investigations commenced, contemplated or threatened against or affecting PT, at law or in equity, before or by any governmental department, commission, board, bureau, court, agency, arbitrator or instrumentality, domestic or foreign, of any kind nor, to the best of the knowledge of PT, after due inquiry, are there any existing facts or conditions which may reasonably be expected, individually or in the aggregate, to be a proper basis for any actions, suits, proceedings or investigations, which in any case would prevent or hinder the consummation of

     




- 5 -

   

the transactions contemplated by this Agreement, or the Plan of Arrangement, or which may reasonably be expected individually or in the aggregate to have a material adverse effect on the business, operations, properties, assets or affairs, financial or otherwise, of PT, either before or after the Effective Date.

   

 
  (f)     

The execution and delivery of this Agreement and the completion of the transactions contemplated herein have been duly approved by the board of directors of PT and this Agreement has been duly executed and delivered by PT and constitutes a valid and binding obligation of PT enforceable against it in accordance with its terms, except as may be limited by bankruptcy, insolvency or other laws affecting the enforcement of creditors’ rights generally and subject to the qualification that equitable remedies may only be granted in the discretion of a court of competent jurisdiction.

   

 

  (g)     

The information set forth in the Circular relating to PT and the interests of PT, its business and properties and the effect of the Arrangement thereon is true, correct and complete in all material respects and does not contain any untrue statement of any material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading in the light of the circumstances in which they are made.

2.2 Representations and Warranties of Newco

Newco represents and warrants to and in favour of PT as follows:

  (a)     

Newco is a company duly organized and validly existing under the BCA.

   

 
  (b)     

Newco has the corporate power and authority to enter into this Agreement and, subject to obtaining the requisite approvals contemplated hereby, to perform its obligations hereunder.

   

 
  (c)     

The authorized capital of Newco consists of an unlimited number of Class A common shares (being Newco Common Shares as defined above) without par value and an unlimited number of Class B preferred shares without par value, of which 1 Newco Common Share is issued and outstanding as at the date hereof. The 1 outstanding Newco Common Share is held by PT.

   

 
  (d)     

Except as contemplated by this Agreement, no individual, firm, corporation or other person holds any securities convertible or exchangeable into any shares of Newco or has any agreement, warrant, option or any right capable of becoming an agreement, warrant or option for the purchase of any unissued shares of Newco.

   

 
  (e)     

The execution and delivery of this Agreement by Newco and the completion of the transactions contemplated herein:

   

 
  (i)     

do not and will not result in the breach of, or violate any term or provision of, the articles of Newco; and

     




- 6 -

  (ii)  

do not and will not, as of the Effective Date, violate any provision of law or administrative regulation or any judicial or administrative award, judgment or decree applicable and known to Newco, after due inquiry, the breach of which would have a material adverse effect on Newco.

   

 
(f)    

The execution and delivery of this Agreement and the completion of the transactions contemplated herein have been duly approved by the board of directors of Newco and this Agreement has been executed and delivered by Newco and constitutes a valid and binding obligation of Newco enforceable against it in accordance with its terms, except as may be limited by bankruptcy, insolvency or other laws affecting the enforcement of creditors’ rights generally and subject to the qualification that equitable remedies may only be granted in the discretion of a court of competent jurisdiction.

   

 
  (g)   

Newco is not engaged in any business nor is it a party to or bound by any contract, agreement, arrangement, instrument, license, permit or authority, other than this Agreement and any transaction or agreement necessary or incidental to the fulfilment of its obligations under Agreement, nor does it have any liabilities, contingent or otherwise, except as provided in or permitted by this Agreement.

3. COVENANTS

3.1 Covenants of PT

PT hereby covenants and agrees with Newco as follows:

  (a)     

Until the Effective Date, PT will carry on its business in the ordinary course and will not enter into any transaction or incur any obligation or liability out of the ordinary course of its business, except as otherwise contemplated in this Agreement.

   

 
  (b)     

Except as otherwise contemplated in this Agreement, until the Effective Date, PT will not merge with, amalgamate, consolidate or enter into any other corporate reorganization with, any other corporation or person or perform any act or enter into any transaction or negotiation which reasonably could be expected to, directly or indirectly, interfere or be inconsistent with the completion of the Arrangement.

   

 
  (c)     

PT will, in a timely and expeditious manner, file the Circular in all jurisdictions where the Circular is required to be filed by PT and mail the Circular to Shareholders in accordance with the terms of the Interim Order and applicable law.

   

 
  (d)     

PT will perform the obligations required to be performed by it hereunder and will do all such other acts and things as may be necessary or desirable in order to carry out and give effect to the transactions under the Arrangement as described in the Circular and, without limiting the generality of the foregoing, PT shall use its reasonable commercial efforts to seek:

   

 
  (i)     

the approval of the Shareholders required for the implementation of the Arrangement,

     




- 7 -

  (ii)    

the approval for the listing of the New Common Shares on the Exchange,

   

 
  (iii)    

the Final Order as provided for in section 3.3, and

   

 
  (iv)  

such other consents, orders, rulings, approvals and assurances as counsel may advise are necessary or desirable for the implementation of the Arrangement, including those referred to in section 4.1.

   

 
  (e)   

PT will convene the Meeting as soon as practicable and will solicit proxies to be voted at the Meeting in favour of the Arrangement and all other resolutions referred to in the Circular.

   

 
  (f)    

PT will use its reasonable commercial best efforts to cause each of the conditions precedent set out in sections 4.1 and 4.2 to be complied with on or before the Effective Date.

3.2 Covenants of Newco

Newco hereby covenants and agrees with PT as follows:

     (a)  

Until the Effective Date, it will not merge into or with, or amalgamate or consolidate with, or enter into any other corporate reorganization with, any other corporation or person, and perform any act or enter into any transaction or negotiation which interferes or is inconsistent with the Arrangement or other transactions contemplated by this Agreement.

   

 
     (b)  

It will perform the obligations required to be performed by it, and will enter into all agreements required to be entered into by it, under this Agreement, the Plan of Arrangement and will do all such other acts and things as may be necessary or desirable in order to carry out and give effect to the Arrangement and related transactions as described in the Circular and, without limiting the generality of the foregoing, it will:

   

 
  (i)  

seek and cooperate with PT in seeking the Final Order as provided for in section 3.3; and

   

 
  (ii)  

seek and cooperate with PT in seeking such other consents, orders, rulings, approvals and assurances as counsel may advise are necessary or desirable for the implementation of the Arrangement, including those referred to in section 4.1.

3.3 Interim Order and Final Order

Each party covenants and agrees that it will, as soon as reasonably practicable, apply to the Court for the Interim Order providing for, among other things, the calling and holding of the Meeting for the purpose of, among other matters, considering and, if deemed advisable, approving the Arrangement and that, if the approval of the Arrangement by Shareholders as set forth in the Interim Order is obtained by PT as soon as practicable thereafter each party will take the necessary steps to submit the





- 8 -

Arrangement to the Court and apply for the Final Order in such fashion as the Court may direct. As soon as practicable thereafter, and subject to compliance with any other conditions provided for in Article 4 hereof, PT will file with the Registrar a certified copy of the Final Order in furtherance of giving effect to the Arrangement.

3.4 Non-Survival of Representations, Warranties and Covenants

The respective representations, warranties and covenants of PT and Newco contained herein will expire and be terminated and extinguished at and from the Effective Date, other than the covenants in sections 3.1(d) and 3.2(b) and no party will have any liability or further obligation to any party hereunder in respect of the respective representations, warranties and covenants thereafter, other than the covenants in sections 3.1(d) and 3.2(b).

4. CONDITIONS

4.1 Conditions Precedent

The respective obligations of each party hereto to complete the transactions contemplated by this Agreement will be subject to the satisfaction, on or before the Effective Date, of the following conditions, any of which may be waived by any party hereto in whole or in part:

  (a)     

The Arrangement, with or without amendment, will have been approved at the Meeting in accordance with the Interim Order.

   

 
  (b)     

The Interim Order and the Final Order will have been obtained in form and substance satisfactory to PT and Newco, acting reasonably.

   

 
  (c)     

The Exchange, if required, will have approved, as of the Effective Date, the listing and posting for trading of the New Common Shares issuable on the Arrangement, subject to compliance with the listing requirements thereof, or the Exchange has prior to the Effective Date conditionally approved the listing and posting for trading of such New Common Shares.

   

 
  (d)     

No action will have been instituted and be continuing on the Effective Date for an injunction to restrain, a declaratory judgment in respect of or damages on account of or relating to the Arrangement and no cease trading or similar order with respect to any securities of PT or Newco will have been issued and remain outstanding.

   

  
  (e)     

All material regulatory requirements will have been complied with and all other material consents, agreements, orders and approvals, including regulatory and judicial approvals and orders, necessary for the completion of the transactions provided for in this Agreement or contemplated by the Circular will have been obtained or received from the persons, authorities or bodies having jurisdiction in the circumstances, with the exception of at most 10% of Shareholders dissenting to the Arrangement.

     




- 9 -

  (f)     

None of the consents, orders, regulations or approvals contemplated herein will contain terms or conditions or require undertakings or security deemed unsatisfactory or unacceptable by PT or Newco acting reasonably.

   

 
  (g)     

PT and Newco have received all necessary orders and rulings from various securities commissions and regulatory authorities in the relevant provinces of Canada, where required.

   

 
  (h)     

This Agreement will not have been terminated under section 6.

4.2 Conditions to Obligations of Each Party

The obligation of each of PT and Newco to complete the transactions contemplated by this Agreement is further subject to the condition, which may be waived by any such party without prejudice to its right to rely on any other condition in favour of such party, that each and every one of the covenants of the other party hereto to be performed on or before the Effective Date pursuant to the terms of this Agreement will have been duly performed by such party and that, except as affected by the transactions contemplated by this Agreement, the representations and warranties of the other party hereto will be true and correct in all material respects as at the Effective Date, with the same effect as if such representations and warranties had been made at and as of such time, and each such party will have received a certificate, dated the Effective Date, of a senior officer of each other party confirming the same unless the party that is to receive such certificate has waived in writing the requirement to receive such certificate.

4.3 Merger of Conditions

The conditions set out in sections 4.1 and 4.2 will be conclusively deemed to have been satisfied, waived or released upon the delivery to the Registrar of a certified copy of the Final Order in furtherance of giving effect to the Arrangement.

5. UNITED STATES SECURITIES LAW MATTERS

The Parties agree that the Arrangement will be carried out with the intention that all New Common Shares, Class 1 Reorganization Shares and the Newco Common Shares issued on completion of the Arrangement to Shareholders will be issued in reliance on the exemption from the registration requirements of the U.S. Securities Act provided by the Section 3(a)(10) Exemption. In order to ensure the availability of the Section 3(a)(10) Exemption, the Parties agree that the Arrangement will be carried out on the following basis:

  (a)     

the Arrangement will be subject to the approval of the Court;

   

 
  (b)     

the Court will be advised as to the intention of the Parties to rely on the Section 3(a)(10) Exemption prior to the hearing required to approve the Arrangement;

   

 
  (c)     

the Court will be required to satisfy itself as to the fairness of the Arrangement to the Shareholders subject to the Arrangement;

     




- 10 -

  (d)     

the Final Order approving the Arrangement that is obtained from the Court will expressly state that the Arrangement is approved by the Court as being fair to the Shareholders;

   

 
  (e)     

PT will ensure that each Shareholder entitled to receive New Common Shares, Class 1 Reorganization Shares and Newco Common Shares on completion of the Arrangement will be given adequate notice advising them of their right to attend the hearing of the Court to give approval of the Arrangement and providing them with sufficient information necessary for them to exercise that right;

   

 
  (f)     

the Shareholders will be advised that the New Common Shares, Class 1 Reorganization Shares and Newco Common Shares issued in the Arrangement have not been registered under the U.S. Securities Act and will be issued in reliance on the exemption from the registration requirements of the U.S. Securities Act provided by Section 3(a)(10) of the U.S. Securities Act and may be subject to restrictions on resale under the applicable Securities Legislation of the United States, including, as applicable, Rule 144 under the U.S. Securities Act with respect to affiliates of PT;

   

 
  (g)     

the Interim Order will specify that each Shareholder will have the right to appear before the Court at the hearing of the Court to give approval of the Arrangement so long as the Shareholder files a Response to Petition within a reasonable time; and

   

 
  (h)     

the Final Order shall include a statement substantially to the following effect:

“THIS ORDER WILL SERVE AS A BASIS OF A CLAIM TO AN EXEMPTION, PURSUANT TO SECTION 3(A)(10) OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED , FROM THE REGISTRATION REQUIREMENTS OTHERWISE IMPOSED BY THAT ACT, REGARDING THE EXCHANGE OF COMMON SHARES FOR NEW COMMON SHARES, CLASS 1 REORGANIZATION SHARES AND NEWCO COMMON SHARES, PURSUANT TO THE PLAN OF ARRANGEMENT.”

6. AMENDMENT AND TERMINATION

6.1 Amendment

This Agreement and the Plan of Arrangement may, at any time and from time to time before and after the holding of the Meeting but not later than the Effective Date, be amended in a manner not materially prejudicial to the Shareholders by written agreement of the parties hereto without, subject to applicable law, further notice to or authorization on the part of the Shareholders or the Court for any reason whatsoever.

6.2 Termination

This Agreement may, at any time before or after the holding of the Meeting but no later than the Effective Date, be terminated by the board of directors of PT without further notice to, or action on the part of, the Shareholders.

Without limiting the generality of the foregoing, PT may terminate this Agreement:





- 11 -

  (a)     

In the event that any right of dissent is exercised pursuant to section 5.1 of the Plan of Arrangement in respect of the Common Shares, immediately prior to the Effective Date, and Shareholders who have exercised their right of dissent and hold 10% or more of the outstanding Common Shares have not abandoned their right of dissent.

   

 
  (b)     

If prior to the Effective Date there is a material change in the business, operations, properties, assets, liabilities or condition, financial or otherwise, of PT and its subsidiaries, taken as a whole, or in Newco, or any change in general economic conditions, interest rates or any outbreak or material escalation in, or the cessation of, hostilities or any other calamity or crisis, or there should develop, occur or come into effect any occurrence which has a material effect on the financial markets of Canada and the Board of Directors determines in its sole judgment that it would be inadvisable in such circumstances for PT to proceed with the Arrangement.

6.3 Effect of Termination

Upon the termination of this Agreement pursuant to section 6.2 hereof, no party will have any liability or further obligation to any other party hereunder.

7. GENERAL

7.1 Notices

A notice or other communication to a party under this Agreement is valid if (a) it is in writing, and (b) it is delivered by hand, by registered mail, or by any courier service that provides proof of delivery, or (c) it is sent by electronic mail, and (d) it is addressed using the information for that party set out below (or any other information specified by that party in accordance with this section 7.1):

  (a) If to PT:
     
   

Suite 605-815 Hornby St.

   

Vancouver, BC, V6Z 2E6

   

Email: brian@howeandbayfinancial.com

   

 

  (b) If to Newco:
     
   

Attention: Robert (Nick) Horsley

   

Email: RNPSHORSLEY@gmail.com

A valid notice or other communication under this Agreement will be effective when the party to which it is addressed receives it. A party is deemed to have received a notice or other communication under this Agreement at the time and date indicated on the signed receipt or in the case of e-mail transmission the day of transmission; and, if the party to which it is addressed rejects or otherwise refuses to accept it, or if it cannot be delivered because of a change in address (including change of an e-mail address) for which no notice was given, then upon that rejection, refusal or inability to deliver.





- 12 -

7.2 Assignment

No party may assign its rights or obligations under this Agreement or the Arrangement without the prior written consent of the other party hereto.

7.3 Binding Effect

This Agreement and the Arrangement will be binding upon and will enure to the benefit of the parties hereto and their respective successors and permitted assigns and, in the case of the Arrangement, will enure to the benefit of the Shareholders.

7.4 Waiver

Any waiver or release of any of the provisions of this Agreement, to be effective, must be in writing executed by the party granting the same. Waivers may only be granted upon compliance with the terms governing amendments set forth in section 6.1 hereof, applied mutatis mutandis .

7.5 Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia and the laws of Canada applicable therein and will be treated in all respects as a British Columbia contract. Each party irrevocably agrees to attorn to the exclusive jurisdiction of the courts of Vancouver, British Columbia, with respect to any legal proceedings arising herefrom.

7.6 Counterparts

This Agreement may be executed in one or more counterparts and delivered by facsimile or e-mail, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. This Agreement may be signed by electronic signature.

7.7 Superseding

This Agreement amends and supersedes the previously entered into agreement on April 18, 2016 between the Parties.

IN WITNESS WHEREOF the parties hereto have executed this Agreement as of the date first written.

  PACIFIC THERAPEUTICS INC.
   
  By: /s/ “Robert Horsley”
  Robert (Nick) Horsley, Director
   
  CABBAY HOLDINGS CORP.
   
  By: /s/ “Robert Horsley”
  Robert (Nick) Horsley, Director

 





- 13 -

Exhibit 1

TO THE ARRANGEMENT AGREEMENT

PLAN OF ARRANGEMENT UNDER SECTION 288
OF THE
BRITISH COLUMBIA BUSINESS CORPORATIONS ACT

1. INTERPRETATION

1.1 Definitions

In this Arrangement, unless there is something in the subject matter or context inconsistent therewith:

1.1.1 “ Arrangement ” means the arrangement proposed under the provisions of section 288 of the BCA on the terms set out in this Plan of Arrangement.

1.1.2 “ Arrangement Agreement ” means the amended and restated arrangement agreement, dated as of April 21, 2016 between PT and Newco to which this Plan of Arrangement is attached as Exhibit 1, as the same may be amended from time to time.

1.1.3 “ BCA ” means the British Columbia Business Corporations Act , as amended from time to time.

1.1.4 “ PT ” means Pacific Therapeutics Ltd., a corporation incorporated under the BCA.

1.1.5 “ Circular ” means the definitive form, together with any amendments thereto, of the management information circular of PT to be prepared and sent to the Shareholders in connection with the Meeting.

1.1.6 “ Class 1 Reorganization Ratio ” means the percentage resulting from the division of 1,379,887, as numerator, by the number of Class 1 Reorganization Shares issued on the Effective Date, as denominator. The ratio is 100% (1:1).

1.1.7 “ Class 1 Reorganization Shares ” means the shares without par value in the capital of PT to be issued as part of the Arrangement.

1.1.8 “ Common Share ” means the Class A common shares without par value in the capital of PT.

1.1.9 “ Court ” means the Supreme Court of British Columbia.

1.1.10 “ Director ” means a director of PT.

1.1.11 “ Effective Date ” means the date the Plan of Arrangement becomes effective with such date being the date as the Directors of PT may determine pursuant to a resolution of the board of directors;

1.1.12 “ Exchange ” means the Canadian Securities Exchange.





- 14 -

1.1.13 “ Final Order ” means the final order of the Court approving the Arrangement pursuant to the BCA.

1.1.14 “ holder ”, when not qualified by the adjective “ registered ”, means the person entitled to a share hereunder whether or not registered or entitled to be registered in respect thereof in the register of Shareholders of PT or Newco, as the case may be.

1.1.15 “ Interim Order ” means the interim order to be obtained from the Court, providing for a special meeting of the Common Shareholders to consider and approve the Arrangement and for certain other procedural matters as well as for the issue of a notice of hearing for the Final Order.

1.1.16 “ ITA ” means the Income Tax Act (Canada), as amended, and the regulations thereunder.

1.1.17 “ Meeting ” means the annual and special meeting of shareholders which will be held on May 20, 2016 to consider, among other matters, the Arrangement, and any adjournment thereof.

1.1.18 “ New Common Shares ” means the new common shares without par value in the capital of PT to be issued as part of the Arrangement.

1.1.19 “ Asset Purchase Agreement ” means the asset purchase agreement between Forge Therapeutics Inc. and Pacific Therapeutics Ltd. dated July 23, 2015.

1.1.20 “ PUC ” means “paid-up capital” as defined in subsection 89(1) of the ITA.

1.1.21 “ Plan of Arrangement ” means this plan of arrangement, as it may be amended from time to time in accordance with section 6 of the Arrangement Agreement.

1.1.22 “ Shareholders ” means those persons who, as at the close of business on the Effective Date, are registered holders of Common Shares.

1.1.23 “ Newco ” means CABBAY HOLDINGS CORP., a private company incorporated under the BCA to facilitate the Arrangement.

1.1.24 “ Newco Common Share ” means the Class A common shares without par value which Newco is authorized to issue.

1.1.25 “ Newco Working Capital ” means the sum of $1,000.

1.1.26 “ Transfer Agent ” means Computershare Trust Company of Canada.

1.2 Headings

The division of this Plan of Arrangement into articles, sections, subsections and paragraphs, and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Plan of Arrangement. The terms “ this Plan of Arrangement ”, “ hereof ”, “ herein ”, “ hereunder ” and similar expressions refer to this Plan of Arrangement as a whole and not to any particular article, section, subsection, paragraph or other part hereof. Unless something in the subject





- 15 -

matter or context is inconsistent therewith, all references herein to articles, sections, subsections and paragraphs are to articles, sections, subsections and paragraphs of this Plan of Arrangement.

1.3 Extended Meanings

In this Plan of Arrangement, words importing the singular number only shall include the plural and vice versa, and words importing the masculine gender shall include the feminine and neuter genders, and words importing persons shall include individuals, partnerships, associations, firms, trusts, unincorporated organizations and corporations.

1.4 Currency

All references to currency herein are to lawful money of Canada unless otherwise specified herein.

2. ARRANGEMENT AGREEMENT

2.1 Arrangement Agreement

This Plan of Arrangement is made pursuant to the provision of the Arrangement Agreement.

3. SUMMARY OF THE ARRANGEMENT

3.1 Summary

This section 3.1 is only a summary and is qualified in its entirety by section 4.1 below.

3.1.1 This Arrangement is being effected as an arrangement pursuant to Section 288 of the BCA.

3.1.2 Subject to section 4.1 below, all holders of Common Shares as of the Share Distribution Date, except for dissenting holders of Common Shares, will exchange each Common Share for one New Common Share and one Class 1 Reorganization Share.

3.1.3 All Class 1 Reorganization Shares will be transferred to Newco for consideration consisting solely of Newco Common Shares in accordance with the Newco Reorganization Ratio.

3.1.4 All of the Class 1 Reorganization Shares owned by Newco will be redeemed for their aggregate redemption value and such redemption value will be satisfied in full by the transfer by PT to Newco of the Asset Purchase Agreement and the Newco Working Capital, after which the Class 1 Reorganization Shares will be cancelled.

3.1.5 Shareholders may dissent in relation to the resolution to approve the Arrangement pursuant to the provisions of the Interim Order and sections 237 to 247 of the BCA.

3.1.6 The exchange of Common Shares for New Common Shares and Class 1 Reorganization Shares; the transfer of the Class 1 Reorganization Shares to Newco in consideration of the issuance of Newco Common Shares and the redemption of the Class 1 Reorganization Shares and the





- 16 -

transfer of the Asset Purchase Agreement and the Newco Working Capital to Newco will all occur on the Effective Date, in the order set out herein.

4. THE ARRANGEMENT

4.1 The Arrangement

On the Effective Date, the following will occur and be deemed to occur in the following order without further act or formality notwithstanding anything contained in the provisions attaching to any of the securities of PT or of Newco, but subject to the provisions of section 5 of this Plan of Arrangement:

4.1.1 The articles and notice of articles of PT will be amended, as applicable, to authorize PT to issue an unlimited number of New Common Shares (to be designated as “ New Common shares ”, or with such designation as decided by PT’s board, in the amended articles and/or notice of articles, as applicable) and an unlimited number of Class 1 Reorganization Shares (to be designated as “ Class 1 Reorganization Shares ”, or with such designation as decided by PT’s board, in the amended articles and/or notice of articles, as applicable) , with the special rights and restrictions substantially in the form as set out in Exhibit 2 to the Arrangement Agreement attached hereto.

4.1.2 Each issued and outstanding Common Share held by holders of Common Shares, except those referred to in section 5.1, will be exchanged for one New Common Share and one Class 1 Reorganization Share, with (i) those who were a holder of Common Shares as of the Share Distribution Date and who had at that date more Common Shares than they have at the time of such exchange being issued such additional number of Class 1 Reorganization Shares (but not any additional New Common Shares) that equals the difference between the Common Shares they held at the Share Distribution Date minus the Common Shares they hold at the time of such exchange, (ii) those who were a holder of Common Shares as of the Share Distribution Date and who had at that date less Common Shares than they have at the time of such exchange only receiving such number of Class 1 Reorganization Shares that is equal to the number of Common Shares they held at the Share Distribution date but will receive number of New Common Shares that is equal to the Common Shares they hold at the time of the exchange , and (iii) those persons who are no longer existing Shareholders but who were holders of Common Shares as of the Share Distribution Date being issued such number of Class 1 Reorganization Shares (but not any New Common Shares) equal to the number of the Common Shares such persons held at the Share Distribution Record Date. In connection with such exchange/issuance:

   (a) 

The issue price for each Class 1 Reorganization Share will be an amount equal to the fair market value, as determined by the Directors, of one Class 1 Reorganization Share immediately following the exchange provided for in this subsection.

   

 
    (b) 

The Company will add to the stated capital account maintained by it for the Class 1 Reorganization Shares the lesser of the issue price thereof and $1.00.

     




- 17 -

  (c)     

The issue price for each New Common Share will be an amount equal to the difference between (i) the fair market value for the Common Share for which it was, in part, exchanged immediately prior thereto and (ii) the amount determined in section 4.1.2(a) hereof.

   

 
  (d)     

The Company will add to the stated capital account maintained by it for the New Common Shares an amount equal to the amount by which the PUC of the Common Shares, immediately before the exchange, exceeds the stated capital account of the Class 1 Reorganization Shares, as determined above.

   

 
  (e)     

The amounts to be added to the stated capital accounts maintained by the Company for the New Common Shares and Class 1 Reorganization Shares shall, notwithstanding paragraph 4.1.2(b) above, not exceed the PUC of the Common Shares at the time of the exchange.

   

 
  (f)     

Each Shareholder will cease to be the holder of the Common Shares so exchanged and will become the holder of New Common Shares and Class 1 Reorganization Shares issued to such Shareholder or person, as applicable. The name of such Shareholder will be removed from the register of holders of Common Shares with respect to the Common Shares so exchanged and the name of such Shareholder or person, as applicable, will be added to the registers of the holders of New Common Shares and Class 1 Reorganization Shares as the holder of the number of New Common Shares and Class 1 Reorganization Shares, respectively, so issued to such Shareholder or person.

4.1.3 No share certificate representing the Class 1 Reorganization Shares issued pursuant to 4.1.2 will be issued. The New Common Shares to be issued pursuant to paragraph 4.1.2 will be evidenced by the existing share certificates and/or direct registration statements (“ DRSs ”) (as applicable) representing the Common Shares which will be deemed for all purposes thereafter to be certificates and/or DRSs representing New Common Shares to which the holder is entitled pursuant to the Arrangement, and no share certificates and/or DRSs representing such New Common Shares will be issued to the Common Shareholders, subject to any requirements by the Transfer Agent and/or any clearing or depository for securities, such as CDS to change such certificates and/or DRSs with new ones reflecting the issuances contemplated for the Arrangement, in which case the changing of such certificate and/or DRSs may occur after the Effective Date and prior to such change the current (pre-arrangement) certificates and/or DRSs are deemed to be representing the New Common Shares.

4.1.4 The Common Shares exchanged for New Common Shares and/or Class 1 Reorganization Shares pursuant to section 4.1.2 will be cancelled.

4.1.5 Each Shareholder or person who was a holder of Common Shares at the Share Distribution Date will transfer all of its Class 1 Reorganization Shares to Newco for consideration consisting solely of Newco Common Shares issued by Newco in accordance with the Newco Reorganization Ratio for the Class 1 Reorganization Shares so transferred. In connection with such transfer:





- 18 -

  (a)     

The issue price for each Newco Common Share will be an amount equal to the fair market value of the fractional Class 1 Reorganization Share for which it was issued as consideration.

   

 
  (b)     

Each holder of Class 1 Reorganization Shares so transferred will cease to be the holder of the Class 1 Reorganization Shares so transferred and will become the holder of Newco Common Shares issued to such holder. The name of such holder will be removed from the register of holders of Class 1 Reorganization Shares with respect to the Class 1 Reorganization Shares so transferred and will be added to the register of holders of Newco Common Shares as the holder of the number of Newco Common Shares so issued to such holder, and Newco will be and will be deemed to be the transferee of Class 1 Reorganization Shares so transferred and the name of Newco will be entered in the register of holders of Class 1 Reorganization Shares as the holder of the number of Class 1 Reorganization Shares so transferred to Newco.

4.1.6 All of the Class 1 Reorganization Shares owned by Newco will be redeemed for their aggregate redemption value and such redemption value will be satisfied in full by the transfer by PT to Newco of the Asset Purchase Agreement and the Newco Working Capital and the redeemed Class 1 Reorganization Shares will be cancelled. NewCo hereby waives any notice requirements or other formalities associated with the redemption of the Class 1 Reorganization Shares, and its entry into this Agreement shall be evidence of its consent to waive any obligations the Company might have to provide notice of redemption or abide by any similar formality with respect to the redemption.

4.1.7 All other holders of Class 1 Reorganization Shares who were not holders of Common Shares as of the Share Distribution Record Date shall be deemed to have surrendered such shares back to PT for cancellation, and such shares shall be cancelled and the name of such holders removed from any registry of the Class 1 Reorganization Shares.

4.1.8 The Arrangement shall become effective in accordance with the terms of the Plan of Arrangement on the Effective Date.

5. RIGHT TO DISSENT

5.1 Right to Dissent

A Shareholder may exercise dissent rights (“ Dissent Rights ”) conferred by the Interim Order in connection with the Arrangement in the manner set out in Section 238 of the BCA, as modified by the Interim Order, provided the Notice of Dissent is received by the Company by no later than 2 p.m. (Vancouver time) on May 18, 2016. Without limiting the generality of the foregoing, Shareholders who duly exercise such Dissent Rights will be deemed to have transferred such Common Shares, as of the Effective Date, without any further act or formality, to the Company in consideration of their entitlement to be paid the fair value of the Common Shares under the Dissent Rights.

6. CERTIFICATES

6.1 Entitlement to Share Certificates or DRSs





- 19 -

As soon as practicable after the Effective Date, Newco will cause the Transfer Agent to deliver share certificates and/or DRSs, as applicable, representing the Newco Common Shares to each of the holders of Newco Common Shares entitled to the same following the Arrangement.

6.2 Use of Postal Services

Any certificate or DRS which any person is entitled to receive in accordance with this Plan of Arrangement will (unless the Transfer Agent has received instructions to the contrary from or on behalf of such person prior to the Effective Date) be forwarded by regular mail, postage prepaid, or in the case of postal disruption in Canada, by such other means as the Transfer Agent may deem prudent.

7. AMENDMENT AND TERMINATION

7.1 Amendment and Termination

7.1.1 The Parties reserve the right to amend, modify and/or supplement this Plan of Arrangement at any time and from time to time, provided that any amendment, modification or supplement made following the Meeting must be contained in a written document which, if required, is filed with the Court and if required by the Court, approved by the Court and communicated to Shareholders in the manner required by the Court.

7.1.2 Any amendment, modification or supplement to this Plan of Arrangement may be proposed by any of the parties at any time prior to or at the Meeting with or without any other prior notice or communication and, if so proposed and accepted by the persons voting at the Meeting, shall become part of this Plan of Arrangement for all purposes without the need for further approval by PT Shareholders.

7.1.3 Any amendment, modification or supplement to this Plan of Arrangement which is approved or directed by the Court following the Meeting shall be effective only if it is consented to by the Parties (acting reasonably) and, if required by the Court, approved by Shareholders voting in the manner directed by the Court.

7.1.4 This Plan of Arrangement may be withdrawn prior to the Effective Date in accordance with the terms of this Agreement.

[The balance of this page is left intentionally blank.]





- 20 -

Exhibit 2
TO THE ARRANGEMENT AGREEMENT

SPECIAL RIGHTS AND RESTRICTIONS

1. New Common Shares

The New Common Shares will have the same rights and restrictions as the Common Shares.

2. Class 1 Reorganization Shares

The following special rights and restrictions are attached to the Class 1 Reorganization shares:

  (a)     

Non-voting . The holders of the Class 1 Reorganization shares are not, as such, entitled to receive notice of or to attend or to vote at any general meetings of the shareholders of the Company.

     
  (b)     

No dividends . No dividend shall be declared or paid at any time on the Class 1 Reorganization shares.

     
  (c)     

Redemption Amount. The “ Redemption Amount ” of each Class 1 Reorganization share will be Cdn$1001 divided by the number of Class 1 Reorganization shares issued and outstanding on the effective date of the arrangement as contemplated in the amended and restated arrangement agreement dated April 21, 2016 between the Company and Newco, to which this Exhibit is attached to, payable in cash, promissory note, assets with a deemed value as determined by the board of directors of the Company, or any combination thereof.

     
  (d)     

Redemption Price . The “ Redemption Price ” for each Class 1 Reorganization share shall be the Redemption Amount thereof.

     
  (e)     

Redeemable . The Company may at any time redeem any Class 1 Reorganization share in accordance with the rules and procedures in Article 24.6 by paying to the holder thereof the Redemption Price thereof.

     
  (f)     

Limited preferred entitlement on dissolution . In the event of a liquidation or dissolution of the Company or other distribution of the assets of the Company among its shareholders for the purpose of winding up its affairs, whether voluntary or involuntary, the holders of the Class 1 Reorganization shares will be entitled, before any distribution or payment of any amounts due to holders of the Pre-Arrangement Common shares, Common shares and Preferred shares as provided for in these articles, to receive the Redemption Price for each Class 1 Reorganization share held, and after such payment will not as such be entitled to participate in any further distribution of property or assets of the Company.

     




- 21 -

3. Procedure for redemption of shares

In the event the Company wishes to redeem one or more shares of a class in respect of which redemption by the Company is permitted under these articles (the “ Redeemable Shares ”):

  (a)     

the Company shall give notice of redemption to each person who at the date of the notice is a holder of a Redeemable Share that is to be redeemed;

     
  (b)     

a notice of redemption shall specify the date on which the redemption is to take place, the Redemption Price, and the number of Redeemable Shares to be redeemed from the holder to whom the notice is addressed;

     
  (c)     

on or after the date specified for redemption, the Company shall, on the holder’s presentation and surrender to the Company of all certificates representing the Redeemable Shares to be redeemed, pay or cause to be paid to or to the order of the holder of such shares the Redemption Price therefor;

     
  (d)     

upon payment of the Redemption Price in respect of the Redeemable Shares to be redeemed as provided in paragraph (c), such shares will be redeemed and any certificate representing the shares will be cancelled;

     
  (e)     

after the date specified for redemption, the holder of a Redeemable Share to be redeemed will not be entitled to exercise any of the rights of a shareholder in respect of that share unless payment of the Redemption Amount is not made on presentation of the certificate for that share in accordance with paragraph (c), in which case the rights of such holder will remain unaffected;

     
  (f)     

if the holder of a Redeemable Share to be redeemed fails to present and surrender the certificate representing such share within 15 days after the date specified for the redemption, the Company may deposit the Redemption Price for such share to a special account in any chartered bank or trust company in British Columbia to be paid without interest to or to the order of such holder upon presentation and surrender to such bank or trust company of the certificate, and upon the making of such deposit every share in respect of which the deposit is made will be deemed to be redeemed and the rights of the holder thereof will be limited to receiving without interest the Redemption Price thereof against presentation and surrender of that certificate;

     
  (g)     

the holder of a Redeemable Share may by instrument in writing waive notice of redemption of such share; and

     
  (h)     

where a notice of redemption has been given, no transfer of any Redeemable Share specified in such notice may be made by the holder of such share unless the holder’s rights with respect to that share have been restored under paragraph (e).

     



Exhibit 4.4

SHARE EXCHANGE AGREEMENT

THIS AGREEMENT is made effective as of the 19 th day of October, 2016.

AMONG :

PACIFIC THERAPEUTICS LTD. a corporation incorporated under the laws of British Columbia

(“ PT ”)

AND :

TOWER THREE SAS , a privately held limited liability company formed under the laws of Colombia

(“ T3 ”)

AND :

THE HOLDERS OF COMMON SHARES ISSUED BY T3, as listed in Schedule “A” attached hereto

(collectively, the “ T3 Shareholders ”)

T3(each a “ Party ”, collectively the “ Parties ”)

WHEREAS :

A.      

PT is a public company listed on the Canadian Securities Exchange (the “ CSE ”);

 

 
B.  

The T3 Shareholders are the owners of all of the issued and outstanding common shares of T3 (“ T3 Shares ”);

 

 
C.  

PT wishes to purchase all of the issued and outstanding T3 Shares from the T3 Shareholders in exchange for 30,000,000 common shares of PT issued on a pro-rata basis to the T3 Shareholders at a deemed issuance price of $0.10 per common share (the “ Acquisition ”), in connection with a proposed business combination and fundamental change;

 

 
D.  

PT and T3 entered into a letter of intent effective August 2, 2016 (the “ LOI ”), in furtherance of the Acquisition;

 

 
E.  

PT and T3 wish for the Acquisition to be upon and subject to the terms and conditions set forth in this share exchange agreement (the “ Agreement ”), and for this Agreement to replace and supersede the LOI;

 

 
F.  

The closing of the Acquisition will be conditional on receipt by the PT of CSE and shareholder approval;

 

 
G.  

As part of the Acquisition all of the T3 Shareholders will enter into a voluntary pooling/escrow agreement as described herein; and

 

 
H.  

As a condition to the Acquisition’s closing, T3 will have obtained any and all regulatory approvals needed to undertake and completed the transactions contemplated in this Agreement.

 

 




NOW THEREFORE , in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1 INTERPRETATION

 

1.1     

Defined terms - The following terms have the following meanings in this Agreement; other terms not listed herein are defined in the Agreement:

 

 
  (a)     

Acquisition ” has the meaning attributed thereto in Recital C;

   

 
  (b)     

Agreement ” means this share exchange agreement and the expressions “hereof”, “herein”, “hereto”, “hereunder”, “hereby” and similar expressions refer to this agreement;

   

 
  (c)     

Applicable Laws ” means all applicable rules, policies, notices, orders and legislation of any kind whatsoever of any governmental authority, regulatory body or stock exchange having jurisdiction over the Parties hereto or the transactions contemplated hereby;

   

 
  (d)     

Break Fee ” has the meaning defined in Section 10.2;

   

 
  (e)     

Business Day ” means any day except Saturday, Sunday or a civic or statutory holiday in Vancouver, British Columbia, Canada;

   

 
  (f)     

Closing ” means the completion of the Acquisition as contemplated in this Agreement;

   

 
  (g)     

Closing Date ” means the date which is ten (10) Business Days after the date on which all Regulatory Approvals, including (i) the conditional acceptance by the CSE of the listing of PT Shares after the completion of the Acquisition and the completion of the Acquisition and the other matters contemplated by this Agreement; and (ii) the receipt of conditional acceptance and all requisite levels of required shareholder approvals have been received, or such other date as is agreed upon by T3 and PT;

   

 
  (h)     

Concurrent Financing ” means either the brokered or non-brokered equity private placement by PT to raise aggregate gross proceeds of a minimum of $1,500,000 at an intended price of $0.15 per unit (each a “ Placement Units ”), each Placement Unit consisting of one common share and one common share purchase warrant (each a “ PT Warrant ”) in the capital of PT with each full warrant entitling the holder to purchase one additional PT Share at an exercise price of $0.40 per share for a period of 12 months from the closing of the financing. Each PT Warrant shall be subject to an acceleration clause in the event that the closing price of the PT common shares on the CSE is equal to or higher than $0.60 per PT Share for 10 consecutive days, in which case the PT Warrants will be exercisable within 10 days after notice of acceleration is made by PT and expire at the end of such 10 days after notice. The funds from the Concurrent financing are to be held in escrow until CSE’s approval for PT to continue to be listed after the Acquisition;

   

 

  (i)     

Consideration Milestone Escrow Agreement ” means the performance escrow agreement to be entered into among PT, the T3 Shareholders and the Escrow Agent in respect of the Consideration Milestone Shares;

   

 

  (j)     

Consideration Milestones ” means those performance milestones governing the release of the Consideration Milestone Shares from the Consideration Milestone Escrow Agreement, as more particularly set forth in Schedule G hereto;

    

 

  (k)     

Consideration Milestone Shares ” means those Issuer Consideration Shares subject to the Consideration Milestones as more particularly set forth in Schedule G hereto;

   

 





  (l)     

CSE ” means the Canadian Securities Exchange;

   

 
  (m)     

Drop Dead Date ” means December 30, 2016 or such other date as T3 and PT may determine;

   

 
  (n)     

Due Diligence Period ” means the period beginning August 2, 2016, and ending on the October 30, 2016;

   

 
  (o)     

Effective Date ” means the date of this Agreement;

   

 
  (p)     

Encumbrances ” means mortgages, charges, pledges, security interests, liens, encumbrances, nay form of securitization or collateralization, actions, claims, demands and equities of any nature, including without limitation, any liability for accrued but unpaid taxes;

   

 
  (q)     

Escrow Agreement ” has the meaning ascribed thereto in Section 2.3;

   

 
  (r)     

Escrow Agent ” means Computershare Trust Company of Canada;

   

 
  (s)     

Escrow Shares ” has the meaning ascribed thereto in Section 2.3;

   

 
  (t)     

Exemptions ” has the meaning ascribed thereto in Section 2.3(b);

   

 
  (u)     

Finder Fee ” means the intended finder’s fee to be paid upon the closing for the Concurrent Financing which will not exceed: (i) a cash equivalent to 8% of the Concurrent Financing and (ii) such number of common share purchase warrants (each a " Finders Warrant ") equivalent to 8% of the number of Units issued pursuant to the Concurrent Financing. Each whole Finders Warrant will entitle the holder to purchase one (1) additional common share of PT at an exercise price of $0.40 per share for a period of one (1) year from the closing of the Concurrent Financing. Such final terms as pricing, financing, commission and finder's or agent's fees relating to the Concurrent Financing will be subject to final approval by PT, the CSE and/or other applicable regulatory authorities. The Finder Warrants will be subject to the applicable statutory hold period along with any escrow restrictions imposed by the CSE or Applicable Laws.

   

 

  (v)     

IFRS ” means International Financial Reporting Standards;

   

 
  (w)     

Information Circular ” means the notice of meeting and management information circular of PT to be sent to the shareholders of PT in respect of the PT Shareholder Meeting, prepared in accordance with the policies of the CSE, if required;

   

 
  (x)     

ITA ” means the Income Tax Act (Canada);

   

 
  (y)     

Listing Statement ” means the listing statement of PT to be prepared in accordance with the requirements of the CSE and filed with the CSE in connection with this Acquisition;

   

 
  (z)     

Material ” means of such a nature or amount as would reasonably be regarded as significant in relation to the business of the applicable person or in relation to the capital, prospects, condition (financial or otherwise) or results of operation of the applicable person, whether or not significant in relation to PT, T3 or the T3 Subsidiary, and “ Materially ” has a corresponding meaning;

   

 

  (aa) 

Material Adverse Change ” or “ Material Adverse Effect ” means any change (or any condition, event or development involving a prospective change) in the business, operations, results of operations, assets, capitalization, financial condition, licences,

   

 





   

permits, concessions, rights, liabilities, prospects or privileges, whether contractual or otherwise, of the party referred to which is, or could reasonably be expected to be, materially adverse to the business of such party other than a change: (i) which has prior to the date hereof been publicly disclosed or otherwise disclosed in writing to the other party; or (ii) resulting from general economic, financial, currency exchange, securities or commodity market conditions in Canada or elsewhere;

   

 
  (bb)     

MD&A ” means the Management Discussion and Analysis prepared in support of the PT Financial Statements and filed on SEDAR;

   

 
  (cc)     

Name Change ” has the meaning ascribed thereto in Section 5.1(h);

   

 
  (dd)     

New T3 Share Certificate ” has the meaning ascribed thereto in subparagraph 7.3(a)(iii);

   

 
  (ee)     

Old T3 Share Certificates ” has the meaning ascribed thereto in subparagraph 7.3(a)(ii);

   

 
  (ff)     

Pro Forma Financial Statements ” means the pro forma financial statements of PT and T3 giving effect to the Acquisition as are required to be included in the Information Circular or the Listing Statement pursuant to the policies of the CSE;

   

 
  (gg)     

Property ” means such property and assets of T3 as described in Schedule “B”;

   

 
  (hh)     

PT Consideration Shares ” means the 30,000,000 PT Shares issuable in exchange for the T3 Shares at Closing;

   

 
  (ii)     

PT Disclosure Record ” means PT’s financial statements, management information circulars, material change reports, technical reports, press releases and all documents filed publicly by PT on SEDAR;

   

 
  (jj)     

" PT Financial Statements ” means the audited financial statements and MD&A of PT for the year ended December 31, 2015, and the interim unaudited financial statements and MD&A of PT, as filed on SEDAR with the applicable Canadian securities regulators;

   

 
  (kk)     

PT Options ” means stock options exercisable to purchase PT Shares;

   

 
  (ll)     

PT Shares ” means Class A common shares without par value in the capital of PT;

   

 
  (mm)     

PT Shareholder Meeting ” has the meaning ascribed thereto in Section 2.5;

   

 
  (nn)     

PT Shareholder Approval Matters ” has the meaning ascribed thereto in Section 2.5;

   

 
  (oo)     

PT Warrants” means common share purchase warrants exercisable to purchase PT Shares pursuant to the Concurrent Financing;

   

 
  (pp)     

Regulatory Approvals ” means all third party approvals required in order for all of the transactions contemplated hereby to be carried out, including without limitation, all required approvals of the CSE and any private and/or governmental entity or individual;

   

 
  (a)     

Share Exchange Ratio ” means the number that results from dividing 30,000,000 PT Shares by the total number of T3 Shares issued and outstanding at the Time of Closing, which number equals the number of PT Shares that will be exchanged for each T3 Share outstanding at the Time of Closing;

   

 
  (b)     

Securities Laws ” means the securities legislation having application to the transactions contemplated hereby and the regulations and rules thereunder and all administrative

   

 




   

policy statements, instruments, blanket orders, notices, directions and rulings issued or adopted by the applicable securities regulatory authorities, all as amended;

     
  (c)     

SEDAR ” means a System for Electronic Document Analysis and Retrieval (www.sedar.com);

     
  (d)     

T3 Shareholder Attorney ” has the meaning ascribed thereto in Section 12;

     
  (e)     

T3 Financial Statements ” means the audited consolidated financial statements of T3 as at and for the year ended December 31, 2015, audited in accordance with IFRS, as attached to Schedule “F” hereto;

     
  (f)     

T3 Shareholders ” means the persons who beneficially own the T3 Shares, as set out in Schedule “A” to this Agreement;

     
  (g)     

T3 Shares ” means common shares in the capital of T3;

     
  (h)     

T3 Subsidiary ” means Fundacion Comunicar Para Educar, a foundation that exists under the laws of Colombia; and

     
  (i)     

Time of Closing ” means 12:00 p.m. (Vancouver, British Columbia local time) on the Closing Date or such other time agreed to between PT and T3.

   

 
1.2     

Schedules — The following schedules attached hereto constitute a part of this Agreement:

Schedule “A” — List of T3 Shareholders
Schedule “B” — Property Description
Schedule “C” — Issued Securities of PT
Schedule “D” — Issued Securities of T3
Schedule “E” — Material Contracts of T3
Schedule “F” — Consolidated Financial Statements for T3
Schedule “G” — Voluntary Pooling and Escrow terms & conditions
Schedule “H” — Certificate of U.S. Shareholder

1.3     

Headings - The headings in this Agreement are for reference only and do not constitute terms of the Agreement.

 

 
1.4     

Interpretation - Whenever the singular or masculine is used in this Agreement the same shall be deemed to include the plural or the feminine or the body corporate as the context may require and vice versa.

 

 
1.5     

Currency — Unless otherwise stated, all references to money in this Agreement shall be deemed to be references to the currency of Canada.

 

 
1.6     

Knowledge – Where a representation or warranty is made in this Agreement on the basis of the knowledge or the awareness of the party, such knowledge or awareness consists only of the actual knowledge or awareness, as of the date of this Agreement, of that party, if an individual, or if a corporation or other legal entity, the directors and senior executive officers of that party, but does not include the knowledge or awareness of any other individual or any constructive, implied or imputed third party knowledge.

 

 
1.7     

Effective Date - This Agreement shall be effective upon the date that this Agreement has been executed by each of PT, T3 and those T3 Shareholders included as signatories to this Agreement, which T3 Shareholders hold not less than 100% of the outstanding T3 Shares.

 

 




2      

PURCHASE AND SALE, PT SHAREHOLDER APPROVAL, INFORMATION CIRCULAR, AND LOAN REQUEST, CONCURRENT FINANCING

 

 
2.1     

Purchase and Sale - Upon and subject to the terms of this Agreement each T3 Shareholder hereby agrees to sell, assign and transfer the T3 Shares owned by the T3 Shareholder to PT as set out in Schedule “A”, and PT agrees to purchase from all T3 Shareholders all right, title and interest of the T3 Shareholders in and to the T3 Shares on the Closing Date, and in consideration for each T3 Share acquired from each T3 Shareholder, PT will issue to such T3 Shareholder that number of PT Shares as is equal to the Share Exchange Ratio. For greater certainty, as of the date of this Agreement the Share Exchange Ratio shall be one (1) T3 Share for one (1) PT Share, resulting in the issue of 30,000,000 PT Consideration Shares to the T3 Shareholders.

 

 

2.2     

Tax Liability — Neither PT nor T3 shall assume and shall not be liable for any taxes under the ITA or any other taxes whatsoever which may become payable by T3 Shareholders or the shareholders of PT including, without limiting the foregoing, any taxes resulting from or arising as a consequence of the sale by T3 Shareholders to PT of the T3 Shares herein contemplated, including the exercise of the PT Warrants and PT Options by the shareholders of PT, and each T3 Shareholder shall severally indemnify and save harmless PT and T3 from and against all such taxes arising in relation to such T3 Shareholder.

 

 
2.3     

PT Consideration Shares — Each T3 Shareholder hereby acknowledges and agrees with PT as follows:

 

 
  (a)     

all of the PT Consideration Shares issued in exchange for the T3 Shares as set forth and described in Schedule A, shall be subject to escrow restrictions (“ Escrow Shares ”) pursuant to both the Consideration Milestone Escrow Agreement and an escrow agreement in the form prescribed by the CSE (“ Escrow Agreement ”);

     
  (b)     

the PT Consideration Shares shall be subject to the Consideration Milestones and as required will be deposited with the Escrow Agent pursuant to the Consideration Milestone Escrow Agreement;

     
  (c)     

the Consideration Milestone Escrow Agreement shall set forth the basis upon which the Issuer and the T3 Shareholders shall determine whether a particular Consideration Milestone has been achieved and the manner in which the Escrow Agent shall be notified;

     
  (d)     

in the event the Consideration Milestones are not achieved by the deadline dates set forth in Schedule G, such Issuer Consideration Shares shall be returned by the Escrow Agent to the PT’s registrar and transfer agent for cancellation; and

     
  (e)     

upon release from the Consideration Milestone Escrow Agreement, the PT Consideration Shares will be deposited pursuant to the Escrow Agreement and shall be subject to further restrictions or release in accordance with the schedule set forth in the Value Escrow Agreement.

     
  (f)     

PT agrees to use commercially reasonable efforts and to take all practical steps available to it to ensure that the CSE does not impose additional escrow conditions on the Escrow Shares on Closing;

     
  (g)     

the Acquisition, transfer of the T3 Shares and the issuance of the PT Consideration Shares in exchange therefor will be made pursuant to appropriate exemptions (the “ Exemptions ”) from the formal takeover bid and registration and prospectus (or equivalent) requirements of the Securities Laws;

     
  (h)     

as a consequence of acquiring the PT Consideration Shares pursuant to the Exemptions:

     




  (i)     

the T3 Shareholder will be restricted from using certain of the civil remedies available under the Securities Laws;

     
  (ii)     

the T3 Shareholder may not receive information that might otherwise be required to be provided to the T3 Shareholders, and PT is relieved from certain obligations that would otherwise apply under Securities Laws if the Exemptions were not being relied upon by PT; and

     
  (iii)     

no securities commission, stock exchange or similar regulatory authority has reviewed or passed on the merits of an investment in the PT Consideration Shares;

     
  (i)     

the certificates representing the PT Consideration Shares will bear such legends as may be required by Securities Laws and the policies of the CSE;

     
  (j)     

the T3 Shareholder is knowledgeable of, or has been independently advised as to, the Applicable Laws of its jurisdiction of residence, which applies to the sale of the T3 Shares and the issuance of the PT Consideration Shares and which may impose restrictions on the resale of such PT Consideration Shares in such jurisdiction and it is the responsibility of the T3 Shareholder to find out what those resale restrictions are, and to comply with them before selling the PT Consideration Shares; and

     
  (k)     

Notwithstanding the foregoing, no T3 Shareholder shall be entitled to, and PT will not issue or deliver, fractions of PT Consideration Shares, as the case may be, pursuant to the Acquisition. In lieu of any fractional entitlement, the number of PT Consideration Shares issued to each former T3 Shareholder shall be rounded down the next lower whole number of PT Shares and by taking into account only the number of PT Consideration Shares being issued to each such former T3 Shareholder.

     
2.4     

As required, on or before the Drop Dead Date, PT shall either:

 

 
  (a)     

convene a special meeting of PT shareholders (the “ PT Shareholder Meeting ”) in order to obtain shareholder approval of the Acquisition, the creation of a new control person, if applicable, the election of the directors identified in Section 3.1 of this Agreement, and any matters related thereto (collectively, the “ PT Shareholder Approval Matters ”); or

     
  (b)     

obtain the written consent to the PT Shareholder Approval Matters from PT shareholders holding greater than 50% of the outstanding PT Shares, in a form acceptable to the CSE.

     
2.5     

As promptly as reasonably practicable, PT shall deliver to T3 drafts of its Information Circular, if required, and Listing Statement together with any other documents required under Applicable Laws in connection with the approval of the PT Shareholder Approval Matters. PT shall give T3 opportunity to review and comment on all such documentation and all such documentation shall be reasonably satisfactory to T3 before it is filed or distributed to the CSE or PT shareholders. As promptly as practicable after receipt of the CSE’s conditional approval letter indicating that it has accepted the Information Circular for the purposes of mailing it to the PT shareholders and filing on SEDAR, PT shall cause the Information Circular and other documentation required in connection with the PT Shareholder Meeting to be mailed to each PT shareholder.

 

 
2.6     

T3 shall assist PT and PT and T3 shall use reasonable efforts to ensure that the Information Circular and Listing Statement as it contains information with respect to each of PT, T3, and the T3 Shareholders complies with all Applicable Laws and, without limiting the generality of the foregoing, that the Information Circular and the Listing Statement does not contain any misrepresentation or any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements contained therein not

 

 




 

misleading in light of the circumstances in which they are made (other than with respect to any information relating to or provided by T3). Without limiting the generality of the foregoing, PT and T3 shall use reasonable efforts to ensure that the Information Circular and the Listing Statement complies with the applicable policies of the CSE. Notwithstanding the foregoing, the parties confirm and agree that each party’s obligations contained in this Section 2.7 shall only apply to each party’s respective information provided in the Information Circular and the Listing Statement and not to that of any other party contained in the Information Circular or the Listing Statement.

 

 
2.7   

Each of the parties shall promptly notify the other parties if at any time before the Time of Closing it becomes aware that the Information Circular or the Listing Statement contains any misrepresentation or any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements contained therein not misleading in light of the circumstances in which they are made, or that otherwise requires an amendment or supplement to the Information Circular or the Listing Statement. In any such event, the parties shall cooperate in the preparation of a supplement or amendment to the Information Circular or the Listing Statement, as required and as the case may be, and, if required, shall cause the same to be distributed to the PT shareholders and/or filed with the relevant securities regulatory authorities.

 

 
2.8    

Loan Request

 

 
 

Subject to the satisfaction of the three following conditions:

 

 
  (i)     

T3 providing to PT the T3 Financial Statements;

   

 
  (ii)     

T3 and PT determining and mutually agreeing to a tax efficient transaction structure; and

   

 
  (iii)     

the signing of this Agreement by all Parties,

   

 
 

T3 may request in writing that PT loan to T3 up to $200,000 (the “ Loan Request ”) on a secured basis. If T3 delivers to PT the Loan Request, then PT, in its sole discretion, acting reasonably, may, subject to any required CSE approval and the execution of a general security agreement (the “ General Security Agreement ”), the terms of which shall be mutually agreed upon by PT and T3, deliver to the T3 the amount requested pursuant to the Loan Request (up to $200,000) on the following terms: (a) an interest rate of 10% per annum; (b) the right to demand repayment of the loan at any time after one-hundred and eighty (180) days following the date of advance of the loan (the “ Maturity Date ”); (c) principal and accrued interest payable on the Maturity Date, with no obligation to make payment of either principal or interest prior to the Maturity Date; and (d) no pre-payment penalty.

 

 
2.9   

Concurrent Financing

 

 
 

PT will undertake the Concurrent Financing and notwithstanding any other provision in this Agreement may pay the Finder Fee, including any cash and/or Finders Warrant related thereto.

 

 
3      

CHANGE IN DIRECTORS AND OFFICERS OF PT

   
3.1    

New directors — Effective at the Closing, the board of directors of PT (the “ Board ”) shall be restructured, through resignations and appointments, so that it shall consist of four (4) directors, with the T3 Shareholders (collectively) selecting two (2) board members (the “T3 Nominees”) , and PT selecting two (2) board members (the “PT Nominees”) . The T3 Nominees shall be Alejandro Ochoa, Fabio Alexander Vasquez (or other individuals as may be decided by the T3 Shareholders), and the PT Nominees shall be Brian Gusko and Robert (Nick) Horsley (or other individuals as may be decided by PT). If any of the proposed directors are not acceptable to the CSE, the applicable nominating party shall appoint such other nominees as may be acceptable to





 

the CSE. Notwithstanding the foregoing, the parties hereto agree that immediately following Closing, PT shall convene a special meeting of the shareholders of PT on a date that is as soon as practicable for the purpose of increasing the size of the Board to five (5) and electing a third nominee of T3 as a director of PT.

 

 
3.2     

New officers - Effective at the Closing, certain existing officers of PT will resign. The officers of PT following the Acquisition will be determined by the reconstituted board of directors of PT upon completion of the Acquisition, and PT and T3 agree to take such commercially reasonable action as permitted under Applicable Laws such that the senior officers of PT after the Acquisition has closed are constituted of the following individuals:

 

 
  (a)     

Alejandro Ochoa, as President and Chief Executive Officer;

  (b)     

Octavio De La Espriella, as the Chief Operating Officer; and

  (c)     

Abbey Abdiye, Chief Financial Officer,

with such officer appointments being subject to the requirement that the T3 Nominees shall be entitled to appoint one (1) officer who has bank signing authority and the PT Nominees shall be entitled to appoint one (1) officer who has bank signing authority. The T3 Shareholders and PT shall each elect one signing officer to manage the companies accounts for the purposes of day to day transactions.

3.3     

PIFs - T3 shall deliver a CSE Form 2A — Personal Information/Consent Form duly completed by each of the proposed directors and officers of PT nominated by T3 and identified in sections 3.1 and 3.2 above, on or before the date that is thirty (30) calendar days prior to the PT Shareholder Meeting, or if no such meeting is held then no later than by fifteen (15) calendar days after the Effective Date.

 

 
3.4     

Resignations — At the Closing, PT shall deliver resignations of those directors and officers of PT who are either not continuing with PT or are continuing in a different capacity or role, such resignations to include waivers in respect of any liabilities of PT to them in a form acceptable to T3, acting reasonably.

 

 
4      

COVENANTS AND AGREEMENTS

 

 
4.1     

Given by T3 — T3 covenants and agrees with PT that T3 will:

 

 
  (a)     

before the expiry of the Due Diligence Period, permit representatives of PT, at their own cost, full access during normal business hours to T3’s documents including, without limitation, all of the assets, contracts, financial records and minute books of T3, so as to permit PT to make such investigation of T3 as PT deems necessary;

   

 
  (b)     

permit representatives of PT, at their own cost, full access during normal business hours, but upon twenty-four (24) hours’ advance written notice, to its books, records and property including, without limitation, all of the assets, contracts, financial records and minute books of T3 and the T3 Subsidiary, so as to permit PT to make such continuing investigation of T3 and the T3 Subsidiary as PT reasonably deems necessary; provide to PT all such further documents, instruments and materials, in accordance with applicable privacy laws, and do all such commercially reasonable acts and things as may be reasonably required by PT to seek the Regulatory Approvals including providing to PT all relevant information concerning it and its business, properties, operations and financial statements for inclusion in the Information Circular, if required, and the Listing Statement, and execute a certificate to be attached to the Information Circular and the Listing Statement certifying that all information concerning it contained in the Information Circular and the Listing Statement

   

 





   

constitutes full, true and plain disclosure of all material facts relating to the particular matters to be acted upon by the shareholders of PT at the PT Shareholder Meeting, and that the information contained in the Information Circular and the Listing Statement does not contain an untrue statement of a material fact with respect to it, contain any misrepresentation or untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances in which they are made, or that otherwise requires an amendment or supplement to the Information Circular, the Listing Statement or such filing or application; and in any such event, shall cooperate in the preparation of a supplement or amendment to the Information Circular, the Listing Statement or such other document, as required and as the case may be;

   

 
  (c)     

permit PT to secure directors' and officers' liability insurance for the current directors and officers of PT on a “trailing” (or “run-off”) basis for a period of five years after the Closing Date. If a trailing policy is not available, PT will maintain in effect the current policies of directors' and officers' liability insurance (it being understood and agreed that PT may substitute therefore policies providing at least the same coverage (including amounts and deductibles), provided the terms and conditions of such substituted policies are not materially less advantageous to the insured) with respect to claims arising from facts or events which occur on or before the Closing Date. T3 agrees to not take any action to terminate or otherwise adversely affect such directors' and officers' insurance;

   

 
  (d)     

permit PT to enter into indemnity agreements with all of its current directors and officers in industry standard form that will be excluded from any mutual release of claims that may be delivered at Closing;

   

 
  (e)     

do all such commercially reasonable acts and things reasonably necessary to ensure that all of the representations and warranties of T3 remain true and correct and, to the extent commercially reasonable, not do any such act or thing that would render any representation or warranty of T3 untrue or incorrect;

   

 
  (f)     

from and including the Effective Date through to and including the Time of Closing, preserve and protect the goodwill, assets including the Property, business and undertaking of T3 and, without limiting the generality of the foregoing, carry on the business of T3 and the T3 Subsidiary in a reasonable and prudent manner;

   

 
  (g)     

use its commercially reasonable efforts to obtain all required Regulatory Approvals and any shareholder approvals, consents or agreements to be able to deliver all of the issued and outstanding T3 Shares on Closing;

   

 
  (h)     

use its commercially reasonable efforts to obtain all required Regulatory Approvals needed by T3 and/or T3 Subsidiary for the Acquisition, the transactions contemplated in this Agreement, and for T3 and T3 Subsidiary becoming part of a publicly listed company as a result of the transactions contemplated herein, which for clarity includes but is not limited to obtaining the approval of any government or private entity that must consent T3 and/or T3 Subsidiary’s acquisition under this Agreement by a publicly listed company such as PT;

   

 
  (i)     

co-operate with any valuator retained to value the T3 Shares;

   

 
  (j)     

comply with the terms hereof and use commercially reasonable efforts to satisfy the conditions precedent set out and to close the Acquisition and related transactions by the Closing Date and in any event no later than the Drop Dead Date or such later date as may be approved in writing by PT and T3;

   

 




  (k)     

from and including the Effective Date through to and including the Time of Closing, except as set out in this Agreement, not issue, nor reach any agreement or understanding with any other party to issue, any securities without the prior written consent of PT, such consent not to be unreasonably withheld; and

   

 
  (l)     

from and including the Effective Date through to and including the Time of Closing, not directly or indirectly, solicit, initiate, assist, facilitate, promote or knowingly encourage the initiation of proposals or offers from, entertain or enter into negotiations with, any person (other than PT), with respect to any amalgamation, merger, consolidation, arrangement, restructuring, sale of any material assets or part thereof of it, unless such action is necessary to comply with the fiduciary duties of the directors and officers of T3 or this Agreement is terminated in accordance with Section 9.1.

 

 
4.2     

Given by T3 and the T3 Shareholders

 

 
  (a)     

Each T3 Shareholder covenants and agrees to enter into a voluntary pooling agreement on the terms and conditions set out in Schedule “G”. Each T3 Shareholder also understand and acknowledge that any PT Shares and/or other securities issued to T3 Shareholders may be subject to certain escrow provisions imposed under Applicable Laws on such PT Shares and other PT securities.

   

 
4.3     

Given by PT - PT covenants and agrees with the T3 Shareholders and T3 that PT will:

 

 
  (a)     

before the expiry of the Due Diligence Period, permit representatives of T3 and the T3 Shareholders full access during normal business hours to PT’s documents including, without limitation, all of the assets, contracts, financial records and minute books of PT, so as to permit such investigation of PT as T3 and the T3 Shareholders deem reasonably necessary;

   

 
  (b)     

at any time up to the PT Shareholder Meeting, permit Article 2 of this Agreement to be amended in any manner determined necessary by T3 to ensure that the Acquisition is completed in the most tax efficient manner for T3 and the T3 Shareholders, provided that Article 2 of this Agreement will not be amended in a manner that results in a materially adverse change in the quantum of consideration payable by PT;

   

 
  (c)     

use commercially reasonable efforts to obtain, in a timely manner, all necessary shareholder and Regulatory Approvals for the transactions contemplated hereunder;

   

 
  (d)     

prepare the Information Circular (if required), the Listing Statement and Pro Forma Financial Statements with the assistance of T3, file it with the CSE and make such amendments to it as may be required by the CSE as part of the approval process for the transactions contemplated by this Agreement;

   

 
  (e)     

on or before the Drop Dead Date, convene the PT Shareholder Meeting for the purpose of approving the PT Shareholder Approval Matters unless the CSE allows for a written consent resolution approved by at least 50.1% of the PT shareholders;

   

 
  (f)     

recommend that PT shareholders approve the PT Shareholder Approval Matters;

   

 
  (g)     

from and including the Effective Date through to and including the Time of Closing, not carry on any business or activity that is not in the ordinary course, except as contemplated herein, or as previously disclosed by PT in public announcements and filings;

   

 
  (h)     

from and including the Effective Date through to and including the Time of Closing, not directly or indirectly, solicit, initiate, assist, facilitate, promote or knowingly encourage the

   

 




   

initiation of proposals or offers from, entertain or enter into negotiations with, any person (other than T3), with respect to any amalgamation, merger, consolidation, arrangement, restructuring, sale of any material assets or part thereof of it except in furtherance of the Acquisition;

   

 
  (i)     

comply with the terms hereof and faithfully and expeditiously seek to satisfy the conditions precedent set out below and to close the Acquisition and related transactions by the Closing Date and in any event no later than the Drop Dead Date, or such later date as may be approved in writing by PT and T3;

     
  (j)     

from and including the Effective Date through to and including the Time of Closing, do all such commercially reasonable acts and things necessary to ensure that all of the representations and warranties of PT remain true and correct and, to the extent commercially reasonable, not do any such act or thing that would render any representation or warranty of PT untrue or incorrect;

     
  (k)     

from and including the Effective Date through to and including the Time of Closing, use commercially reasonable efforts to ensure that it remains in good standing under all Applicable Laws;

     
  (l)     

use its commercially reasonable efforts to reduce its liabilities to not more than $10,000 on or before the Closing Date (the “ Permitted Liabilities ”);

     
  (m)     

use its commercially reasonable efforts to complete the Concurrent Financing concurrently with or shortly after the Acquisition;

     
  (n)     

use its commercially reasonable efforts to obtain all consents, approvals, permits, authorizations or filings as may be required under applicable corporate laws, securities laws, the rules and policies of the CSE and the constating documents of PT for the performance by PT of its obligations under this Agreement prior to the Closing; and

     
  (o)     

from and including the Effective Date through to and including the Time of Closing, not directly or indirectly, solicit, initiate, assist, facilitate, promote or knowingly encourage the initiation of proposals or offers from, entertain or enter into negotiations with, any person (other than T3 and the T3 Shareholders), with respect to any amalgamation, merger, consolidation, arrangement, restructuring, sale of any material assets or part thereof of it, unless such action is necessary to comply with the fiduciary duties of the directors and officers of T3 or this Agreement is terminated in accordance with Section 9.1.

   

 
4.4     

Given by PT and T3 – PT covenants and agrees with T3 and T3 covenants and agrees with PT that except as contemplated in this Agreement, each shall continue to conduct its respective business and affairs in the ordinary and normal course and agrees not to enter into or terminate any material contracts or transactions or to incur any liabilities, other than in the ordinary course, with respect to its respective business, without first obtaining the prior written consent of PT or T3 as applicable.

 

 
5      

CONDITIONS PRECEDENT

 

 
5.1     

In favour of all parties - The respective obligations of the Parties hereto to consummate the transactions contemplated hereby, and in particular the Acquisition, are subject to the satisfaction, on or before the Time of Closing, of the following conditions:

 

 
  (a)     

all of the T3 Shareholders shall be a party to, and bound by, the terms and conditions of this Agreement;

   

 




  (b)     

this Agreement and the transactions contemplated hereby, including, in particular, the PT Shareholder Meeting Matters, shall be approved by the shareholders of PT, if required by the CSE, at the PT Shareholder Meeting or by a written consent resolution of at least 50.1% of the PT Shareholders, to be held on or before the Drop Dead Date;

     
  (c)     

this Agreement and the transactions contemplated hereby have been approved by the CSE;

     
  (d)     

PT being in a position to close the Concurrent Financing;

     
  (e)     

this Agreement and the transactions contemplated hereby, including, in particular, the Acquisition, will have been approved or consented to by the T3 Shareholders, if and to the extent applicable;

     
  (f)     

this Agreement and the transactions contemplated hereby have been approved by the board of directors of PT and T3 or such other persons who have authority to approve this Agreement;

     
  (g)     

the PT Shares to be issued in connection with the Acquisition will have been approved for issuance by the directors of PT and conditionally accepted for listing by the CSE, subject to PT fulfilling the CSE's listing requirements;

     
  (h)     

Name Change– Prior to the Time of Closing, PT shall:

     
  (i) 

change its name to “Tower One Wireless Corp.”, or such other name as is acceptable to T3 and applicable regulatory authorities (the “ Name Change ”); and

   

 
  (i)     

there will not be in force any order or decree restraining or enjoining the consummation of the transactions contemplated by this Agreement, including, without limitation, the Acquisition and all consents, orders and approvals required or necessary or desirable for the completion of the transactions provided for in this Agreement will have been obtained or received from the persons, authorities or bodies having jurisdiction in the circumstances, all on terms satisfactory to PT and T3, acting reasonably;

     
  (j)     

All other necessary regulatory approvals with respect to the Acquisition and the Concurrent Financing having been obtained, including but not limited to the approval of the CSE and the other applicable securities regulatory authorities;

     
  (k)     

Until Closing, each of the Parties shall notify the other of any significant developments or material change relating to the Party, its business, assets or financial condition, promptly after becoming aware of any such development or change.

     
 

The conditions precedent set forth above are for the benefit of each of PT, T3 and the T3 Shareholders and may be waived by PT for itself or T3 for itself and on behalf of each T3 Shareholder for each of themselves, in whole or in part on or before the Time of Closing.

 

 
5.2     

In favour of PT — PT's obligations under this Agreement are subject to the fulfilment of the following conditions:

 

 
  (a)     

T3 and the T3 Shareholders will have complied in all material respects with all of their respective covenants and agreements contained in this Agreement;

   

 
  (b)     

the representations and warranties of T3 and the T3 Shareholders will be true in all material respects at the Time of Closing as if such representations and warranties had been made by T3 and the T3 Shareholders as of the Time of Closing;

   

 




  (c)     

T3 will have delivered to PT written evidence that T3 has received all the required third party consents to the Acquisition and the transactions contemplated in this Agreement, or T3 will have delivered to PT a written statement representing that no such consent was and is at the Time of Closing required;

     
  (d)     

there will not be outstanding at the Time of Closing any warrants or options or any other securities to purchase or securities convertible into T3 Shares, or any other securities of T3, and the cancellation of currently issued and outstanding T3 options, share purchase warrants and any other securities exercisable or convertible into T3 Shares and/or any other security of T3, except for the T3 Shares to be exchanged with PT Shares in accordance with this Agreement;

     
  (e)     

T3 and the T3 Shareholders will have delivered to PT the documents described in Section 7.3; and

     
  (f)     

except as set out in this Agreement or consented to by PT, there will have been no material transaction out of the ordinary course of business of T3 or the T3 Subsidiary or any Material Adverse Change in the financial condition, assets or liabilities (contingent or otherwise) of T3 or the T3 Subsidiary.

     
 

The conditions precedent set forth above are for the exclusive benefit of PT and may be waived by it in whole or in part on or before the Time of Closing.

     
5.3     

In favour of T3 and the T3 Shareholders — T3 and the T3 Shareholders' respective obligations under this Agreement are subject to the fulfilment of the following conditions:

 

 
  (a)     

completion of the Concurrent Financing on the Closing Date;

     
  (b)     

the liabilities of PT as at the Closing Date shall not exceed the Permitted Liabilities;

     
  (c)     

PT will have complied in all material respects with all of its covenants and agreements contained in this Agreement;

     
  (d)     

the representations and warranties of PT will be true in all material respects at the Time of Closing as if such representations and warranties had been made by PT as of the Time of Closing;

     
  (e)     

PT will have delivered to T3 and the T3 Shareholders the documents described in Section 7.4;

     
  (f)     

immediately prior to Closing there will not be outstanding any securities of PT other than as set out in Schedule “C”;

     
  (g)     

from and including the Effective Date through to and including the Time of Closing not issue any securities and not enter into any agreement or understanding with any other party other to issue any securities, without the prior written consent of T3 such consent shall not to be unreasonably withheld;

     
  (h)     

from and including the Effective Date through to and including the Time of Closing, not directly or indirectly, solicit, initiate, assist, facilitate, promote or knowingly encourage the initiation of proposals or offers from, entertain or enter into negotiations with, any person (other than T3 and the T3 Shareholders), with respect to any amalgamation, merger, consolidation, arrangement, restructuring, sale of any material assets or part thereof of it;

     




  (i)     

from and including the Effective Date through to and including the Time of Closing, to use its reasonable commercial efforts to ensure that its common shares remain listed on the CSE and that it remains in good standing under Applicable Laws; and

   

 
  (j)     

except as set out in this Agreement or consented to by T3, there will have been no material transaction out of the ordinary course of business of PT or any Material Adverse Change in PT's financial condition, assets or liabilities (contingent or otherwise) or prospects.

   

 
 

The conditions precedent set forth above are for the exclusive benefit of T3 and the T3 Shareholders and may be waived by T3 for itself, and on behalf of the T3 Shareholders, in whole or in part on or before the Time of Closing.

 

 
6      

REPRESENTATIONS AND WARRANTIES

 

 
6.1     

Concerning PT - In order to induce T3 and the T3 Shareholders to enter into this Agreement and complete their respective obligations hereunder, PT represents and warrants to T3 and the T3 Shareholders that:

 

 
  (a)     

PT is a corporation duly incorporated and validly existing under the laws of British Columbia, Canada and is in good standing with respect to the filing of annual reports, and has the power, authority and capacity to enter into this Agreement and carry out its terms, and to conduct its business as such businesses is now being conducted;

     
  (b)     

PT is a “reporting issuer” within the meaning of securities laws in British Columbia, Canada and Ontario, Canada;

     
  (c)     

no order ceasing or suspending trading in securities of PT or prohibiting the sale of securities by PT has been issued and no proceedings for this purpose have been instituted, or are pending, or, to the knowledge of PT, after due inquiry, are contemplated or threatened;

     
  (d)     

the PT Shares are listed for trading on the CSE, and is not in material default of any requirement contained in its listing agreement with the CSE;

     
  (e)     

the execution and delivery of this Agreement and all other related agreements or documents, and the completion of the transactions contemplated hereby, will by Closing have been duly and validly authorized by all necessary corporate acts on the part of PT, and this Agreement constitutes a legal, valid and binding obligation of PT, enforceable in accordance with its terms;

     
  (f)     

the authorized share capital of PT consists of an unlimited number of common shares of which as of the date of this Agreement, 6,735,885 PT Shares are issued and outstanding as fully paid and non-assessable shares, subject only to the issuance of additional PT Shares upon exercise of outstanding share purchase warrants and PT Options described in Schedule “C” and PT Shares or other securities of PT issued upon the closing of Concurrent Financing;

   

 

  (g)     

other than as disclosed in writing to T3 or as contemplated by this Agreement, PT does not have any agreements, options or commitments to acquire any shares or securities of any corporation or to acquire or lease any business operations, real property or assets;

     
  (h)     

subject to Securities Laws and compliance with the rules and policies of the CSE, PT has the full and lawful right and authority to issue the PT Shares to the T3 Shareholders in connection with the Acquisition and upon completion of the Acquisition, such PT Shares

     




   

will be validly issued as fully paid and non-assessable common shares in the capital stock of PT free and clear of all Encumbrances;

   

 
  (i)     

neither the execution and delivery of this Agreement nor consummation of the transactions contemplated hereby will conflict with or result in the breach of any of the terms or provisions of, or constitute a default under, the constating documents, director or shareholder resolutions of PT or any agreement or instrument to which PT is a party or by which it or its assets are bound or any order, decree, statute, regulation, covenant or restriction applicable to PT;

     
  (j)     

except as qualified by the PT Disclosure Record, PT is the legal and beneficial owner of and has good and marketable title to the properties, business and assets or the interests in the properties, business or assets referred to in the PT Disclosure Record, all material agreements to which PT holds an interest in a property, business or assets are in good standing according to their terms;

     
  (k)     

the PT Disclosure Record and all financial, marketing, sales and operational information provided to T3 and the T3 Shareholders do not contain any misrepresentations (as such term is defined in the Securities Laws) and do not omit to state a material fact which, at the date thereof, was required to have been stated or was necessary to prevent a statement that was made from being false or misleading in the circumstances in which it was made;

     
  (l)     

all financial statements filed in the PT Disclosure Record, including the PT Financial Statements, have been prepared in accordance with IFRS, present fairly, in all material respects, the financial position and all material liabilities (accrued, absolute, contingent or otherwise) of PT, as of the date thereof, and there have been no Adverse Material Changes in the financial position of PT since the date thereof and the business of PT has been carried on in the usual and ordinary course consistent with past practice since the date thereof;

     
  (m)     

the auditors of PT who audited the financial statements of PT for the period ended December 31, 2015 and who provided their audit report thereon are independent public accountants as required under applicable legislation and there has never been a reportable disagreement (within the meaning of National Instrument 51-102) with the present auditors of PT;

     
  (n)     

PT has complied fully in all material respects with the requirements of all applicable corporate and securities laws and administrative policies and directions, including, without limitation, the Securities Laws in relation to the issue of its securities;

     
  (o)     

PT is in material compliance with all applicable laws, regulations and statutes (including all environmental laws and regulations) in the jurisdictions in which it carries on business and which may materially affect PT, has not received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that could give rise to a notice of non- compliance with any such laws, regulations and statutes, and is not aware of any pending change or contemplated change to any applicable law or regulation or governmental position that would materially affect the business of PT or the business or legal environment under which PT operates;

     
  (p)     

PT has filed all federal, provincial, local and foreign tax returns which are required to be filed, or have requested extensions thereof, and have paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, or any amounts due and payable to any governmental authority, to the extent that any of the foregoing is due and payable;

     




  (q)     

PT does not have any loans or other indebtedness outstanding which has been made to any of its shareholders, officers, directors or employees, past or present, or any person not dealing at “arm’s length”, as such term is used in the Income Tax Act (Canada);

     
  (r)     

PT shall not take any action which would be expected to result in the delisting or suspension of its common shares on or from the CSE and PT shall comply, in all material respects, with the rules and regulations thereof;

     
  (s)     

PT has and will have filed all documents that are required to be filed under the continuous disclosure provisions of the Securities Laws, including annual and interim financial information, press releases disclosing material changes and material change reports;

     
  (t)     

PT has not incurred and will not incur any liability for brokers or finder’s fees of any kind whatsoever with respect to this Agreement or any transaction contemplated under this Agreement other than as provided for herein;

     
  (u)     

PT will not incur any liability for payment of severance or other compensation of any kind whatsoever to any directors officers or consultants of PT in connection with completion of the Acquisition or any of the matters contemplated by this Agreement;

     
  (v)     

PT’s constating documents are in the form contained in its minute book and no modifications or alterations have been proposed or approved by its shareholders;

     
  (w)     

upon their issuance, the PT Shares will be validly issued and outstanding as fully paid and non-assessable securities of PT registered as directed by the T3 Shareholders, free and clear of all liens, charges, escrow conditions or encumbrances of any kind whatsoever other than those imposed by applicable securities laws under the Securities Laws or the CSE;

     
  (x)     

upon their issuance, the Concurrent Financing securities will be validly issued and outstanding as fully paid and non-assessable securities of PT, free and clear of liens, charges, escrow conditions or encumbrances, other than imposed by applicable Securities Laws; and

     
  (y)     

since December 31, 2015, there has not been any Material Adverse Change of any kind whatsoever to the financial position or condition of PT or any damage, loss or other change of any kind whatsoever in circumstances materially affecting the business, assets or listing of PT or the right or capacity of PT to carry on its business; and

     
  (z)

except as disclosed in the PT Disclosure Record, there are no actions, suits or proceedings, judicial or administrative (whether or not purportedly on behalf of PT) pending or, to the knowledge of PT, threatened by or against PT, at law or in equity, or before or by any federal, provincial, state, municipal or other governmental court, department, commission, board, bureau, agency or instrumentality, domestic or foreign and PT is not aware of any existing ground on which any such action, suit or proceeding might be commenced with any reasonable likelihood of success.

   

 
6.2     

Concerning T3 - In order to induce PT to enter into this Agreement and complete its obligations hereunder, T3 represents and warrants to PT that:

 

 
  (a)     

T3 and the T3 Subsidiary have been duly organized, and are validly existing as corporations under the laws of each of their respective jurisdictions of incorporation and have full corporate power and authority to own each of their respective licenses and assets and conduct each of their respective businesses as now owned and conducted, and have all necessary corporate power to own the assets, licenses or interests presently

   

 




   

owned by T3 and the T3 Subsidiary. Neither T3 nor the T3 Subsidiary have engaged in any activities prohibited by law or by either its constating documents.

   

 
  (b)     

the entry into this Agreement does not violate Applicable Laws related to T3, T3 Subsidiary, and/or affecting both or either of their business, operations and assets including the Property;

     
  (c)     

T3 has the power, authority and capacity to enter into this Agreement;

     
  (d)     

the constating documents of T3 and the T3 Subsidiary as amended to the date hereof, copies of which have been delivered to PT, are complete and accurate;

     
  (e)     

T3 and the T3 Subsidiary are each not a “reporting issuer” under Securities Laws in any jurisdiction and there is no published market in respect of the T3 Shares, and the T3 Shares are not are listed or quoted on any stock exchange, quotation or trading system;

     
  (f)     

no order ceasing or suspending trading in securities of T3 or prohibiting the sale of securities by T3 has been issued and no proceedings for this purpose have been instituted, or are pending, or, to the knowledge of T3, after due inquiry, are contemplated or threatened;

     
  (g)     

the execution and delivery of this Agreement and all other related agreements or documents, and the completion of the transactions contemplated hereby, will by Closing have been duly and validly authorized by all necessary corporate acts on the part of T3, and this Agreement constitutes a legal, valid and binding obligation of T3, enforceable in accordance with its terms;

     
  (h)     

the authorized capital of T3 consists of an unlimited number of common shares of which 30,000,000 T3 Shares are duly and validly issued and outstanding as fully paid and non- assessable as at the date hereof. Other than as disclosed in Schedule “E”, there is no other agreement, obligation (contractual or otherwise), right or option, existing or pending pursuant to which T3 is or might be required to issue any further shares or other securities of its capital which would increase or decrease the issued and outstanding share capital of T3;

     
  (i)     

to the best of T3's knowledge and other than any power of attorney granted by the T3 Shareholders to Alejandro Ochoa pursuant to Part 12 of this Agreement, there is no shareholders' agreement in force with respect to T3;

     
  (j)     

neither T3 nor the T3 Subsidiary has ever declared a dividend;

     
  (k)     

except for the T3 Subsidiary, T3 has no and never has had any subsidiaries and neither T3 nor the T3 Subsidiary is a partner or participant in any partnership, joint venture, profit- sharing arrangement or other association of any kind;

     
  (l)     

T3 Subsidiary has no and never has had any subsidiaries;

     
  (m)     

the authorized capital of the T3 Subsidiary consists of an unlimited number of common shares of which one (1) is duly and validly issued and outstanding as fully paid and non- assessable as at the date hereof. There is no other agreement, obligation (contractual or otherwise), right or option, existing or pending pursuant to which the T3 Subsidiary is or might be required to issue any further shares or other securities of its respective capital;

     
  (n)     

no person owns, has or is entitled to any royalty, net profits interest, commission, fee, carried interest or any other Encumbrances or claims of any nature whatsoever which are

     




   

based on use of the Property or assets of T3 or the T3 Subsidiary or any revenue or rights attributed thereto or any deferred consideration which remains unpaid;

   

 
  (o)     

any and all operations of T3 and the T3 Subsidiary, and to the best of T3’s knowledge, any and all operations by third parties on or in respect of the business of T3 and the T3 Subsidiary, including the Property, have been conducted in accordance with good industry practice and in material compliance with Applicable Laws, except where the failure to so conduct the operations would not have a Material Adverse Effect on T3 or the T3 Subsidiary;

     
  (p)     

T3 has made available to PT all documents of title and other material documents and agreements in its possession related to T3’s and T3 Subsidiary’s business and those affecting the title of T3 and the T3 Subsidiary to their assets including the Property;

     
  (q)     

other than as contemplated in this Agreement, T3 does not have any agreements, options or commitments to acquire any shares or securities of any corporation or to acquire or lease any business operations, real property or assets;

     
  (r)     

no person other than T3 has or will have any agreement, option, understanding or commitment, royalty, or any right or privilege (whether by law, pre-emptive or contractual) capable of becoming an agreement, option or commitment for the acquisition of an interest in the T3 Subsidiary or the Property;

     
  (s)     

T3 and the T3 Subsidiary are duly licensed, registered and qualified, in all material respects, and possess all material certificates, authorizations, permits or license issued by the appropriate regulatory authorities in the jurisdictions necessary to enable their respective business to be carried on as now conducted and to enable their respective property and assets to be owned, leased and operated as they are now, and all such licenses, registrations and qualifications are in good standing, in all material respects and none of such licenses, registrations or qualifications contains any burdensome term, provision, condition or limitation which has or would reasonably be expected to have any Material Adverse Effect on the business of T3 or the T3 Subsidiary, as now conducted;

     
  (t)     

T3, after making all due inquiries, does have reason to believe that T3 and the T3 Subsidiary’s has valid and legal title to its Property and to provide its services through its business and using its Property, and holds the same free and clear of any claims by any party.

     
  (u)     

except as disclosed herein, there are no adverse, proprietary, possessory or other interests or agreements affecting the Property and no person is entitled to any royalty or other payment in the nature of rent or royalty from the Property or its usage by T3 or the T3 Subsidiary or the resulting company after the Acquisition;

     
  (v)     

T3 and T3 Subsidiary, as applicable, are the legal and beneficial owners of their respective assets including the Property and their respective businesses and operations free and clear from any Encumbrances;

     
  (w)     

except to the extent that any violation or other matter referred to in this subparagraph does not have a Material Adverse Effect on T3 or the T3 Subsidiary, in respect of T3 and the T3 Subsidiary:

     
  (i)     

they have not received any order or directive which relates to any material work, repairs, construction, or capital expenditures on the properties or assets of T3 and the T3 Subsidiary;





  (ii)     

they are not in violation of any applicable federal, provincial, state, territory, municipal or local laws, regulations, orders, government decrees, approvals, licenses, permits or ordinances with respect to environmental, health or safety matters (collectively, “ Environmental Laws ”);

   

 
  (iii)     

they have operated their business at all times and have received, handled, used, stored, treated, shipped and disposed of all contaminants without violation of Environmental Laws;

   

 
  (iv)     

there have been no spills, releases, deposits or discharges of hazardous or toxic substances, contaminants or wastes into the earth, air or into any body of water or any municipal or other sewer or drain water systems, in violation of any Environmental Laws, by T3 or the T3 Subsidiary that have not been remedied;

   

 
  (x)     

neither the execution and delivery of this Agreement, nor the completion of the transactions contemplated hereby will conflict with or result in any breach of any of the terms and provisions of, or constitute a default under, the constating documents, director or shareholder resolutions of T3 or the T3 Subsidiary, or any agreement or instrument to which T3 or the T3 Subsidiary is a party or by which the Property is bound or any order, decree, statute, regulation, covenant or restriction applicable to T3 or the T3 Subsidiary;

   

 
  (y)     

except as disclosed in writing to PT, T3 and the T3 Subsidiary have conducted and are conducting each of their respective businesses in compliance in all material respects with all Applicable Laws of each jurisdiction in which its business is carried on and holds all necessary licences, permits, approvals, consents, certificates, registrations and authorizations, whether governmental, regulatory or otherwise, to enable each to carry on their respective businesses as now conducted and their property and assets to be owned, leased and operated, and the same are validly existing and in good standing and none of such licenses, permits, approvals, consents, certificates, registrations and authorizations contain any burdensome term, provision, condition or limitation, which has or would reasonably be expected to have a Material Adverse Effect on the operation of its business as now carried on;

   

 
  (z)     

there is no suit, action, litigation, arbitration proceeding or governmental proceeding, including appeals and applications for review, in progress, or, to the knowledge of T3, pending or threatened against or relating to T3, the T3 Subsidiary or affecting the assets including the Property of T3 which if determined adversely to T3 or the T3 Subsidiary might have or might reasonably be expected to have a Material Adverse Effect on the properties including the Property, business, future prospects or the financial condition of T3 and there is no circumstance, matter or thing known to T3 which might give rise to any such proceeding or to any governmental investigation relative to T3 and there is not outstanding against T3 any judgment, decree, injunction, rule or order of any court, government department, commission, agency or arbitrator;

   

 
  (aa)     

to the knowledge of T3, there is not pending, threatened or contemplated, any suit, action, legal proceeding, litigation or governmental investigation of any sort which would:

   

 
  (i)     

in any manner restrain or prevent any of the T3 Shareholders from legally transferring the T3 Shares to PT in accordance with this Agreement;

     
  (ii)     

cause an Encumbrance to be attached to the Property, or the T3 Shares or the Escrow Shares;

     
  (iii)     

to make T3, the T3 Subsidiary or PT liable for damages in connection with the Acquisition;

     




  (bb)     

neither T3 nor the T3 Subsidiary is party to any loan agreement, credit agreement, hypothec agreement or other agreement of the same nature, other than: (i) as previously disclosed in writing to PT; (ii) as contemplated by the terms of this Agreement; or (iii) as may be entered into following the date hereof and disclosed to PT and agreed to by PT, acting reasonably;

     
  (cc)     

the Information Circular and the Listing Statement will contain a list of all material contracts, agreements and commitments (whether written or oral) to which either T3 or the T3 Subsidiary is a party, and all of such material contracts, agreements and commitments are in full force and effect and neither T3 nor the T3 Subsidiary is and will not be at Closing, in default under any of such contracts, agreements or commitments, save and except for any breach or default which is not material or which has been waived in writing by the other party to such contract, agreement or commitment;

     
  (dd)     

there does not exists any state of facts which after notice or lapse of time, or both, will constitute a material default or breach on the part of T3 under any of the provisions contained in any of the material contracts, commitments or agreements referred to in subsection 6.2(aa) hereof;

     
  (ee)     

the corporate records and minute books of T3 and the T3 Subsidiary contain, in all material respects, complete and accurate minutes of all material decisions made at any meeting of the directors, their respective manager(s) and investment committee(s), if any, and their shareholders since their date of incorporation, together with the full text of all resolutions of directors, their respective manager(s) and investment committee(s), if any, and shareholders passed in lieu of such meetings, duly signed;

     
  (ff)     

there is no pending disagreement between T3 and its auditors which could materially affect the financial situation of T3;

     
  (gg)     

since June 30, 2016, other than as disclosed in writing to PT prior to the date hereof, there has not been any Material Adverse Change in the condition or operation of T3 or the T3 Subsidiary or in their respective assets, liabilities or financial condition;

     
  (hh)     

neither T3 nor the T3 Subsidiary is in default or breach of its obligations under any material contracts to which it is a party and to the knowledge of T3, there exists no state of facts which, after notice or lapse of time or both, would constitute such a default or breach, and all such material contracts are now in good standing and in full force and effect without amendment thereto and T3 and the T3 Subsidiary are entitled to all benefits thereunder. Further, there are no outstanding material disputes under any such contracts and no Regulatory Approvals, releases, or waivers are necessary under such contracts with regard to the transactions described in this Agreement. T3 is not aware of any other party having an intention to terminate, either by notice or breach, any material contract made with T3 or made with the T3 Subsidiary;

     
  (ii)     

neither T3 nor the T3 Subsidiary is a party to any material contract except as described in Schedule “E”;

     
  (jj)     

both T3 and the T3 Subsidiary have filed with appropriate taxation authorities, federal, state, provincial and local, all returns, reports and declarations which are required to be filed by it and has paid all taxes which have become due and no taxing authority is asserting or has, to the knowledge of T3, threatened to assert, or has any basis for asserting against T3 or the T3 Subsidiary any claim for additional taxes or interest thereon or penalty;

     




  (kk)     

the T3 Financial Statements, when available, will be based on the books and records of T3 and the T3 Subsidiary, which are true and correct in every material respect, and will fairly present the assets and liabilities of T3 and the T3 Subsidiary, and the financial condition of T3 and the T3 Subsidiary at the date thereof and the results of the operations for such periods, in accordance with IFRS;

   

 
  (ll)     

neither T3 nor the T3 Subsidiary have any indebtedness, liabilities or obligations, secured or unsecured (whether accrued, absolute, contingent or otherwise) other than as previously disclosed in writing to PT, except for those incurred in the ordinary course of business and those incurred in connection with the transactions contemplated by this Agreement;

   

 
  (mm)     

neither T3 nor the T3 Subsidiary have or have ever had any employees and neither is a party to any written or verbal contracts of employment, whether contracts for service or management agreements;

   

 
  (nn)     

neither T3 nor the T3 Subsidiary have any obligations or liabilities to pay any amount to its officers, directors or employees relating to salary and directors' fees in the ordinary course, including but not limited to the obligations of T3 or the T3 Subsidiary to officers, directors or employees for severance, retention, termination or bonus payments as a result of the Acquisition;

   

 
  (oo)     

T3 has withheld from each payment to its officers, directors, employees and shareholders the amount of all taxes and other deductions required to be withheld therefrom and has paid the same to the proper receiving officer within the time required under applicable legislation;

   

 
  (pp)     

no unfair labour practice complaint against T3 is pending before any labour relations board or similar governmental tribunal or agency and no such complaint has been filed since the incorporation of T3, and no notice has been received by T3 of any complaints filed by any employees against T3 claiming that T3 has violated any employee or human rights or similar legislation in any jurisdiction in which the business of T3 is conducted, and no such complaint has been filed since the incorporation of T3; and

   

 
  (qq)     

neither T3 nor the T3 Subsidiary have, with respect to each of its businesses, assets including the Property, and operations, at any time received any written notice, written notice of default, order, summons, or notice of judgment or commencement of proceedings related to any material breach, liability or remedial action (or alleged material breach, liability or remedial action) arising under Environmental Laws, and neither T3 nor the T3 Subsidiary have with respect to such businesses, assets including the Property, and operations, at any time given any written undertakings with respect to remedying any breach of, or liability under, Environmental Laws that have not been duly performed. No hazardous substances have been used in the operation of T3’s or T3 Subsidiary's business except those hazardous substances used in the ordinary course of T3’s or T3 Subsidiary's business, and, to T3's knowledge, there has been no release of any such substances in the operation of its business in contravention or violation of any Applicable Laws.

   

 
6.3     

Concerning the T3 Shareholders - In order to induce PT to enter into this Agreement and complete its obligations hereunder, each of the T3 Shareholders severally (as opposed to jointly) represents and warrants to PT solely with respect to itself that:

 

 
  (a)     

the T3 Shareholder is the legal and beneficial owner of the T3 Shares registered in its name as set out in Schedule “A”, with the exception of shares registered in a brokerage or other custodial account, in which case the T3 Shareholder is a the sole beneficial holder of such T3 Shares free and clear of any Encumbrances;





  (b)     

the T3 Shareholder has the complete and unrestricted right, power and authority to transfer legal and beneficial title in and to its T3 Shares to PT, free and clear of all liens, claims, charges and Encumbrances whatsoever;

   

 
  (c)     

the T3 Shareholder has not granted to anyone any option or right to acquire any of its T3 Shares;

   

 
  (d)     

if a corporation, the T3 Shareholder has taken all necessary corporate action to permit and authorize the sale of its T3 Shares to PT;

   

 
  (e)     

neither the execution and delivery of this Agreement or any other agreements and instruments executed in connection with the Acquisition by the T3 Shareholder nor the performance by the T3 Shareholder of its obligations thereunder will conflict with or result in:

   

 
  (i)     

a violation, contravention or breach by the T3 Shareholder of any of the terms, conditions or provisions of any agreement or instrument to which it is a party, or by which it is bound or constitute a default by it thereunder, or, to the knowledge of the T3 Shareholder, after due inquiry, under any statute, regulation, judgment, decree or law by which it is subject or bound, or result in the creation or imposition of any mortgage, lien, charge or Encumbrance of any nature whatsoever upon the T3 shares it holds; or

   

 
  (ii)     

a violation by the T3 Shareholder of any law or regulation or any applicable order of any court, arbitrator or governmental authority having jurisdiction over it, or require the T3 Shareholder, prior to the Closing or as a condition precedent thereof, to make any governmental or regulatory filings, obtain any consent, authorization, approval, clearance or other action by any person or entity or await the expiration of any applicable waiting period;

   

 
  (f)     

this Agreement constitutes a valid and binding obligation of the T3 Shareholder enforceable against the T3 Shareholder in accordance with its terms subject, however, to limitations with respect to enforcement imposed by law in connection with bankruptcy, insolvency, reorganization or other laws affecting creditors' rights generally and to the extent that equitable remedies such as specific performance and injunctions are only available in the discretion of a court of competent jurisdiction from which they are sought;

   

 
  (g)     

there is not pending or, to the knowledge of the T3 Shareholder, after due inquiry, threatened or contemplated, any suit, action, legal proceeding, litigation or governmental investigation of any sort which would:

   

 
  (i)     

in any manner restrain or prevent the T3 Shareholder from legally transferring the T3 Shares held by it to PT in accordance with this Agreement;

   

 
  (ii)     

cause any Encumbrance to be attached to the T3 Shares held by it;

   

 
  (iii)     

affect title to the T3 Shares held by it; or

   

 
  (iv)     

make PT or T3 liable for damages in connection with the Acquisition;

   

 
  (h)     

the T3 Shareholder acknowledges and agrees to be bound by any restrictions on the resale of the PT Shares, including any escrow provisions set forth in Schedule “G”, issued to it on the completion of this Agreement that may be imposed by Applicable Laws, as contemplated by this Agreement, and the CSE;

   

 




  (i)     

the T3 Shareholder has been advised to obtain independent legal advice prior to entering into this Agreement, and has either obtained or waived its right to obtain such independent legal advice;

   

 
  (j)     

the offer to purchase the T3 Shareholder's T3 Shares by payment of the PT Shares being exchanged therefor was not made to the T3 Shareholder when either the T3 Shareholder or any beneficial purchaser for whom it is acting, if applicable, was in the United States and the individuals executing and delivering this Agreement on behalf of the T3 Shareholder or any beneficial purchaser for whom it is acting, if applicable, were not in the United States when this Agreement was executed and delivered;

   

 
  (k)     

the T3 Shareholder is not a U.S. Person, as defined under applicable United States securities laws, and is not purchasing the applicable PT Shares for the account or benefit of a U.S. Person or a person in the United States;

   

 
  (l)     

the information concerning T3, the T3 Subsidiary and the T3 Shareholders set forth in the Information Circular will contain no untrue statement of a material fact and will not omit to state a material fact that is required to be stated or that was necessary to make a statement herein not misleading in light of the circumstances in which it was to be made, and such information in the Information Circular will when finalized with input from each of PT, T3 and the T3 Shareholders constitute full, true and plain disclosure of all material facts relating to T3, the T3 Subsidiary and the T3 Shareholders therein.

   

 
6.4     

Survival — The representations and warranties made by the parties under this Part 6 are true and correct as of the Effective Date and will be true and correct at the Time of Closing as though they were made at that time, and should such not be the case, the parties to whom the representations and warranties were made shall be entitled, for a period of two years following the Closing, to seek remedy against that party for any such misrepresentation or breach of warranty. After the expiration of such two-year period, no party shall have any further liability with respect to any breach of any representation or warranty contained herein, except for those alleged breaches for which notice has been given prior to the end of such two-year period.

 

 
6.5     

No limit on rights — The parties jointly and severally acknowledge and agree, each with the other, that a party's investigations shall in no way limit or otherwise adversely affect that party's rights under the representations and warranties given to it by any other party under this Agreement.

 

 
6.6     

Limitations on Representations and Warranties — The parties shall not be deemed to have made any representation or warranty other than as expressly made in this Agreement.

 

 
7      

CLOSING

 

 
7.1     

Closing Date - The Closing shall take place at the Time of Closing on the Closing Date, or such other time, date or place as the parties may mutually agree upon.

 

 
7.2     

Location of Closing — The Closing shall take place at the offices of AFG Law LLP (“ AFG ”), Suite 605-815 Hornby St., Vancouver, BC, Canada or such other place that PT and T3 may mutually agree upon.

 

 
7.3     

Deliveries by T3 and the T3 Shareholders - At the Closing, T3 and the T3 Shareholders shall deliver to PT the following documents:

 

 
  (a)     

a certified true copy of the resolutions of the directors evidencing that the board of directors of T3 have approved this Agreement and all of the transactions of T3 and the T3 Shareholders contemplated hereunder, which resolutions will include specific reference to:

   

 




  (i)     

the sale and transfer of the T3 Shares from the T3 Shareholders to PT as provided for in this Agreement and the exchange of each outstanding convertible security of T3, if any, for an equivalent convertible security of PT, subject to adjustment (as to the number of PT Shares and the exercise price) in accordance with the Share Exchange Ratio;

   

 
  (ii)     

the cancellation of the certificates and any uncertificated shares (the “ Old T3 Share Certificates ”) representing the T3 Shares held by the T3 Shareholders; and

   

 
  (iii)     

the issuance of a new certificate (the “ New T3 Share Certificate ”) representing the T3 Shares registered in the name of PT;

   

 
  (b)     

the Old T3 Share Certificates, accompanied by a duly executed stock power of attorney, or alternatively, with the form of transfer on the reverse duly executed for transfer;

   

 
  (c)     

the New T3 Share Certificate;

   

 
  (d)     

copies of the Consideration Milestone Escrow Agreement and the Escrow Agreement executed by applicable T3 Shareholders;

   

 
  (e)     

an opinion letter from Colombian counsel for T3 dated as of the Closing Date, in a form acceptable to PT and its counsel, acting reasonably;

   

 
  (f)     

a certificate signed by two directors or officers of T3 confirming that the representations and warranties of T3 contained in this Agreement are true and correct in every respect as of the Time of Closing on the Closing Date, that T3 has complied with all covenants which must be complied with prior to Closing and that all conditions precedent in favour of T3 have been either fulfilled or are being waived by T3;

   

 
  (g)     

if the parties settle on a mutually acceptable form of closing agenda prior to the Time of Closing, then such other Closing documents as are listed on that closing agenda as closing documents to be delivered by T3;

   

 
  (h)     

if the parties choose not to or are unable to settle on a mutually acceptable form of closing agenda prior to the Time of Closing, then such other materials that are, in the opinion of PT acting reasonably, required to be delivered by the T3 Shareholders and by T3 in order for them to meet their obligations under this Agreement; and

   

 
  (i)     

duly executed copies of all Regulatory Approvals and any other approvals required by this Agreement to be obtained by T3 and/or T3 Shareholders, in form and substance reasonably satisfactory to PT.

   

 
7.4     

Deliveries by PT - At the Time of Closing on the Closing Date, PT shall deliver to T3 and the T3 Shareholders:

 

 
  (a)     

certified true copies of the resolutions of the directors of PT evidencing the approval of this Agreement and all of the transactions of PT contemplated hereunder, which resolutions will include, inter alia , specific reference to:

   

 
  (i)     

the Acquisition and the Concurrent Financing;

   

 
  (ii)     

the resignation and appointment of officers and directors described in Section 3.1 of this Agreement; and

   

 




  (b)     

a certified true copy of the resolutions of its shareholders evidencing the approval of the PT Shareholder Approval Matters;

   

 
  (c)     

copies of the Consideration Milestone Escrow Agreement and the Escrow Agreement executed by PT;

   

 
  (d)     

evidence of the CSE conditional approval of the Acquisition, the Name Change, and the Concurrent Financing;

   

 
  (e)     

a certificate signed by two directors or officers of PT confirming that PT is in a position to close the Concurrent Financing;

   

 
  (f)     

certificates or other evidence, which may be a signed treasury order sent to PT’s transfer agent, representing the PT Consideration Shares other than those PT Consideration Shares which are to be held by the Escrow Agent, registered (or in the case of a treasury order to be issued for registration) in the respective names of the T3 Shareholders;

   

 
  (g)     

a letter from the Escrow Agent, confirming that the PT Consideration Shares that are not eligible for release at Closing are being held by it pursuant to the Consideration Milestone Escrow Agreement and the Escrow Agreement;

   

 
  (h)     

a certificate signed by two directors or officers of PT confirming that the representations and warranties of PT contained in this Agreement are true and correct in every respect as of the Time of Closing on the Closing Date, that PT has complied with all covenants which must be complied with prior to Closing and that all conditions precedent in favour of PT have been either fulfilled or are being waived by PT; and

   

 

  (i)     

if the parties settle on a mutually acceptable form of closing agenda prior to the Time of Closing, then such other Closing documents as are listed on that closing agenda as closing documents to be delivered by PT.

   

 
8      

ORDINARY COURSE

 

 
8.1     

Except as contemplated herein or as agreed to in writing by T3 and PT, until the Closing, neither T3 nor PT shall, without the prior written consent of the other party, enter into any contract in respect of its business or assets (which includes in T3’s case the Property), other than in the ordinary course of business, and each party shall continue to carry on its business and maintain its assets (which includes in T3’s case the Property) in the ordinary course of business, with the exception of reasonable costs incurred in connection with the Acquisition and the Concurrent Financing, and, without limitation, but subject to the above exceptions, shall maintain payables and other liabilities at levels consistent with past practice, shall not engage in any extraordinary material transactions and shall make no distributions, dividends or special bonuses, shall not repay any shareholders' loans, or enter into or renegotiate any employment or consulting agreement with any senior officer, in each case without the prior written consent of the other.

 

 
9      

TERMINATION

 

 
9.1     

Termination — This Agreement may, prior to the Time of Closing, be terminated by mutual agreement of PT and T3, without further action on the part of the shareholders of PT or T3. This Agreement shall also terminate without further notice or agreement on the day (the “ Termination Date ”) on which the earliest of the following events occurs:

 

 
  (a)     

any applicable regulatory authority, including the CSE, having notified in writing any of the parties that it will not permit the Acquisition to proceed and all recourse or rights of appeal have been exhausted;

   

 




  (b)     

by PT on or before the end of the Due Diligence Period, upon written notice to T3, if PT is not satisfied, in its sole discretion, with the results of its due diligence review of T3;

   

 
  (c)     

upon written notice by PT if, at any time, there occurs a Material Adverse Change in the business, affairs or prospects of T3 prior to the Time of Closing;

   

 
  (d)     

the Acquisition is not approved by the shareholders of PT prior to the Closing Date;

   

 
  (e)     

by T3 on or before the end of the Due Diligence Period, upon written notice to PT, if T3 is not satisfied, in its sole discretion, with the results of its due diligence review of PT;

   

 
  (f)     

upon written notice by T3 if, at any time, there occurs a Material Adverse Change in the business, affairs or prospects of PT prior to the Time of Closing;

   

 
  (g)     

any conditions precedent set out in Sections 5.1, 5.2, and 5.3 hereof are not satisfied or waived on or before the Closing Date or such earlier date indicated therein; or

   

 
  (h)     

the Closing has not occurred on or before the Drop Dead Date, or such later date as may be approved in writing by PT and T3.

   

 
9.2     

Effect of Termination – Upon termination of this Agreement, the Parties shall have no further obligations to each other, other than in respect of the provisions of Part 11 and Sections 15.5 and 14.5 which shall survive the termination.

 

 
10      

STANDSTILL AGREEMENT

 

 
10.1     

Standstill – From the date of the acceptance of this Agreement until completion of the transactions contemplated herein or the earlier termination hereof, T3 and PT will not, directly or indirectly, solicit, initiate, assist, facilitate, promote or encourage proposals or offers from, entertain or enter into discussions or negotiations with, or provide information relating to its securities, business, operations, affairs or financial condition to any persons in connection with the acquisition or distribution of any securities of T3 or PT, or any amalgamation, merger, consolidation, arrangement, restructuring, refinancing, sale of any material assets of T3 or PT, unless such action, matter or transaction is part of the transactions contemplated in this Agreement or is satisfactory to, and is approved in writing in advance by the other party hereto (with such approval not being unreasonably withheld or delayed) or is necessary to carry on the normal course of business or is necessary to comply with the fiduciary duties of the directors and officers of T3 or PT.

 

 
10.2     

Break Fee – In the event that this Agreement is terminated by PT, except by mutual agreement or as contemplated by Section 9.1 herein, then PT shall pay to T3, within twenty (20) business days following the date of termination, the sum of $50,000 (the “ Break Fee ”). Similarly, in the event that this Agreement is terminated by T3 or the T3 Shareholders, except by mutual agreement or as contemplated by Section 9.1 herein, then T3 shall pay to PT within twenty (20) Business Days following the date of termination, an amount equal to the Break Fee.

 

 
11      

PUBLIC DISCLOSURE

 

 
11.1     

Disclosure - No disclosure or announcement, public or otherwise, in respect of this Agreement or the transactions contemplated herein will be made by any party without the prior written agreement of the other parties as to timing, content and method, provided that the obligations herein will not prevent any party from making, after consultation with the other parties or as to matters already consulted with the other parties, such disclosure as its counsel advises is required by applicable laws or the rules and policies of the CSE or as is required to carry out the transactions contemplated in this Agreement or the obligations of any of the parties hereto. The

 

 





 

Parties hereby agree to coordinate making public disclosure with respect to the Acquisition as soon as possible after the execution by the Parties of this Agreement. If any Party is required by Applicable Law to make a public announcement with respect to the Acquisition and the transactions contemplated herein, such Party will provide as much notice to the other Party as soon as reasonably possible, including the proposed text of the announcement.

 

 
11.2     

Confidentiality - Except with the prior written consent of the other parties, each of the parties and its respective employees, officers, directors, shareholders, agents, advisors and other representatives will hold all information received from the other party concerning any of PT, T3 or the T3 Shareholders in strictest confidence and such information shall be used only for the purposes of completing the Acquisition and will not be disclosed by the recipients thereof, except such information and documents available to the public other than through a breach of the confidentiality provisions of this Agreement or as are required to be disclosed by Applicable Laws. All such information in written or electronic form and documents will be promptly returned to the party originally delivering them in the event that the transactions provided for in this Agreement are not completed and in the case of electronic information be destroyed unless prohibited by Applicable Laws.

 

 

11.3     

Personal Information - Each of the T3 Shareholders hereby consents to the disclosure of his or her personal information in connection with the Acquisition and acknowledges and consents to the fact that T3 and PT are collecting the personal information (as that term is defined under applicable privacy legislation, including the Personal Information Protection and Electronic Documents Act (Canada) and any other applicable similar, replacement or supplemental provincial or federal legislation or laws in effect in Canada from time to time) of the T3 Shareholder for the purposes of completing this Agreement and the transactions contemplated hereby. Each T3 Shareholder acknowledges and consents to T3 and PT retaining such personal information for as long as permitted or required by Applicable Laws or reasonable business practices. Each T3 Shareholder further acknowledges and consents to the fact that T3 and PT may be required by Applicable Laws or the rules and policies of the CSE to provide regulatory authorities with any personal information provided by each T3 Shareholder in this Agreement and each T3 Shareholder further consents to the public disclosure of such information by electronic filing or by any other means.

 

 
12      

POWER OF ATTORNEY

 

 
12.1     

Any T3 Shareholder who cannot personally or, in the case such a shareholder is a non-individual who cannot through its representative, undertake its obligations under this Agreement shall hereby nominate, constitute and appoint without the need for any further action Alejandro Ochoa as such shareholder’s true and lawful attorney-in-fact and agent (the “ T3 Shareholder Attorney ”), with full power of substitution and re-substitution, and in such shareholder’s name, place and stead, to execute any and all documents, instruments and agreements relating to the Acquisition or this Agreement, including, without limitation, approving any amendment to this Agreement and executing duly executed stock powers of attorney authorizing the transfer to PT of T3 Shares held by each respective T3 Shareholder, with full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully and to all intents and purposes as each of the undersigned T3 Shareholders might or could do in person, and each of the undersigned T3 Shareholders hereby ratifies and agrees to ratify and confirm all that the said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

 
13      

Exemptions from Registration Requirements of U.S. Securities Laws

 

 
13.1     

The Parties hereto intend for the issuances and exchanges of shares contemplated hereby to be exempt from the registration requirements of any applicable United States federal and state securities laws and, accordingly, each agrees to take such further commercially reasonable actions (including the execution and delivery of such further instruments and documents) as any

 

 




 

other Party may reasonably request with regards to ensuring the availability of and maintaining such exemptions. The PT Shares to be issued to the T3 Shareholders that are outside the United States will be issued in “offshore transactions” (as such term is defined in Regulation S under the U.S. Securities Act) in reliance on Regulation S under the U.S. Securities Act, and the PT Shares to be issued to the T3 Shareholders that are in the United States will be issued to Accredited Investors in reliance on Rule 506(b) of Regulation D under the U.S. Securities Act. Each T3 Shareholder that is in the United States will be required to sign and deliver a certificate in the form attached hereto as Schedule “H” in order to make the necessary representations and warranties to confirm the availability of this exemption from registration under the U.S. Securities Act prior to receipt of the PT Shares. Each T3 Shareholder that does not sign and deliver such certificate will be deemed to be representing and warranting that such T3 Shareholder is not in the United States. The PT Shares to be issued to the T3 Shareholders in the United States in connection with the Amalgamation will be “restricted securities” within the meaning of Rule 144(a)(3) under the U.S. Securities Act. Each certificate representing such PT Shares issued to holders in the United States will bear a legend in substantially the form that follows:

 

 
 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS AND ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE U.S. SECURITIES ACT. THE HOLDER HEREOF, BY ACQUIRING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE ISSUER THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE ISSUER; (B) OUTSIDE THE UNITED STATES IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS; (C) IN COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS; (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT AND, IN THE CASE OF PARAGRAPH (C) OR (D), THE SELLER FURNISHES TO THE ISSUER AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO SUCH EFFECT.”

 

 
14      

INDEMNIFICATION

 

 
14.1     

PT agrees to indemnify and save harmless T3, and T3 similarly agrees to indemnify and save harmless PT, from and against all losses, claims, actions, causes of action and liabilities, including legal fees and disbursements, of any and all nature whatsoever, which the other may suffer, sustain or incur or which may be brought, made or asserted against the other as the result of any inaccuracy in any representation and warranty made in this Agreement by the indemnifying party, or which may be suffered or incurred as a result of, in respect of or arising out of any non- fulfillment of any covenant or agreement on the part of such indemnifying party, subject to the following limitations:

 

 
  (a)     

there shall be no obligation to indemnify in respect of a claim not made in writing within either (i) the two year survival period; or (ii) the period of 180 days from the date upon which the party claiming the indemnity first learned of the facts giving rise to the claim;

   

 
  (b)     

none of the T3 Shareholders or T3 shall be considered to be in breach of any representation or warranty concerning the assets or liabilities of T3 by reason of an inaccuracy in aggregate assets or aggregate liabilities which occurs in good faith and does not exceed $20,000; and

   

 




  (c)     

PT shall not be considered to be in breach of any representation and warranty concerning the assets or liabilities of PT by reason of an inaccuracy in aggregate assets or aggregate liabilities, which occurs in good faith and does not exceed $20,000.

   

 
15      

GENERAL

 

 
15.1     

Time - Time shall be of the essence of this Agreement and any waiver by the parties of this paragraph or any failure by them to exercise any of their rights under this Agreement shall be limited to the particular instance and shall not extend to any other instance or matter in this Agreement or otherwise affect any of their rights or remedies under this Agreement.

 

 
15.2     

Entire agreement - This Agreement and the agreements sets forth the entire agreement and understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings among the parties with respect to the matters herein, including the LOI, as amended, and there are no oral or written agreements, promises, warranties, terms, conditions, representations or collateral agreements whatsoever, express or implied, other than those contained in this Agreement.

 

 
15.3     

Independent Legal Advice

 

 
15.4     

Each of the parties to this Agreement acknowledges and agrees that AFG has acted as legal counsel to PT only, and that Miller Thomson LLP (“ MT ”) has acted as legal counsel to T3 only, and, and not to any other party to this Agreement, and that MT has not been engaged to protect the rights and interests of any of the other parties, meaning the individual T3 Shareholders. Each of the T3 Shareholders acknowledges and agrees that PT, T3, the other T3 Shareholders, AFG and MT have given them adequate opportunity to seek, and have recommended that they seek and obtain, independent legal and taxation advice with respect to the subject matter of this Agreement and for the purpose of ensuring their rights and interests are protected. Each of the T3 Shareholders represents and warrants to PT, T3, AFG and MT that they have sought independent legal and taxation advice or consciously chosen not to do so with full knowledge of the risks associated with not obtaining such independent legal and taxation advice.

 

 
15.5     

Further assurances - The parties hereto shall execute and deliver all such further documents and instruments and do all such acts and things as any party may, either before or after the Closing, reasonably require of the others in order that the full intent and meaning of this Agreement is carried out. The provisions contained in this Agreement which, by their terms, require performance by a party to this Agreement subsequent to the Closing of this Agreement, shall survive the Closing of this Agreement.

 

 
15.6     

Expenses – Each of the Parties agrees that, whether or not the Transaction is consummated, each will pay its own and its representatives’ fees and expenses, including any fees for advice or opinions incurred in connection with the negotiation, preparation, execution and delivery of this Agreement and any other agreements, documents, opinions or evaluations contemplated hereby, and in connection with the Acquisition and the transactions contemplated herein, subject to the Expense Reimbursement, if applicable.

 

 
15.7     

Amendments - No alteration, amendment, modification or interpretation of this Agreement or any provision of this Agreement shall be valid and binding upon the parties hereto unless such alteration, amendment, modification or interpretation is in written form executed by all of the parties to this Agreement.

 

 
15.8     

Notices - Any notice, request, demand, election and other communication of any kind whatsoever to be given under this Agreement shall be in writing and shall be delivered by hand, e-mail or by fax to the parties at their following respective addresses:

 

 




  To: T3 or the T3 Shareholders:
     
 

1060 Brickell Ave Suite 2501 Miami FL 33131

  Attention: Alejandro Ochoa
  Phone: (Colombia) +57-300-710-7169
    (USA) +1-786-280-2160
  Email: a.ochoa@towerthreewireless.com
     
 

with a copy to :

   
 

Miller Thomson LLP
1000 – 840 Howe St.
Vancouver BC
Attention : Gregory Smith
email : gsmith@millerthomson.com

  To: PT:
     
 

500-666 Burrard Street
Vancouver, BC
V6C3P6

  Attention: Brian Gusko
  Email: brian@howeandbayfinancial.com
     
 

with a copy to :

 

 

 

AFG Law LLP
605 – 815 Hornby St.
Vancouver BC
Attention : Nick Ayling
email : nick@afgllp.com

or to such other addresses as may be given in writing by the parties hereto in the manner provided for in this paragraph, and the party sending such notice should request acknowledgment of delivery and the party receiving such notice should provide such acknowledgment. Notwithstanding whether or not a request for acknowledgment has been made or replied to, whether or not delivery has occurred will be a question of fact. If a party can prove that delivery was made as provided for above, then it will constitute delivery for the purposes of this Agreement whether or not the receiving party acknowledged receipt after the following times have elapsed

  (i)     

Any such communication so given or made shall be deemed to have been given or made and to have been received on the day of delivery if delivered;

   

 
  (ii)     

on the day of faxing or sending by other means of recorded electronic communication, if faxed or sent prior to 4:30 p.m. on a business day, and otherwise such communication shall be deemed to have been given and made and to have been received on the next following business day; and

   

 
  (iii)     

E-mail notification is deemed to have been received when sent.

   

 
15.9     

Assignment - This Agreement may not be assigned by any Party hereto without the prior written consent of all of the Parties hereto.

 

 




15.10     

Governing law - This Agreement shall be subject to, governed by, and construed in accordance with the laws of the Province of British Columbia, Canada and the federal laws of Canada applicable therein, without giving effect to any rule or principle of the conflict of laws that would apply the laws of any other jurisdiction, and the parties hereto hereby attorn to the non-exclusive jurisdiction of the Courts of British Columbia in respect of any action relating to this Agreement or the transactions contemplated hereby, provided that nothing in this Agreement shall prevent either Party from seeking injunctive relief in the courts of any competent jurisdiction.

 

 
15.11     

Severability - If any provision (or parts thereof) contained in this Agreement should be invalid, illegal or unenforceable in any respect in any jurisdiction, the validity, legality and enforceability of such provision or provisions will not in any way be affected or impaired thereby in any other jurisdiction and the validity, legality and enforceability of the remaining provisions contained herein will not in any way be affected or impaired thereby, unless in either case as a result of such determination this Agreement would fail in its essential purpose.

 

 
15.12     

Enurement — This Agreement shall enure to the benefit of and be binding upon the parties hereto and their respective successors, permitted assigns, trustees, representatives, heirs and executors.

 

 
15.13     

Counterparts - This Agreement may be signed electronically and in counterpart, and each copy so signed shall be deemed to be an original, and all such counterparts together shall constitute one and the same instrument. This Agreement may be delivered by email.

(the remainder of this page is blank)





IN WITNESS WHEREOF the parties hereto have executed this Agreement as of the Effective Date first above written.

PACIFIC THERAPEUTICS LTD.  
     
Per: X  
  Authorized Signatory  
     
TOWER THREE SAS  
     
Per: /s/ Alejandro Ochoa  
  Authorized Signatory  
     
And by the following T3 Shareholders:  

 

SIGNED, SEALED AND DELIVERED )  
in the presence of )  
  )  
  )  
/s/ Camila Ochoa ) /s/ Alejandro Ochoa
Witness ) Alejandro Ochoa
     
SIGNED, SEALED AND DELIVERED )  
in the presence of )  
  )  
  )  
X ) /s/ Fabio Alexander Vasquez
Witness ) Fabio Alexander Vasquez

 

FOREMOST CAPITAL INC.  
     
Per: /s/ Yari Nieken  
  Authorized Signatory  
 

 

SIGNED, SEALED AND DELIVERED )  
in the presence of )  
  )  
  )  
  ) /s/ Yari Nieken
Witness ) Yari Nieken

 





SCHEDULE “A”

Holders of T3 Shares

      # of PT
Registered Name Shares Owned % Ownership Consideration
      Shares
Alejandro Ochoa 12,000,000 40% 12,000,000
Fabio Alexander Vasquez 12,000,000 40% 12,000,000*
Foremost Capital 3,000,000 10% 3,000,000
Yari Nieken 3,000,000 10% 3,000,000
Totals 30,000,000 100.00% 30,000,000

 

*     

to be issued to Executive Investment Partners Inc., a corporation controlled by Fabio Alexander Vasquez





SCHEDULE “B”

Description of T3 Property

Tower 1:BAR0460 ALTOS DE SEVILLA

Location: SOLEDAD, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Tower 2: VAL0118, RINCON DE ZIRUMA II

Location: VALLEDUPAR, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Tower 3: VAL0109 Mayales II

Location: VALLEDUPAR, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Tower 4: VAL0113 Don Alberto II

Location: VALLEDUPAR, Colombia

Status: Construction

Carrier: TIGO

Term of Lease: 13 years

 

Tower 5: VAL0117 El Paramo II





Location: VALLEDUPAR, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Tower 6: COR0160 Chinu – Santo Domingo

Location: Chinu, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Tower 7: BOG1671 BOG_ISABEL_PERDOMO

Location: BOGOTA, Colombia

Status: Construction

Carrier: TIGO

Terms of Lease: 13 years

 

Agreement With Public Lighting





SCHEDULE “C”

Issued & Outstanding Securities of PT

Class of Securities Authorized Number Outstanding
Class A Common Shares without par value Unlimited 6,735,885
Class B Series I Common Shares without par value 1,500,000 nil
Class B Series II Common Shares without par value 1,500,000 nil
Stock options* nil 13,333
Warrants** nil 368,333
     
Fully Diluted Share Capital   7,117,551

 

*     

exercisable at $3.00 per share until November 5, 2016

**     

exercisable at $3.00 per share until October 28, 2019





SCHEDULE “D”

Issued Securities of T3

Registered Name Shares Owned % Ownership
Alejandro Ochoa 12,000,000 40%
Fabio Alexander Vasquez 12,000,000 40%
Foremost Capital 3,000,000 10%
Yari Nieken 3,000,000 10%
Total 30,000,000 100.00%

 





SCHEDULE “E”

Material Contracts of T3

1. Tower Rental Contract with Colombia Movil S.A. E.S.P. (Sitio No. VAL0109)

2. Tower Rental Contract with Colombia Movil S.A. E.S.P. (Sitio No. VAL0113)

3. Tower Rental Contract with Colombia Movil S.A. E.S.P. (Sitio No. VAL0118)

4. Tower Rental Contract with Colombia Movil S.A. E.S.P. (Sitio No. VAL0117)

5. Tower Rental Contract with Colombia Movil S.A. E.S.P. (Sitio No. BAR0460)

6. Consulting agreement between T3 and Octavio De La Espriella

7. Consulting agreement between T3 and Miguel Caballos





SCHEDULE “F”

Consolidated Financial Statements for T3





TOWER THREE SAS

FINANCIAL STATEMENTS

December 31, 2015

(Expressed in Canadian Dollars)









TOWER THREE SAS
STATEMENT OF FINANCIAL POSITION
(Expressed in Canadian Dollars)

    December 31,  
  Notes   2015  
ASSETS
Current        

Due from related parties

5 $ 4,300  
    $ 4,300  
LIABILITIES
Current        

Due to related party

5 $ 21,151  
      21,151  
SHAREHOLDERS’ DEFICIENCY
Share capital 6   4,300  
Deficit     (21,151
      (16,851
    $ 4,300  

Nature and continuance of operations (Note 1)
Commitment (Note 10)
Subsequent events (Note 11)

Approved on behalf of the Board of Directors;

“Name”   “Name”  

THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS





TOWER THREE SAS
STATEMENT OF LOSS AND COMPREHENSIVE LOSS
(Expressed in Canadian Dollars)

    For the period from  
    incorporation on  
    December 30, 2015 to  
    December 31, 2015  
Expenses      
Legal fees $ 21,151  
       
Loss and comprehensive loss $ (21,151 )
       
Basic and diluted loss per share $ (2.12 )
       
Weighted average number of common shares outstanding   10,000  

THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS





TOWER THREE SAS
STATEMENT OF CASH FLOWS
(Expressed in Canadian Dollars)

    For the period from  
    Incorporation on  
    December 30, 2015 to  
    December 31, 2015  
       
Loss for the period $ (21,151 )
       
Changes in non-cash working capital item related to operations:      

Due to related parties

  21,151  
       
Cash used in operating activities   -  
       
Decrease in cash during the period   -  
       
Cash, beginning of the period   -  
       
Cash, end of the period $ -  
       
Supplemental disclosure of cash flow information:      

Non-cash transactions

     

Shares issued on incorporation

$ 4,300  

THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS





TOWER THREE SAS
STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIENCY
For the period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

    Number     Share              
    of Shares     Capital     Deficit     Total  
Balance, December 30, 2015   -   $ -   $ -   $ -  
 
Shares issued on incorporation   10,000     4,300     -     4,300  
 
Loss for the period   -     -     (21,151 )   -  
 
Balance, December 31, 2015   10,000   $ 4,300   $ (21,151 ) $ 4,300  

THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

1. NATURE AND CONTINUANCE OF OPERATIONS

Tower Three SAS (“Tower Three” or “the Company”) was incorporated on December 30, 2015 under the Business Corporation Act of Colombia. The head office of the Company is located at Carrera 8A #99-22 Unit 903, Bogota, Colombia.

Tower Three has secured 4G LTE cellular tower development contracts in Colombia. The Company focuses primarily on building towers in municipalities where there currently is very limited or no cellular coverage, which enhances the probability of multiple carriers sharing the tower and minimizes competitive risk.

These financial statements have been prepared on a going concern basis, which contemplates continuity of operations and the realization of assets and settlement of liabilities in the ordinary course of business. The continued operations of the Company are dependent on its ability to generate future cash flows or obtain additional financing. Management is of the opinion that sufficient working capital needs to be obtained from external financing to meet the Company’s liabilities and commitments as they become due. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern. These conditions indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern.

2. STATEMENT OF COMPLIANCE AND BASIS OF PRESENTATION

(a) Statement of Compliance

These financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and the interpretations of the International Financial Reporting Interpretations Committee (IFRIC”).

These financial statements were approved and authorized for issue by the Board of Directors on October 5, 2016

(b) Basis of Presentation

These financial statements were prepared on a historical cost basis, except for financial instruments classified as fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information. The financial statements are presented in Canadian dollars. The Company’s functional currency is the Colombian Peso.

(c) Use of Estimates and Judgements

The preparation of these financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of expenses during the period. These estimates are, by their nature, uncertain. The impact of such estimates are pervasive throughout the financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and future periods if the revision affects both current and future periods. These estimates are based on historical experience, current and future economic conditions and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Significant assumptions about the future and other sources of estimation uncertainty that management has made at the reporting date that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following:

a) the recognition and recoverability of the Company’s deferred tax assets





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

3. SIGNIFICANT ACCOUNTING POLICIES

The following is a summary of significant accounting policies used in the preparation of these financial statements:

Foreign exchange

The functional currency of an entity is the currency of the primary economic environment in which the entity operates. The presentation currency is the Canadian dollar and the functional currency of the Company is the Colombia Peso (“COP”). The functional currency determinations were conducted through an analysis of the consideration factors identified in IAS 21, The Effects of Changes in Foreign Exchange Rates.

Transactions in currencies other than the Colombian Peso are recorded at exchange rates prevailing on the dates of the transactions. On the translation from the functional currency of COP to Canadian dollars, revenue and expense items are translated at average rates of exchange where there is a reasonable approximation of the exchange rate at the dates of the transactions. Statement of financial position items are translated at closing exchange rates at the reporting date. Exchange differences on the re-translation at closing rates together with the difference between the revenue and expenses translated at average and closing rates are recorded in the currency translation reserve in shareholders’ deficiency.

Income taxes

Income tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.

Deferred tax is recorded for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Temporary differences are not provided for relating to goodwill not deductible for tax purposes, the initial recognition of assets or liabilities that affect neither accounting or taxable loss, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the statement of financial position date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered the deferred tax asset is not set up.

Loss per share

Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common shareholders by the weighted average number of shares outstanding during the reporting period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of stock options and warrants, if dilutive. The number of additional shares is calculated by assuming that outstanding stock options and warrants were exercised and that proceeds from such exercises were used to acquire common stock at the average market price during the reporting periods. For the periods presented, the calculations proved to be anti-dilutive.

Impairment

Non-financial assets are tested for impairment whenever events or changes in circumstances indicate that an asset’s carrying amount may be less than its recoverable amount. Management uses judgment to estimate these inputs and any changes to these inputs could have a material impact on the impairment calculation. For impairment testing, non-financial assets that do not generate independent cash flows are





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

grouped together into cash-generating units (CGUs), which represent the levels at which largely independent cash flows are generated. An impairment loss is recognized in earnings to the extent that the carrying value of an asset, CGU or group of CGU’s exceeds its estimated recoverable amount. The recoverable amount of an asset, CGU or group of CGU’s is the greater of its value in use and its fair value less cost to sell. Value in use is calculated as the present value of the estimated future cash flows discounted at appropriate discount rates. An impairment loss relating to a specific asset reduces the carrying value of the asset. An impairment loss relating to a group of CGU’s is allocated on a pro-rata basis to reduce the carrying value of the assets in the units comprising the group. A previously recognized impairment loss related to non-financial assets is assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss related to non-financial assets is reversed if there is a subsequent increase in the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying value does not exceed the carrying value that would have been determined, net of depreciation or amortization, if no loss had been recognized.

Financial instruments

(a) Financial assets

The Company classifies its financial assets in the following categories: held-to-maturity, fair value through profit or loss (“FVTPL”), loans and receivables, and available-for-sale (“AFS”). The classification depends on the purpose for which the financial assets were acquired. The Company's accounting policy for each category is as follows:

Fair value through profit or loss

This category comprises derivatives, or assets acquired or incurred principally for the purpose of selling or repurchasing it in the near term. They are carried in the statement of financial position at fair value with changes in fair value recognized through profit or loss.

Loans and receivables

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are carried at amortized cost less any provision for impairment. Individually significant receivables are considered for impairment when they are past due or when other objective evidence is received that a specific counterparty will default.

Held-to-maturity

These assets are non-derivative financial assets with fixed or determinable payments and fixed maturities that the Company's management has the positive intention and ability to hold to maturity. These assets are measured at amortized cost using the effective interest method. If there is objective evidence that the investment is impaired, determined by reference to external credit ratings and other relevant indicators, the financial asset is measured at the present value of estimated future cash flows. Any changes to the carrying amount of the investment, including impairment losses, are recognized through profit or loss.

Available-for-sale

Non-derivative financial assets not included in the above categories are classified as available-for- sale. They are carried at fair value with changes in fair value recognized directly in equity. Where a decline in the fair value of an available-for-sale financial asset constitutes objective evidence of impairment, the amount of the loss is removed from equity and recognized through other comprehensive income (loss).

Impairment of financial assets

A financial asset is assessed at each reporting date to determine whether there is any objective evidence that it is impaired. A financial asset could be impaired if objective evidence indicates that one or more events have had a negative effect on the estimated future cash flows of that asset.

An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows, discounted at the original effective interest rate.





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

Individually significant financial assets are tested for impairment on an individual basis. The remaining financial assets are assessed collectively in groups that share similar credit risk characteristics.

An impairment loss is reversed if the reversal can be related objectively to an event occurring after the impairment loss was recognized. For financial assets measured at amortized cost, this reversal is recognized in profit or loss.

(b) Financial liabilities

The Company classifies its financial liabilities into one of two categories, depending on the purpose for which the liability was acquired. The Company's accounting policy for each category is as follows: Fair value through profit or loss - This category comprises derivatives, or liabilities acquired or incurred principally for the purpose of selling or repurchasing it in the near term. They are carried in the statement of financial position at fair value with changes in fair value recognized through profit or loss.

Other financial liabilities: This category consists of liabilities carried at amortized cost using the effective interest method.

The Company classified its due to related party as other financial liabilities.

4. RECENT ACCOUNTING PRONOUNCEMENTS

At the date of authorization of these financial statements, the IASB and IFRIC have issued the following new and revised standards, amendments and interpretations which are not yet effective.

Effective for annual periods beginning on or after January 1, 2018

Effective for annual periods beginning on or after January 1, 2019.

(a)

IFRS 16, Leases :

 

 
 

IFRS 16 specifies how an IFRS reporter will recognize, measure, present and disclose leases. The standard provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term is 12 months or less or the underlying asset has a low value. Lessors continue to classify leases as operating or finance, with IFRS 16’s approach to lessor accounting substantially unchanged from its predecessor, IAS 17. The extent of the impact of adoption has not yet been determined.

The Company has not early adopted these standards, amendments and interpretations and anticipates that the application of these standards, amendments and interpretations will not have a material impact on the financial position and financial performance of the Company.





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

5. RELATED PARTY TRANSACTIONS

Related parties include key management, personnel, and affiliated companies. Key management personnel include officers, directors or companies with common directors of the Company who have direct or indirect authority and responsibility for planning, directing and controlling the activities of the Company.

During the period ended December 31, 2015, legal fees of $21,151 was paid to a director of the Company.

As at December 31, 2015, there was $21,151 due to an affiliated company which is included in due to related party and $4,300 due from related parties for the issuance of common shares.

6. SHARE CAPITAL

a) Authorized

10,000 common shares with a par value at COP 1,000 per common share

b) Issued

On December 30, 2015, the Company issued 10,000 common shares at COP 1,000 ($0.43) per share for gross proceeds of COP 10,000,000 ($4,300). The proceeds were included in due from related parties at December 31, 2015. (Note 5)

7. FINANCIAL INSTRUMENTS

The Company is exposed to varying degrees to a variety of financial instrument related risks: Credit risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge any obligations. The Company is currently not exposed to any credit risk. Interest rate risk Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Financial assets and liabilities with variable interest rates expose the Company to cash flow interest rate risk. The Company does not hold any financial liabilities with variable interest rates. The Company does maintain bank accounts which earn interest at variable rates but it does not believe it is currently subject to any significant interest rate risk.

Liquidity risk

The Company’s ability to continue as a going concern is dependent on management’s ability to raise required funding through future equity issuances and through short-term borrowing. The Company manages its liquidity risk by forecasting cash flows from operations and anticipating any investing and financing activities. Management and the Board of Directors are actively involved in the review, planning and approval of significant expenditures and commitments.

Fair value

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

The fair value of due from related party and due to related party approximates fair value due to the short term nature of the financial instruments. These accounts are classified as loans and receivables.

8. CAPITAL RISK MANAGEMENT

The Company defines its capital as shareholders’ deficiency. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the development of its technologies and to maintain a flexible capital structure for its projects for the benefit of its shareholders. As the Company is in the development stage, its principal source of funds is from the issuance of common shares.

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares, acquire or dispose of assets or adjust the amount of cash.

The Company is not subject to externally imposed capital requirements.

9. INCOME TAXES

A reconciliation of income taxes at statutory rates with the reported taxes is as follows:

          2015  
Loss for the period       $ (21,151)  
             
Expected income tax recovery       $ (5,000)  
Change in unrecognized deductible temporary differences         5,000  
Total income tax expense       $ -  
         
      Expiry Date  
    2015     Range  
Temporary Differences            
Non-capital losses available for future period   $ 21,000     No expiry date  

Tax attributes are subject to review, and potential adjustment, by tax authorities.

10. COMMITMENT

During the year ended December 31, 2015, the Company entered into a contract for legal services with a related party whereas the Company is required to pay US$15,000 ($21,151 CDN) on the signing of the agreement and six equal payments of US$3,000 commencing January 1, 2016 for a total of USD $18,000 ($24,954 CDN).

Subsequent to year end, the Company entered into construction contracts with Global Engineering Developments (“GLEND”) whereas the Company engaged GLEND to build six cellphone towers in Colombia for a total cost of $230,939.





TOWER THREE SAS
Notes to the Financial Statements
Period from incorporation on December 30, 2015 to December 31, 2015
(Expressed in Canadian Dollars)

11. SUBSEQUENT EVENTS

  (a)   

Subsequent to year end, the Company received total funding of USD $200,000 ($260,090) from an affiliated company. On June 14, 2016, the Company entered into a loan agreement whereby USD $100,000 ($135,045) of the advances would be due 90 days from the date of the agreement. The loan accrues interest at a rate of 10% per annum. If the loan is not repaid within the 90 days, a monthly penalty of 2% of the principal loan will be charged. The remaining USD $100,000 ($135,045) will be converted to equity upon the successful completion of a public listing transaction.

   

 
  (b)    

Subsequent to year end, the Company entered into six lease agreements with Columbia Movil whereas the Company will lease space on six separate cell phone towers for thirteen years. Colombia Movil will pay rent installments of COP 2,100,000 to COP 2,350,000 ($900 to $1,000) on a monthly basis. The agreements will come into effect on the year of completion of the cellphone towers.

   

 
  (c)   

On August 2, 2016, the Company announced that it entered into a letter of intent (the “LOI”) with Pacific Therapeutics Ltd. ("PTL") to acquire all of the issued and outstanding membership interests of the Company (the “Transaction”). PTL will have until October 30, 2016 to conduct due diligence on the Company, with a view to negotiating the terms of a definitive agreement in order to complete the Transaction.

   

 
    

Pursuant to the terms of the LOI, in consideration of the Transaction, PTL will issue 30,000,000 common shares at a deemed price of $0.10 per common share to the existing members of the Company on a pro-rata basis in exchange for 100% ownership of all of the issued and outstanding membership interests of the Company.

   

 




SCHEDULE “G”

Voluntary Pooling and Escrow Terms & Conditions

Consideration Milestone Escrow Agreement (Operations)

Shareholder Number of Release Milestones Percentage of Total
  Escrow Shares 20 new towers to be constructed Escrow Shares to be
    within 24 months of the Closing Date Released
Alejandro Ochoa 12,000,000 Upon final CSE approval of the Acquisition 50% of escrow shares
    20 additional towers constructed within 24 months of the Closing Date 50% of escrow shares
Executive Investment 12,000,000 Upon final CSE approval of the Acquisition 50% of escrow shares
    20 additional towers constructed within 24 months of the Closing Date 50% of escrow shares

Consideration Milestone Escrow Agreement (Financing)

Shareholder Number of Escrow Release Milestones Percentage of Total
  Shares $4,000,000 to be raised within 24 Escrow Shares to be
    months after the Closing Date Released
Foremost Capital 3,000,000 Closing of financing for $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares
Yari Nieken 3,000,000 Closing of financing for $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares
    Closing of financing for a further $1,000,000 25% of escrow shares

The Financing consideration milestones must be completed within 24 months of the Closing Date, and the Concurrent Financing shall be included in the $4,000,000 to be raised by Foremost Capital and Yari Nieken. For





greater certainty, in order to qualify for the release of shares from escrow, the financing must be initiated and led by Foremost Capital and Yari Nieken.

Following release of shares from the Consideration Milestone Escrow Agreement (Operations and Financing) the shares shall be held pursuant to the Escrow Agreement

Escrow Agreement

Release Dates Percentage of Total Escrow Securities to be
  Released
Upon Final CSE approval of the Acquisition 10% of escrow securities
6 Months after listing 15% of the remaining escrow securities
12 Months after listing 15% of the remaining escrow securities
18 Months after listing 15% of the remaining escrow securities
24 Months after listing 15% of the remaining escrow securities
30 Months after listing 15% of the remaining escrow securities
36 Months after listing 15% of the remaining escrow securities

 





SCHEDULE “H”

CERTIFICATE OF U.S. T3 SHAREHOLDER

TO: Pacific Therapeutics Ltd.
   
AND TO: Tower Three SAS

Pursuant to a share exchange agreement (the “ Agreement ”) among Pacific Therapeutics Ltd., a British Columbia corporation (the “ Issuer ”), Tower Three SAS (“ T3 ”), a company formed under the laws of Colombia and the shareholders of T3 (the “ Shareholders ”) pursuant to which the Shareholders will exchange their outstanding common shares of T3 (“ T3 Shares ”) for common shares of the Issuer (the “ PT Shares ”) (the “ Transaction ”). Immediately following the closing of the Transaction the name of the Issuer will be changed to “Tower One Wireless Corp.” or another name acceptable to the parties.

The representations, warranties and covenants in this Certificate will form the basis for the exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the “ U.S. Securities Act ”), and applicable state securities laws, for the issuance of the PT Shares to T3 Shareholders in exchange for the T3 Shares upon completion of the Transaction (the “ Exchange ”).

In connection with the Transaction and the Exchange, the undersigned T3 Shareholder, on its own behalf and on behalf of any beneficial holder for whom it is acting, represents and warrants to, and covenants with, the Issuer and T3 that:

1.     

It has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the PT Shares and it is able to bear the economic risk of loss of its entire investment.

 

 
2.     

The Issuer has provided to it the opportunity to ask questions and receive answers concerning the terms and conditions of the Exchange, and it has had access to such information concerning the Issuer as it has considered necessary or appropriate in connection with its investment decision to acquire the PT Shares.

 

 
3.

It understands that none of the PT Shares have been or will be registered under the U.S. Securities Act, or the securities laws of any state of the United States, and that the issuance of the PT Shares in exchange for the T3 Shares is being made only to “accredited investors”, as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (“ Accredited Investors ”), in reliance on the exemption from such registration requirements provided by Rule 506(b) of Regulation D under the U.S. Securities Act.

 

 
4.     

It is an Accredited Investor and is acquiring the PT Shares for its own account, or for the account of another Accredited Investor as to which the undersigned exercises sole investment discretion, for investment purposes only and not with a view to any resale, distribution or other disposition of the PT Shares in violation of the United States federal or state securities laws.

 

 
5.     

If the T3 Shareholder is an individual (that is, a natural person and not a corporation, partnership, trust or other entity), then it (and any beneficial holder on whose behalf it is acting) satisfies one or more of the categories of Accredited Investor indicated below (please place an “S” on the appropriate line(s) below that applies to the undersigned T3 Shareholder and a “BH” on the appropriate line(s) below that applies to the beneficial holder (if any)) :

 

 




  _____

A natural person whose individual “net worth”, or joint “net worth” with that person’s spouse, at the date of this Certificate exceeds US $1,000,000;

Note: For purposes of calculating “net worth” under this paragraph:

   

 
  (i)     

The person’s primary residence shall not be included as an asset;

   

 
  (ii)     

Indebtedness that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of the sale of securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and

   

 
  (iii)     

Indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability.

   

 
  _____

A natural person who had an individual income in excess of US $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of US $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year.

   

 
6.     

If the T3 Shareholder is a corporation, partnership, trust or other entity, then it (and any beneficial T3 Shareholder on whose behalf it is acting) satisfies one or more of the categories of Accredited Investor indicated below (please place an “S” on the appropriate line(s) below that applies to the undersigned T3 Shareholder and a “BH” on the appropriate line(s) below that applies to the beneficial holder (if any)) :

 

 
  _____

A bank as defined in section 3(a)(2) of the U.S. Securities Act, or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the U.S. Securities Act whether acting in its individual or fiduciary capacity;

   

 
  _____

A broker or dealer registered pursuant to section 15 of the United States Securities Exchange Act of 1934, as amended;

   

 
  _____

An insurance company as defined in section 2(a)(13) of the U.S. Securities Act;

   

 
  _____

An investment company registered under the United States Investment Company Act of 1940, as amended, or a business development company as defined in Section 2(a)(48) of that Act;

   

 
  _____

A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the United States Small Business Investment Act of 1958, as amended;

   

 
  _____

A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of US $5,000,000;

   

 
  _____

An employee benefit plan within the meaning of the United States Employee Retirement Income Security Act of 1974, as amended, if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of US $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;

   

 




  _____

An organization described in Section 501(c)(3) of the United States Internal Revenue Code of 1986, as amended (the “ Code ”), a corporation, a Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring PT Shares, with total assets in excess of US $5,000,000;

   

 
  _____

A trust that (a) has total assets in excess of US $5,000,000, (b) was not formed for the specific purpose of acquiring the Shares, and (c) whose purchase is directed by a person who has such knowledge and experience in financial and business matters that he/she is capable of evaluating the merits and risks of an investment in the PT Shares;

     
  _____

A private business development company as defined in Section 202(a)(22) of the United States Investment Advisers Act of 1940, as amended; or

     
  _____

An entity in which all of the equity owners satisfy the requirements of one or more of the foregoing categories set forth in paragraph 5 of this Certificate and/or this paragraph 6.

   

 
7.     

It is not acquiring the PT Shares as a result of any form of “general solicitation or general advertising” (as such terms are used in Regulation D under the U.S. Securities Act), including, without limitation, advertisements, articles, notices or other communications published in any newspaper, magazine or similar media or on the Internet, or broadcast over radio, television or the Internet, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising.

 

 
8.     

It agrees that if it decides to offer, sell, pledge or otherwise transfer any of the PT Shares, it will not offer, sell, pledge or otherwise transfer any of such PT Shares, directly or indirectly, unless the transfer is made:

 

 

(a) to the Issuer;

(b) outside the United States in a transaction meeting the requirements of Rule 904 of Regulation S under the U.S. Securities Act and in compliance with applicable local laws and regulations;

(c) pursuant to the exemption from the registration requirements of the U.S. Securities Act provided by Rule 144 thereunder, if available, and in accordance with any applicable state securities laws; or

(d) in a transaction that does not require registration under the U.S. Securities Act or any applicable state securities laws; and

 

it has prior to such transfer pursuant to subsection (c) or (d) furnished to the Issuer an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Issuer to such effect.

 

 
9.     

The certificates representing the PT Shares, and any certificates issued in exchange or substitution for such securities, will bear a legend in substantially the following form:

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS AND ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE U.S. SECURITIES ACT. THE HOLDER HEREOF, BY ACQUIRING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE ISSUER THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE ISSUER; (B) OUTSIDE THE UNITED STATES IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS; (C) IN COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE,





AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS; (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT AND, IN THE CASE OF PARAGRAPH (C) OR (D), THE SELLER FURNISHES TO THE ISSUER AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO SUCH EFFECT. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE GOOD DELIVERY IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA.”

If the PT Shares are being sold in compliance with the requirements of Rule 904 of Regulation S under the U.S. Securities Act and in compliance with Canadian local laws and regulations, the legend may be removed by providing a declaration to the Issuer and its transfer agent substantially in the form set forth in Exhibit I hereto (or as the Issuer may prescribe from time to time), and, if requested by the Issuer’s transfer agent, an opinion of counsel of recognized standing, in form and substance reasonably satisfactory to the Issuer, to the effect that the transfer is being made in compliance with Rule 904 of Regulation S under the U.S. Securities Act.

If any of the PT Shares are being sold pursuant to Rule 144 under the U.S. Securities Act, if available, the legend may be removed by delivery to the Issuer and its transfer agent of an opinion of counsel of recognized standing, in form and substance reasonably satisfactory to the Issuer, to the effect that the legend is no longer required under applicable requirements of the U.S. Securities Act or state securities laws.

10.     

It consents to the Issuer making a notation on its records or giving instructions to its transfer agent in order to implement the restrictions on transfer set forth and described in this Certificate.

 

 
11.     

It understands and agrees that there may be material tax consequences to the T3 Shareholder of the acquisition, holding, exercise or disposition of the PT Shares, and that it is the sole responsibility of the T3 Shareholder to determine and assess such tax consequences as may apply to its particular circumstances. The Issuer does not give any opinion or make any representation with respect to the tax consequences to the T3 Shareholder under United States, state, local or foreign tax law of the undersigned’s acquisition, holding, exercise or disposition of such PT Shares; in particular, no determination has been made whether the Issuer will be a “passive foreign investment company” within the meaning of Section 1297 of the Code.

 

 
12.     

It understands that the financial statements of the Issuer have been prepared in accordance with International Financial Reporting Standards, which differ in some respects from United States generally accepted accounting principles, and thus may not be comparable to financial statements of United States companies.

 

 
13.     

The T3 Shareholder is in the United States. The address at which the T3 Shareholder received and accepted the offer to acquire the PT Shares is the address listed on the execution page of this Certificate.

 

 
14.     

It understands that the PT Shares are “restricted securities”, as defined in Rule 144(a)(3) under the U.S. Securities Act, and that the T3 Shareholder may dispose of the PT Shares only pursuant to an effective registration statement under the U.S. Securities Act or an exemption from the registration requirements of the U.S. Securities Act. The T3 Shareholder understands and acknowledges that the Issuer is not obligated to file and has no present intention of filing with the United States Securities and Exchange Commission or with any state securities administrator any registration statement in respect of resales of the PT Shares in the United States. Accordingly, the T3 Shareholder understands that absent registration under the U.S. Securities Act or an exemption therefrom, the T3 Shareholder may be required to hold the PT Shares indefinitely.

 

 




15.     

It understands that (i) if the Issuer is deemed to be an issuer that is, or that has been at any time previously, an issuer with no or nominal operations and no or nominal assets other than cash and cash equivalents (a “ Shell Company ”), Rule 144 under the U.S. Securities Act may not be available for resales of the PT Shares, and (ii) the Issuer is not obligated to make Rule 144 under the U.S. Securities Act available for resales of the PT Shares. Because the Issuer is considered to have been a “capital pool company” prior to the Transaction, the Issuer would be considered to have been a Shell Company, and consequently, Rule 144 under the U.S. Securities Act is not available for resales of the PT Shares unless and until the Issuer has satisfied the applicable conditions set forth in Rule 144 under the U.S. Securities Act or in other guidance issued by the United States Securities and Exchange Commission. In general terms, the satisfaction of such conditions would require the Issuer to have been a registrant under the United States Securities Exchange Act of 1934, as amended, for at least 12 months, to be in compliance with its reporting obligations thereunder, and to have filed certain information with the United States Securities and Exchange Commission at least 12 months prior to the intended resale (or to have satisfied similar requirements under applicable Canadian securities laws). As a result, Rule 144 under the U.S. Securities Act may never be available for resales of the PT Shares.

 

 

16.     

It understands that the Issuer is incorporated under the laws of Canada, that substantially all of the Issuer’s assets are located outside the United States and that most or all of its directors and officers are residents of countries other than the United States, and, as a result, it may be difficult for the T3 Shareholder to effect service of process within the United States upon the Issuer or its directors or officers, or to realize in the United States upon judgments of courts of the United States predicated upon civil liability of the Issuer and its directors and officers under the U.S. federal securities laws.

 

 
17.     

It understands that no agency, governmental authority, regulatory body, stock exchange or other entity (including, without limitation, the United States Securities and Exchange Commission or any state securities commission) has made any finding or determination as to the merit of investment in, nor have any such agencies or governmental authorities made any recommendation or endorsement with respect, to the PT Shares.

 

 
18.     

If required by applicable securities legislation, regulatory policy or order or by any securities commission, stock exchange or other regulatory authority, it will execute, deliver and file and otherwise assist the Issuer in filing reports, questionnaires, undertakings and other documents with respect to the issue of the PT Shares.

 

 
19.     

It understands and acknowledges that it is making the representations and warranties and agreements contained herein with the intent that they may be relied upon by the Issuer and T3 in determining its eligibility to acquire the PT Shares in exchange for the T3 Shares upon completion of the Transaction. It understands that the representations, warranties and covenants made by the T3 Shareholder in this Certificate will form the basis of the exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws for the issuance of the PT Shares in exchange for the T3 Shares following completion of the Transaction.

 

 

United States ” means the United States of America, its territories and possessions, any State of the United States and the District of Columbia.

The statements made in this Certificate are true and accurate to the best of my information and belief and I will promptly notify the Issuer and T3 of any changes in any representation, warranty, agreement or other information relating to the undersigned set forth herein which takes place prior to the acquisition of the PT Shares.

In order to receive their PT Shares, each T3 Shareholder that is in the United States must complete and sign this Certificate.





Capitalized terms used in this Schedule C and not defined herein have the meaning ascribed thereto in the Certification to which this Schedule is annexed.

ONLY U.S. T3 SHAREHOLDERS NEED COMPLETE AND SIGN

Dated _____________________________, 20__

  X
  Signature of individual (if T3 Shareholder is an individual)
   
  X
  Authorized signatory (if T3 Shareholder is not an individual)
   
   
  Name of T3 Shareholder ( please print )
   
   
  Name of authorized signatory ( please print )
   
   
  Official capacity of authorized signatory ( please print )

 





EXHIBIT I

TO SCHEDULE H

DECLARATION FOR REMOVAL OF LEGEND

TO: Computershare Investor Services Inc., as registrar and transfer agent for the common shares of the Pacific Therapeutics Ltd. (to be renamed Tower One Wireless Corp.).
   
AND TO: Pacific Therapeutics Ltd. (to be renamed Tower One Wireless Corp.) (the “Issuer”)

The undersigned (A) acknowledges that the sale of the common shares of the Issuer represented by certificate number _______________, to which this declaration relates, is being made in reliance on Rule 904 of Regulation S under the United States Securities Act of 1933, as amended (the “ U.S. Securities Act ”), and (B) certifies that (1) the undersigned is not an “affiliate” (as that term is defined in Rule 405 under the U.S. Securities Act) of the Issuer; (2) the offer of such securities was not made to a person in the United States and either (a) at the time the buy order was originated, the buyer was outside the United States, or the seller and any person acting on its behalf reasonably believed that the buyer was outside the United States, or (b) the transaction was executed on or through the facilities of the TSX Venture Exchange, the Canadian Securities Exchange or another designated offshore securities market (as such term is defined in Regulation S under the U.S. Securities Act) and neither the seller nor any person acting on its behalf knows that the transaction has been prearranged with a buyer in the United States; (3) neither the seller nor any affiliate of the seller nor any person acting on their behalf has engaged or will engage in any directed selling efforts in the United States in connection with the offer and sale of such securities; (4) the sale is bona fide and not for the purpose of “washing off” the resale restrictions imposed because the securities are “restricted securities” (as that term is defined in Rule 144(a)(3) under the U. S. Securities Act); (5) the seller does not intend to replace such securities with fungible unrestricted securities; and (6) the contemplated sale is not a transaction, or part of a series of transactions, which, although in technical compliance with Regulation S under the U.S. Securities Act, is part of a plan or scheme to evade the registration provisions of the U.S. Securities Act. Terms used herein have the meanings given to them by Regulation S under the U.S. Securities Act.

      X
      Signature of individual (if T3 Shareholder is an individual)
Dated:      
      X
      Authorized signatory (if T3 Shareholder is not an individual)
       
       
      Name of T3 Shareholder (please print)
       
       
      Name of authorized signatory (please print)
       
       
      Official capacity of authorized signatory (please print)

 




Exhibit 8.1

TOWER ONE WIRELESS CORP.
LIST OF SIGNIFICANT SUBSIDIARIES

    Proportion
  Country of of Voting
Subsidiaries Incorporation Interest
Tower Two SAS Argentina 100%
Tower Three SAS Columbia 100%

 




Exhibit 12.1

CERTIFICATION OF ANNUAL REPORT

I, Alejandro Ochoa, certify that:

1.      I have reviewed this annual report on Form 20-F of Tower One Wireless Corp. (the “Registrant”);
 
2.      Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
3.      Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this annual report;
 
4.      The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
 
  a)      Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
   
  b)      Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  c)      Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and
   
  d)      Disclosed in this annual report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of this annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
   
5.      The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
 
  a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
   
  b)      Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: September 8, 2017

  /s/ Alejandro Ochoa
  Alejandro Ochoa
  Chief Executive Officer
   
   


Exhibit 12.2

CERTIFICATION OF ANNUAL REPORT

I, Abbey Abdiye, certify that:

1.      I have reviewed this annual report on Form 20-F of Tower One Wireless Corp. (the “Registrant”);
 
2.      Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
3.      Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this annual report;
 
4.      The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
 
  a)      Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
   
  b)      Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  c)      Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and
   
  d)      Disclosed in this annual report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of this annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
   
5.      The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
 
  e)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
   
  a)      Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: September 8, 2017

  /s/ Abbey Abdiye
  Abbey Abdiye
  Chief Financial Officer

2




Exhibit 13.1



CERTIFICATION OF PERIODIC REPORT PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

I, Alejandro Ochoa , Chief Executive Officer of Tower One Wireless Corp. (the “Company”), certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 , that, to my knowledge:

(1)      the annual report on Form 20-F of the Company for the year ended December 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Dated: September 8, 2017

  /s/ Alejandro Ochoa
  Alejandro Ochoa
  Chief Executive Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Tower One Wireless Corp. and will be retained by Tower One Wireless Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

3




Exhibit 13.2


CERTIFICATION OF PERIODIC REPORT PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

I, Abbey Abdiye, Chief Financial Officer of Tower One Wireless Corp. (the “Company”), certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 , that, to my knowledge:

(1)      the annual report on Form 20-F of the Company for the year ended December 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Dated: September 8, 2017

  /s/ Abbey Abdiye
  Abbey Abdiye
  Chief Financial Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Tower One Wireless Corp. and will be retained by Tower One Wireless Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

4




Exhibit 15.1

J AMES S TAFFORD
 

James Stafford, Inc.
Chartered Professional Accountants
Suite 350 – 1111 Melville Street
Vancouver, British Columbia
Canada V6E 3V6
Telephone +1 604 669 0711
Facsimile +1 604 669 0754
www.JamesStafford.ca

8 September 2017

Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549

Subject: Tower One Wireless Corp. (the “Company”)

Dear Sirs:

We have read Item 16F – Change in Registrant’s Certifying Accountant of the Form 20-F –Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Form 20-F”) of the Company dated 8 September 2017 and provide the following comments:

We agree with the statements concerning our Firm concerning our Firm in the Form 20-F dated 8 September 2017.

We have no basis on which to agree or disagree with other statements of the registrant contained therein.

Yours truly,

/s/ James Stafford
Chartered Professional Accountants





Exhibit 15.2